HTML

Egyik 19

Magyarországról, utódállami területekről, Európáról, Európai Unióról, további földrészekről, globalizációról, űrről (kiemelten: a Covid-19 világjárványról)

Friss topikok

Címkék

1956 (78) accademiaungheresedellescienze (1) ádeniöböl (1) adriaitenger (10) adriaticsea (4) aegeansea (3) aegyptus (1) afganisztán (62) afghanistan (49) africa (49) afrika (70) agriculture (1) ajurabirodalom (1) akabaiöböl (1) alánia (1) alaptörvény (36) albánia (18) albania (10) algeria (6) algéria (12) algérie (2) alkotmány (24) alkotmánybíróság (19) államadósság (2) állambiztonságiszolgálatoktörténetilevéltára (5) államiszámvevőszék (5) állandóválasztottbíróság (1) állat (2) állatorvostudományiegyetem (1) allemagne (1) alpok (3) altai (1) altáj (2) amazon (2) amazonas (1) americae (1) americanhungarianfederation (1) americansamoa (1) americas (2) amerika (9) amerikahangja (1) amerikaimagyarkoalíció (1) amerikaimagyarmúzeum (1) amerikaimagyarszépművesczéh (1) amerikaimagyarszövetség (2) amnestyinternational (8) andorra (2) andrássygyulabudapestinémetnyelvűegyetem (1) angara (1) anglia (6) angola (4) antarctic (6) antiguaésbarbuda (1) antiókhiaifejedelemség (1) appenines (1) aquincumimúzeum (1) arabfélsziget (1) arabianpeninsula (1) arabköztársaságokszövetsége (1) araltó (1) arctic (14) arcticocean (1) ardeal (3) argentina (19) argentine (1) armenia (8) árpádvonal (1) asia (38) asianinfrastructureinvestmentbank (1) assyria (1) asteroid (18) athén (1) atlanticocean (9) atlantióceán (10) atom (1) audio (1) australia (40) austria (54) austrohungarianmonarchy (3) ausztrália (33) ausztria (132) autonómia (32) autonomy (3) azerbaijan (11) azerbajdzsán (12) azovitenger (5) ázsia (56) babesbolyaitudományegyetem (1) babilon (1) babilónia (1) badeniőrgrófság (1) bahamas (2) bahamaszigetek (1) bahrain (6) bahrein (2) bajkáltó (1) bajorország (3) balassiintézet (6) balaton (7) balcans (19) balkán (55) baltics (16) balticsea (7) baltikum (20) baltitenger (15) balti államok (1) banat (3) banglades (9) bangladesh (9) bánság (17) baptistaszeretetszolgálat (1) barentssea (4) barentstenger (2) barlang (1) bashichannel (1) batthyáneum (3) bayofbengal (2) bécsimagyartörténetiintézet (1) békásszoros (1) belarus (16) belgakongó (1) belgium (74) belgrádimagyarkulturálisintézet (1) belize (1) benesdekrétumok (4) beringszoros (1) besszarábia (6) bethlengáboralap (3) bevándorlásihivatal (7) bhután (1) bhutan (1) Biblia (7) bissauguinea (1) bizánc (2) bizáncibirodalom (2) blacksea (26) bluestream (1) boek (1) bog (1) bok (1) bolivia (5) bolyaiegyetem (2) bolyaitudományegyetem (2) book (52) bősnagymaros (1) bosniaandherzegovina (5) bosphorus (2) bosporus (2) bosznia (5) boszniahercegovina (21) boszporusz (1) brandenburg (1) brazil (26) brazília (32) britbirodalom (3) britishpetroleum (2) britszomália (1) brunei (3) buch (13) budapest (1) budapestfővároslevéltára (1) budapesthistorymuseum (2) budapesticorvinusegyetem (2) budapestiközlekedésiközpont (1) budapestiműszakiésgazdaságtudományiegyetem (4) budapestitörténetimúzeum (2) budapestneutroncentre (1) budapestostroma (2) bukovina (1) bulgária (68) bulgaria (26) bulgarianacademyofsciences (1) burkinafaso (1) burma (4) burundi (2) burzenland (1) byzantium (1) caboverde (1) calvinjteológiaiakadémia (1) cambodia (2) cameroon (1) canada (51) canto (1) caribbean (1) caribbeansea (4) caritashungarica (1) carpathianbasin (5) carpathians (1) carte (7) cartoon (1) caspiansea (7) catalonia (4) caucasus (8) centralafricanrepublic (1) centralbankofhungary (1) chevron (2) chile (25) china (151) chinoingyógyszergyár (1) chorwerke (1) címer (1) Címkék (2) ciprus (14) collègebaronjózsefeötvös (1) colombia (6) comet (6) communism (3) communist (7) constitution (1) costarica (8) crimea (5) crisana (1) croatia (18) csád (2) csángórádió (2) csecsenföld (2) csehország (75) csehszlovákia (41) csendesóceán (11) csónak (1) cuba (6) cyprus (15) czechia (24) czechoslovakia (4) dal (8) dalszöveg (1) dance (13) dánia (22) danube (31) danubianresearchcenter (1) dardanelles (3) debreceniegyetem (8) debrecenireformátuskollégium (1) defenseadvancedresearchprojectsagency (1) délafrika (14) délamerika (21) déliáramlat (23) déljemen (1) délkínaitenger (5) délkorea (12) délszudán (2) délvidék (53) democraticrepublicofcongo (5) demográfia (1) denmark (26) deutschland (5) dévaiszentferencalapítvány (3) djibouti (2) dobrudzsa (1) dominica (3) don (2) donau (1) dráva (1) drávaszög (2) dubai (5) dubliniegyezmény (2) duna (80) dunaipolynemzetipark (2) dunamédiaszolgáltatónonprofitzrt (1) dunamellékireformátusegyházkerület (1) dunamúzeum (1) dunatelevízió (5) dzsibuti (1) earth (83) earthquake (29) eastchinasea (3) eastgermany (1) easttimor (5) ebolajárvány (2) ecocalipse (2) ecuador (14) ég (22) égeitenger (4) egészségügy (2) egészségügyivilágszervezet (9) egriérsekség (1) egyenlítőiguinea (1) egyesültállamok (294) egyesültarabemírségek (12) egyesültarabköztársaság (2) egyesültkirályság (15) egyesültnemzetekszervezete (46) egyházikönyvtárakegyesülése (1) egyiptom (58) egyiptom(hellenisztikus) (1) egypt (32) ekokalipszis (1) elba (1) elsővilágháború (72) emberijogokeurópaibírósága (10) ének (13) england (5) englishchannel (3) ensz (54) eötvösjózsefcollegium (5) eötvöslorándtudományegyetem (15) eötvösloránduniversity (1) építészet (12) equatorialguinea (1) erdély (271) erdélyimagyarközművelődésiegyesület (2) erdélyimagyarműszakitudományostársaság (1) erdélyimagyarnemzetitanács (17) erdélyimagyarnyelvmívelőtársaság (1) erdélyiművészetiközpont (2) erdélyimúzeumegyesület (19) erdélyinemzetimúzeum (1) erdélyinemzetimúzeumkézirattára (1) erdélyinemzetimúzeumlevéltára (1) erdélyireformátusegyházkerület (18) erdélyirómaikatolikusegyházmegye (2) erdélyirómaikatolikuspüspökség (1) erdélyirómaikatolikusstátus (1) erdélyiszépmívescéh (1) eritrea (17) estonia (17) eswatini (1) északamerika (9) északiáramlat (9) északiáramlat2 (1) északisark (5) északitenger (3) északjemen (1) északkorea (9) északmacedónia (2) északvietnam (1) esztergomiérsekség (1) esztergomifőegyházmegyeikönyvtár (1) eszterházakulturáliskutatóésfesztiválközpont (1) eszterházykárolyegyetem (1) észtország (18) ethiopia (8) etiópia (8) eufrátesz (3) euphrates (8) eurasia (9) eurázsia (21) európa (345) europa (4) európaibékeintézet (1) európaibetegségmegelőzésiésjárványügyiközpont (1) európaibíróság (7) európaibizottság (103) európaibiztonságiésegyüttműködésiértekezlet (4) európaibiztonságiésegyüttműködésiszervezet (24) európaifejlesztésiésújjáépítésibank (1) európaiközpontibank (2) európainemzetiségekföderatívuniója (2) európainukleáriskutatásiszervezet (1) európaiparlament (88) európaitanács (52) európaiújjáépítésiésfejlesztésibank (3) európaiunió (271) europe (175) europeanantifraudoffice (1) europeancentralbank (3) europeancommission (36) europeancouncil (11) europeancourtofjustice (4) europeangeosciencesunion (1) europeaninvestmentbank (2) europeanparliament (15) europeansciencefoundation (1) europeanspaceagency (11) europeanunion (121) europol (2) eurostat (4) evangélikusországoskönyvtár (1) exxon (1) eυρώπη (1) fák (22) federationofhungarians (1) fehéroroszország (17) fehértenger (1) feketetenger (50) felhők (15) felvidék (71) fénykép (17) fényképek (38) ferenchoppmuseumofasiaticarts (1) ferenczjózseftudományegyetem (1) fertőtó (1) festmény (1) fidzsiszigetek (1) fiji (7) film (93) finland (14) finnország (31) firstworldwar (3) fiumeitengerészetiakadémia (1) főgáz (3) föld (16) földközitenger (42) földrajziintézet (1) földrengés (2) forsterközpont (3) fórumkisebbségkutatóintézet (4) france (99) franciaország (185) franciapolinézia (1) franciavichykormány (2) frenchpolynesia (1) frontex (11) függetlenállamokközössége (3) fülöpszigetek (7) fundamentallaw (1) galaxy (1) galícia (2) galilea (1) gambia (3) gangesz (1) gáza (3) gaza (3) gazprom (45) generalelectric (1) genfikonvenció (2) georgia (14) germanreich (2) germany (136) ghana (3) ghána (2) globalizáció (43) globalization (89) globalizmus (4) góbisivatag (1) golfáram (1) google (1) görögbirodalom (1) görögkatolikusmetropólia (1) görögország (87) greatbritain (131) greece (43) greenland (1) grenada (1) grófklebelsbergkunómagyartörténetiintézet (1) grönland (1) grúzia (12) guatemala (15) guinea (5) guineabissau (1) gulfofaden (1) gulfofmexico (3) győriegyházmegyeilevéltár (1) gyulafehérvárirómaikatolikusérsekség (8) gyulafehérvárirómaikatolikusteológia (1) haázrezsőmúzeum (1) habsburgbirodalom (11) Habsburgermonarchie (1) habsburgmonarchia (3) hadtörténelmilevéltár (1) hadtörténetiintézetésmúzeum (15) hágainemzetközibíróság (1) hagyományokháza (2) haiti (3) hajó (10) hangzóanyag (12) hargitanemzetiszékelynépiegyüttes (1) havasalföld (7) hegyek (1) híd (10) himalája (2) himalaya (6) himnusz (4) hitelminősítők (7) (3) hold (2) hollandia (43) holyland (1) honduras (8) hongrie (9) hoppferencázsiaiművészetimúzeum (1) horvátország (79) hunbirodalom (2) hungaria (7) HungariaArchiregnum (1) hungarianacademyofarts (1) hungarianacademyofsciences (4) hungarianamericancoalition (1) hungarianhumanrightsfoundation (1) hungariannationalbank (1) hungariannationalmuseum (2) hungarianradio (1) hungarianstateopera (1) hungaricanaközgyűjteményikönyvtár (1) hungary (165) hunkultúramúzeuma (1) husarenlieder (1) hussarsongs (1) huszárnóta (2) iaea (1) ibériaifélsziget (1) iceland (12) ifla (3) IIbécsidöntés (1) IIrákócziferenckárpátaljaimagyarfőiskola (7) IIworldwar (1) imf (36) india (112) indiaióceán (6) indianocean (8) indonesia (21) indonézia (6) induló (1) influenzavirus (1) információshivatal (1) inkabirodalom (1) instituthongroisdeparis (1) interjú (1) internationalatomicenergyagency (3) internationalbankofreconstructionanddevelopment (1) internationalenergyagency (2) internationalmonetaryfund (5) internationalspacestation (10) interpol (4) iparművészetimúzeum (5) irak (88) iran (101) irán (68) iraq (102) ireland (21) írország (17) israel (78) istitutobalassi (1) italia (6) itália (5) italy (68) ithakaprogram (1) ivorycoast (4) Iworldwar (2) izland (6) izráel (2) izrael (84) jagellóegyetem (1) jamaica (1) japan (62) japán (49) járművek (15) jegestenger (1) jemen (11) jeruzsálemikirályság (3) jordan (20) jordánia (33) józsefnádorműszakiésgazdaságtudományiegyetem (1) jugoszlávia (37) julianusprogram (1) jupiter (3) kaliningrad (1) kalocsabácsifőegyházmegye (2) kalocsaifőegyházmegyeilevéltár (1) kambodzsa (4) kamerun (3) kanada (44) karasea (1) karibtenger (3) károligáspáregyetem (3) kárpátalja (104) karpatenbecken (1) kárpátmedence (87) kárpátmedenceintézet (1) kárpátok (30) kaszpitenger (5) katalónia (1) katar (14) katolikuskaritász (2) katonaiműszakifőiskola (1) katonanóta (1) kaukázus (10) kazahsztán (13) kazakhstan (19) kelet (1) keletikárpátok (1) keletkínaitenger (6) kenya (14) képeslap (1) kgst (2) kína (134) kínaikultúramúzeuma (1) királyhágó (4) királyhágómellékireformátusegyház (5) kirgizisztán (5) kisebbségijogvédőintézet (3) kisebbségkutatóintézet (2) kitap (2) kitelepítés (1) knjiga (1) köd (1) kodályinstitute (1) kodályzoltánemlékmúzeumésarchívum (1) kolozsváriegyetemikönyvtár (1) kolozsvárifőkonzulátus (2) kolozsvárimagyarkirályiferenczjózseftudományegyetem (1) kolumbia (4) kommunista (53) kommunizmus (33) kongóidemokratikusköztársaság (3) kongóiköztársaság (1) konstantinápolyipatriarchátus (1) könyv (132) korea (6) kőrösicsomasándorprogram (1) kórus (1) kórusmű (1) kosovo (10) kossuthdíj (1) koszovó (33) kosztolányidezsőszínház (1) középafrikaiköztrásaság (3) középamerika (3) központistatisztikaihivatal (11) krím (7) krizajánosnéprajzitársaság (3) książka (2) kuba (7) külügyiéskülgazdaságiintézet (3) kurdistan (1) kurdisztán (8) kúria (7) kuvait (4) kuwait (10) kyrgyzstan (4) lamanchecsatorna (2) laos (3) laptewsea (1) latinamerica (2) latvia (12) leagueofnations (1) lebanon (31) lechnerlajostudásközpont (1) lengyelország (132) lettország (18) libanon (33) libéria (3) liberia (4) líbia (52) libri (9) libro (7) lisztferencacademyofmusic (2) lisztferenczeneművészetiegyetem (1) lithuania (19) litvánia (18) livre (7) ludovikaakadémia (3) ludwigmúzeumkortársművészetimúzeum (1) lukoil (2) luxembourg (4) luxemburg (20) lybia (33) macedónia (36) macedonia (6) macedonia(provincia) (1) madagascar (6) madagaszkár (1) madár (4) madžarska (1) magyarállaminépiegyüttes (1) magyarállamvasút (2) magyarenergetikaiésközműszabályozásihivatal (2) magyarfejedelemség (1) magyarföldrajzitársaság (1) magyarföldtaniésgeofizikaiintézet (3) magyarhonvédség (1) magyarírókszövetsége (1) magyarkanizsaiudvarikamaraszínház (1) magyarkirályság (49) magyarkülügyiintézet (1) magyarmáltaiszeretetszolgálat (2) magyarmérnökikamara (2) magyarművészetiakadémia (6) magyarnemzetibank (27) magyarnemzetigaléria (7) magyarnemzetilevéltár (6) magyarnemzetimúzeum (16) magyarnemzetitanács (2) magyarnemzetiüdülésialapítvány (1) magyarnóta (2) magyarokvilágszövetsége (14) magyarország (605) magyarországireformátusegyház (4) magyarországiruszintudományosintézet (1) magyarországkrakkóifőkonzulátusa (1) magyarpolitikaifoglyokszövetsége (1) magyarrendőrség (2) magyarságkutatóintézet (1) magyartáviratiiroda (3) magyartelevízió (1) magyartudománygyűjtemény (1) magyartudományosakadémia (51) magyartudományosakadémiakönyvtárésinformációsközpont (3) magyarunitáriusegyház (3) magyarvillamosművekzrt (2) magyarvöröskereszt (4) mahart (2) malajzia (10) malawi (3) malaysia (10) malév (1) mali (9) malta (6) málta (13) mamelukbirodalom (1) mansziget (1) map (24) máramaros (5) maramures (1) march (1) marcia (1) máriarádió (1) marokkó (16) maros (2) marosmegyeimúzeum (1) marosvásárhelyiművészetiegyetem (1) marosvásárhelyiorvosiésgyógyszerészetiegyetem (13) mars (6) marsch (1) másodikvilágháború (66) mauritania (2) mauritánia (2) máv (2) médiatudományiintézet (5) mediterraneansea (34) mekong (1) memorandum (1) menekültügyihivatal (1) mercury (1) meteor (4) mexico (45) mexikó (28) mexikóiöböl (2) mezőgazdaság (1) michelincsillag (2) micronesia (1) middleamerica (1) migrációkutatóintézet (1) mikeskelemenprogram (1) miskolciegyetem (1) mississippi (2) miyakostrait (1) mol (18) moldova (45) moldva (14) molnáristvánmúzeum (1) monaco (2) mongolbirodalom (3) mongólia (1) mongolia (2) montenegro (10) montenegró (10) moon (16) móraferencmúzeum (1) morocco (6) morvaország (4) mountain (1) mozambik (4) műcsarnok (2) műegyetem (1) munkácsigörögkatolikusegyházmegye (2) munkácsirómaikatolikusegyházmegye (1) munkácsymihálymúzeum (1) muravidék (4) museumofappliedarts (1) museumofhungarianagriculture (1) music (1) nabucco (4) naftogaz (1) nagorno-karabakh (3) nagybritannia (166) nagyváradirómaikatolikusegyházmegye (1) namíbia (2) nap (15) naplemente (3) nasa (44) nationalheritageinstitute (1) nationalszéchényilibrary (2) nationaluniversityofpublicservice (1) nato (178) nauru (1) németausztria (1) németbirodalom (34) németdemokratikusköztársaság (9) németkeletafrika (1) németország (234) németrómaibirodalom (6) németszövetségiköztársaság (11) nemzetekszövetsége (1) nemzetgyűlés (3) nemzetiadóésvámhivatal (1) nemzetiaudiovizuálisarchivum (1) nemzeticsaládésszociálpolitikaiintézet (1) nemzetiélelmiszerláncbiztonságihivatal (2) nemzetifenntarthatófejlődésstratégia (1) nemzetikisebbségkutatóintézet (5) nemzetiközszolgálatiegyetem (7) nemzetikulturálisalap (7) nemzetikutatásifejlesztésiésinnovációshivatal (1) nemzetinépegészségügyiközpont (10) nemzetiörökségintézete (2) nemzetiszínház (4) nemzetköziatomenergiaügynökség (7) nemzetközibíróság (1) nemzetközibüntetőbíróság (2) nemzetközimigrációsszervezet (3) nemzetköziűrállomás (1) nemzetközivalutaalap (25) nemzetközivöröskereszt (1) nemzetpolitikaikutatóintézet (1) nemzetstratégiaikutatóintézet (7) nepal (3) népdal (1) néprajzimúzeum (3) népszövetség (4) néptánc (1) newcaledonia (1) newzealand (14) nicaragua (12) niger (10) nigéria (14) nigeria (19) nílus (1) nobeldíj (8) nordstream2 (1) northamerica (12) northamericanfreetradeagreement (5) northcorea (1) northernireland (1) northernsea (1) northkorea (42) northmacedonia (2) northsea (1) norvégia (26) norvegiansea (1) norway (31) norwegiansea (1) norwey (1) nyár (11) nyugat (1) nyugatnémetország (1) nyugatrómaibirodalom (2) nyugatszahara (3) óceánia (1) oecd (1) okhotsksea (1) ókoriegyiptom (1) ókorigörögország (1) ókoriróma (1) ökumenikussegélyszervezet (1) olaszkeletafrika (1) olaszország (140) olimpia (6) olympics (1) omán (1) oman (3) opalvezeték (1) opec (8) operaház (2) organizationforsecurityandcooperationineurope (3) örményország (9) oroszbirodalom (7) oroszország (253) országgyűlés (73) országgyűlésikönyvtár (4) országház (10) országoskatasztrófavédelmifőigazgatóság (2) országoslevéltár (4) országosmagyargyűjteményegyetem (1) országosmeteorológiaiszolgálat (3) országosszéchényikönyvtár (27) országosszínháztörténetimúzeumésintézet (2) őrvidék (6) österreich (2) ősz (6) ősziszínek (1) oszmánbirodalom (28) osztrákmagyarmonarchia (29) ottomanempire (9) oυγγαρία (1) pacificocean (29) pakistan (27) pakisztán (35) paks (1) palestine (17) palesztina (13) pallaszathénéközgondolkodásiprogram (1) panama (6) panamacsatorna (1) pannonhalmifőapátság (1) pannonia (2) pannónia (1) pannontenger (1) pápaiállam (1) papuanewguinea (9) paraguay (2) parlament (8) parliament (4) partium (51) partiumiésbánságiműemlékvédőésemlékhelytársaság (1) partiumikeresztényegyetem (4) pázmánypétercatholicuniversity (1) pázmánypéterkatolikusegyetem (10) pechorasea (1) pécsitudományegyetem (2) penclub (3) persia (1) persiangulf (15) peru (18) perzsabirodalom (1) perzsaöböl (13) perzsia (2) petőfiirodalmimúzeum (5) philippines (21) philippinesea (5) photo (26) photos (38) pianomusic (1) picture (1) piemont (1) pireneusok (1) pluto (1) poland (63) polishamericancongress (1) polonia (1) poroszország (2) portugal (14) portugálguinea (1) portugália (23) portugálmozambik (1) portugálnyugatafrika (1) puertorico (3) qatar (14) rajna (2) redsea (4) reformátussegélyszervezet (1) regát (1) regionálisnyelvekeurópaichartája (5) RegnumHungariae (2) rendszerváltástörténetétkutatóintézet (1) restitution (1) retyezát (1) robot (3) rodézia (1) rómaibirodalom (13) rómaicsászárság (1) romanempire (2) románia (253) romania (39) romániaievangélikuslutheránusegyház (1) romántudományosakadémia (1) rosatom (4) rosneft (6) roszatom (3) rosznyeft (4) rovar (2) ruanda (1) russia (180) russianfederalspaceagency (1) ruténia (1) rwanda (2) SacraCorona (2) sahara (10) salamonszigetek (1) salvador (10) samoa (3) sanmarino (1) sapientiaerdélyimagyartudományegyetem (8) sarkvidék (1) saturn (3) saudiarabia (63) scandinavia (3) schengenagreement (10) schengeniövezet (38) schengenzone (1) scotland (12) seaofjapan (3) seaofmarmara (1) seaofokhotsk (1) secondworldwar (4) semmelweisegyetem (4) senegal (2) serbia (34) seychelles (1) seychelleszigetek (1) shell (1) siberia (1) siebenbürgen (7) sierraleone (7) sinaibirodalom (1) singapore (8) skandinávia (2) skócia (15) slovakia (25) slovenia (12) slovenija (1) solarandheliosphericobservatory (1) solemne (1) solomonislands (1) somalia (13) southafrica (33) southamerica (23) southchinasea (20) southkorea (23) southstream (1) southvietnam (1) sovietunion (33) space (91) spain (38) spanyolország (59) srilanka (5) Stephanskrone (1) straitofbosphorus (1) straitofhormuz (2) stratégiakutatóintézet (1) stratfor (1) sudan (5) suezcanal (4) sumer (1) sun (40) supernova (1) svájc (50) svédország (46) swaziland (2) sweden (47) switzerland (23) syria (138) szabadeuróparádió (4) szabadkainépszínházmagyartársulata (1) szabótattilanyelviintézet (1) szahara (7) szászföld (1) szatmárirómaikatolikusegyházmegye (1) szatmárirómaikatolikuspüspökség (1) szaudarábia (3) szaúdarábia (42) száva (1) szegeditudományegyetem (9) székelyföld (84) székelyhadosztály (2) székelymikókollégium (1) székelynemzetimúzeum (4) szellemitulajdonnemzetihivatala (1) szemerebertalanmagyarrendvédelemtörténetitudományostársaság (1) szenegál (1) szentföld (1) szentistvánegyetem (1) SzentKorona (26) szépművészetimúzeum (7) szerbhorvátszlovénkirályság (1) szerbia (122) szibéria (3) szicíliaikirályság (1) szingapúr (8) szíria (131) szivárvány (1) szlavónia (1) szlovákia (107) szlovénia (35) szolyvaiemlékpark (1) szomália (13) szövetségesellenőrzőbizottság (1) szovjetunió (125) szudán (16) szuezicsatorna (6) szváziföld (1) tádzsikisztán (4) taiwan (11) taiwanstrait (2) tajikistan (3) tajvan (7) tajvaniszoros (1) tánc (13) tanganyika (1) tanzania (3) tanzánia (1) tátra (1) tavasz (22) ted (1) tejút (1) tél (4) telekilászlóalapítvány (2) telekilászlóintézet (1) télisportok (1) térkép (31) thaiföld (2) thailand (8) thecentralbankofhungary (1) thefederalreserve (1) thenetherlands (27) tibet (3) tigáz (1) tigris (2) tisza (16) tiszántúlireformátusegyházkerület (2) togo (2) tonga (5) törökáramlat (3) törökország (149) transatlantictradeandinvestmentpartnership (8) transilvania (6) transpacificpartnership (4) transsilvania (1) transsylvania (1) transvaal (1) transylvania (12) transylvanianreformedchurchdistrict (1) transylvanie (1) transzatlantiszabadkereskedelmimegállapodás (1) transzjordánemirátus (1) transznisztria (1) transznyeft (2) trianon (2) trinidadandtobago (3) tripoliszigrófság (1) tunézia (12) tunisia (13) turkey (91) türkiye (1) turkmenistan (4) türkmenisztán (3) Türkmenisztán (1) uganda (2) újzéland (7) ukraine (79) ukrajna (169) ukrtranszgaz (1) unesco (14) ungaria (1) ungarischesinstitut (1) ungarn (2) ungheria (4) unitedarabemirates (14) unitedkingdom (13) unitednations (55) unitedstates (227) universityofarizona (1) ünnep (9) űr (11) ural (1) urál (5) uruguay (3) usa (55) üstökös (1) üzbegisztán (3) Üzbegisztán (1) uzbekistan (3) vanuatu (3) váradhegyfokipremontreiprépostság (1) városkép (15) varsóimagyarkulturálisintézet (1) varsóiszerződés (5) vaskapu (4) vatican (20) vatikán (26) velenceiköztársaság (2) velenceitó (1) venezuela (15) venus (2) veritastörténetkutatóintézet (1) vers (17) video (176) vidéo (4) vietnám (1) vietnam (19) világbank (10) vinagora (1) virág (17) vírus (28) virus (32) visegradcountries (4) visegrádialap (1) visegrádiországok (45) visztula (1) víz (24) vízuminformációsrendszer (1) volcanoes (22) volga (2) vöröskereszt (5) vöröstenger (3) vulkán (3) wales (2) warsawpact (1) węgrzech (1) westafrica (1) westernsahara (1) who (18) worldbank (2) worldhealthorganizaton (17) worldmeteorologicalorganization (1) worldtradeorganization (1) worldwarI (4) worldwarII (13) worshipsong (1) yellowsea (1) yemen (26) yugoslavia (5) yukos (1) zaire (1) zambia (3) zanzibár (2) zene (4) zeneakadémia (5) zenemű (3) zeneszám (2) zimbabwe (3) zöldfokiszigetek (1) zongorajáték (1) βιβλίο (1) книга (1) книгата (1) унгария (1) Címkefelhő

2021. IV. 14-21. Vírusfertőzés és védőoltás adatok. United States, South America

2021.04.23. 00:43 Eleve

21 4 22 00:41 .

 Vírusfertőzés és védőoltás adatok

United States: Herd immunity shouldn't be the focus - the future of COVID-19 ultimately will be up to the willingness to embrace the vaccines;

Three new seasonal routes to Europe in destinations now open to Americans ready to fly internationally;

It will deliver less Covid-19 vaccine than planned to the U.K., Canada this quarter, Moderna Inc. said;

Researchers still don’t know how long protection against the virus lasts once someone has been fully vaccinated;

At the rate of about 3 million vaccinations per day, over 70 percent of eligible Americans will be at least partially vaccinated by June 10.

South America: Many people traveling thousands of miles to get the COVID-19 vaccine because supplies are limited in their own countries

Szólj hozzá!

Címkék: térkép magyarország vírus franciaország olaszország india oroszország törökország mexikó virus brazília who croatia europe canada switzerland greece egyesültkirályság iceland egyesültállamok southafrica southamerica

Danube photos

2021.04.22. 14:18 Eleve

 

Budapest 2020. IV. 22. Kaán Károly-kilátó

 

Szólj hozzá!

Címkék: tavasz magyarország photos ég építészet fák fényképek

2021. IV. 18. Czechia

2021.04.19. 10:36 Eleve

.

Czechia
April 18, 2021   The Czech Republic ordered 18 Russian diplomats to leave the country, accusing them of being spies after Czech intelligence linked Russian military agents to a massive ammunition depot explosion in October 16, 2014. The blast in Vrbetice, in the eastern Zlin region, set off 50 metric tons of stored ammunition. Two people died. Two months later, another blast of 13 tons of ammunition occurred at the same site. The Czech news magazine Respekt reported that the ammunition and weaponry that was destroyed was intended for Ukraine, which in 2014 was battling Russia-backed fighters in eastern Ukraine. A Bulgarian arms trader named Gebrev was reportedly the organizer of the arms deal with Ukraine. Respekt said investigators last year received new information regarding the explosion, and the government's intelligence committee had discussed the case just two weeks ago. Hamacek, the interior minister who is also acting foreign minister, said that the case would be discussed by European Union foreign ministers on April 19. In his announcement, PM Andrej Babis blamed the blasts on the Russian military intelligence agency known as the GRU, and specifically on a secretive unit known as Unit 29155. That unit has been linked to a series of attempted assassination plots and other sabotage across Europe, it has also been linked to an attack against Gebrev in 2015. Gebrev, who survived, was targeted with a substance similar to Novichok. In January 2019, Bulgarian officials charged three Russians, including a top GRU officer, in absentia in connection with that case. As part of the government announcement on April 17, Czech police announced they were seeking two suspected Russian agents carrying various passports, including Russian documents, in the names of Petrov and Boshirov. The names match those of the two men that Britain has blamed for the Skripal poisonings. The open-source investigation organization Bellingcat identified the suspects as Mishkin and Chepiga and said they both worked for Unit 29155. Vystrcil, the president of the Czech Senate, a political opponent and longtime critic of Babis, suggested that the explosion could be considered an act of "state terrorism." The U.S. Embassy in Prague tweeted following Babis's announcement that “the United States stands with its steadfast ally, the Czech Republic. We appreciate their significant action to impose costs on Russia for its  dangerous actions on Czech soil.” (Source: RadioFreeEurope)

.

Szólj hozzá!

Címkék: russia europe bulgaria ukraine europeanunion unitedstates czechia

2021. IV. 6-13. Vírusfertőzés és védőoltás adatok. Magyarország, France, Poland, European Union, Russia, Ukraine, United Kingdom, China, India, Iran, Canada, Mexico, United States, Brazil, Chile, WHO, globalization

2021.04.06. 23:56 Eleve

.

Tartalom     Content

 Vírusfertőzés és védőoltás adatok

 Magyarország: A járvány újabb tetőzése érzékelhető;

Egy nap alatt elhunyt 311 fertőzött beteg. Az oltások ütemét a rendelkezésre álló oltóanyagok határozzák meg.

France: HAS, the top health advisory body actually want to be cautious

Poland: strengthening on its eastern border

European Union: EU medicines regulator launched a review of Johnson & Johnson vaccine authorised in March

Russia: a planned "combat readiness" inspection of its army

Ukraine: Tempting fate over Ukraine today in the face of shifting geopolitical winds

United Kingdom: Under-30s be offered an alternative to the AstraZeneca vaccine - recommended;

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus.

China: “It’s now under formal consideration whether we should use different vaccines from different technical lines for the immunization process” - top disease control official Gao

India: Rise in cases has forced India to focus on satisfying its domestic demand, and delay deliveries to COVAX and elsewhere;

The Serum Institute of India - the world’s largest vaccine manufacturer which is producing AstraZeneca’s Covid-19 shot in the country - has said its production capacity is “very stressed”;

Covishield’s efficacy is reported only 55.1 percent when the two doses are administered less than six weeks apart.

Iran: Incident at Iran’s Natanz nuclear facility

Canada: A nasal spray kills the bug in the upper airways, lab tests in the US and United Kingdom showed

Mexico: 15,200 sex workers on Mexico City’s streets in August, about twice the number before the pandemic

The United States today recommended a “pause” in use of the single-dose Johnson & Johnson COVID-19 vaccine;

Biotech company Moderna announced its Covid vaccine is 90 percent effective against all forms of the disease and 95 percent effective against severe disease; 

DARPA developed a microchip to detect asymptomatic COVID and created a filter which can remove COVID virus from the blood;

The UK B117 variant is now dominant.; the more infectious Brazilian variant - known as P1 - accounts for about one percent of cases and the South African variant 424 confirmed cases;

Lost on the frontline: 3607 US healthcare worker deaths. The comprehensive count, investigative reports into this tragedy;

Army researchers hope the vaccine started clinical testing will combat variants of SARS-COV-2 and could help fight other coronaviruses.

Brazil: daily death records since late February

Chile: speedy vaccination programme have instilled false sense of security that led the country to ease restrictions too soon without people appreciating the ongoing risks

WHO: call on all national competent authorities to suspend the trade in live caught wild animals of mammalian species for food or breeding and close sections of food markets selling live
caught wild animals

Globalization: the trajectory of the pandemic growing exponentially - Covid-19 cases climbed by 9% across the globe last week;

How worried should we be about blood clots linked to J&J and AstraZeneca vaccines?

Szólj hozzá!

Címkék: kína video térkép magyarország chile vírus franciaország olaszország india oroszország taiwan japan törökország mexikó sweden virus iran photo nato brazília who germany europe israel georgia canada poland norway egyesültkirályság ukraine belarus európaiunió egyesültállamok schengeniövezet southafrica blacksea eurasia globalization worldwarII crimea

2021. III. 29 - IV. 5. Vírusfertőzés és védőoltás adatok: I. Magyarország - Hungary, Czechia, France, Italy, Románia, Slovenia, Russia, United Kingdom, Europe

2021.03.29. 00:49 Eleve

.

Tartalom     Content

 Vírusfertőzés és védőoltás adatok

Magyarország: a brit vírusmutáns továbbra is nagyon gyorsan terjed. Április 7.-én életbe lép a védelmi intézkedések első feloldásáról szóló rendelkezés;
Kovidők - útmutató a koronavírusos betegek otthoni ápolásához;
Hungary: in 26 March over 21,6 percent of Hungary's adult population received at least the first dose of a coronavirus vaccine.

Czechia: the country with the highest COVID death rate on Earth. People expect the government to solve their problems rather that taking personal responsibility

France: medical workers have urged the French government in recent weeks to impose stronger national restrictions. Rising number of patients in intensive care

Italy: COVID-19 vaccine mandatory for all health workers. Tightened restrictions on businesses and movements to contain the virus

Románia: Citu Florin miniszterelnök június elsején lazítana  járványügyi korlátozásokon

Slovenia: increased coronavirus transmission rates - 11-day lockdown from 1 April

Russia: Ceasefire is at risk of expiring tomorrow.
The world’s first Covid-19 vaccine for animals has been registered

United Kingdom: Nearly a third of people who have been in hospital suffering from Covid-19 are readmitted for further treatment within four months of being discharged.
The UK will focus on inoculating its entire adult population before sharing Covid-19 vaccine doses with other countries

Europe: French President Macron, German Chancellor Angela Merkel and Russial President Putin discussed

Szólj hozzá!

Címkék: magyarország ünnep vírus románia russia india törökország mexikó virus iran brazília france earth germany europe italy singapore canada malta finland ireland slovenia poland switzerland ukraine syria communist unitedkingdom estonia czechoslovakia europeanunion unitedstates sovietunion czechia semmelweisegyetem organizationforsecurityandcooperationineurope crimea

2021. III. 29 - IV. 5. Vírusfertőzés és védőoltás adatok: II. Central Europe and a smaller part of Eurasia.

2021.03.29. 00:42 Eleve

.

 Tartalom     Content

 Vírusfertőzés és védőoltás adatok

Central Europe has been one of the world’s worst-hit regions

Szólj hozzá!

Címkék: magyarország franciaország olaszország india oroszország törökország china virus iran brazília romania moldova germany montenegro europe mongolia georgia malta armenia bulgaria kosovo poland slovakia egyesültkirályság ukraine serbia albania kazakhstan belarus uzbekistan estonia europeanunion egyesültállamok turkmenistan eurasia czechia azerbaijan kyrgyzstan bosniaandherzegovina northmacedonia

2021. III. 29 - IV. 5. Vírusfertőzés és védőoltás adatok: III. India, Israel, Japan, Taiwan, United States, South America

2021.03.29. 00:38 Eleve

.

 Tartalom     Content:

 Vírusfertőzés és védőoltás adatok

India: temporary restrictions on exporting COVID-19 vaccines to meet domestic demand because of the rising number of COVID-19 cases

Israel: foreigners still need an exemption to enter Israel - keeping out thousands of pilgrims. High infection rates, low vaccination rates in the occupied territories

Japan: to be able to source the number of vaccine doses wanted before hosting the Olympics in four months

Taiwan: recent Chinese warplane exercises around the island

United States: 100 million people aged 16 and above have gotten at least one dose of a COVID vaccine;
Covid-19 vaccine 100% effective in a study of adolescents ages 12 to 15 - already authorized for use in people 16 and older

Latin America, the Caribbean and the P1 variant

Szólj hozzá!

Címkék: magyarország chile vírus franciaország peru olaszország oroszország taiwan japan törökország mexikó china virus uruguay brazília israel bolivia canada egyesültkirályság olympics caribbean palestine europeanunion egyesültállamok southafrica southamerica eastchinasea taiwanstrait miyakostrait bashichannel

2021. III. 29 - IV. 5. Vírusfertőzés és védőoltás adatok: IV. Globalization

2021.03.29. 00:33 Eleve

.

 Tartalom     Content

Vírusfertőzés és védőoltás adatok

Globalization:

How are different countries using the AstraZeneca vaccine?    

 What Covid vaccines cost?

Szólj hozzá!

Címkék: magyarország franciaország olaszország oroszország törökország sweden virus brazília who romania belgium croatia germany latvia montenegro denmark israel bulgaria ireland lithuania slovenia austria poland slovakia switzerland portugal spain greece norway egyesültkirályság iceland serbia albania cyprus estonia egyesültállamok southafrica czechia thenetherlands bosniaandherzegovina

2021. III. 21 - 28. Vírusfertőzés és védőoltás adatok. I. Magyarország, Ausztria, France, Italy, Németország - Germany, European Council, European Union, Szerbia - Serbia, United Kingdom

2021.03.22. 16:38 Eleve

 .

2021. III. 28.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
127 014 568

Országonként:

Egyesült Államok 30 255 303
Brazília 12 490 326
India 11 971 624
Franciaország * 4 606 185
Oroszország 4 469 327
Egyesült Királyság ** 4 347 010

...
Magyarország *** 633 861

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 780 749

Országonként:

Egyesült Államok 549 288
Brazília 310 550
Mexikó 201 429
India 161 552
Egyesült Királyság 126 832
Olaszország **** 107 933

...
Magyarország 19 972

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
71 958 415

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 11 323 762
Brazília 10 948 382
Oroszország 4 092 015
Törökország 2 957 093
Olaszország 2 850 889

...
Magyarország 395 790

-----------------------------------------

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/28/2021 10:26 p. m."

------------------------------------------------

*** Magyarország
2021. 03. 27. Müller országos tiszti főorvos elmondta: nemzetközi tapasztalatok és tudományos ajánlások alapján Magyarországon is megfogalmaztak egy iránymutatást a várandós nők számára. „A szóba jöhető két mRNS-alapú oltás első dózisát a terhesség 12. hete után, a második dózist a szülést követően veheti fel a kismama” – részletezte. Jelezte: tudományos tapasztalatok alapján elmondható, hogy eddig nem bizonyosodott be semmilyen magzatkárosító hatás, illetve fejlődési rendelleneség a beadott oltások után. (Forrás: Híradó)

2021. 03. 26. Ragaszkodom ahhoz, hogy mielőtt a regisztrált 65 éven felüliek nincsenek beoltva, addig semmilyen újranyitásról nem lehet beszélni. Ha megkapták, és elmúlt a közvetlen életveszély, akkor lehet. Jelenleg 71 százalékot már beoltottunk a regisztrált 65 éven felüliek közül. ​Pfizerrel és Modernával szabad oltani a kismamákat, kérem őket, hogy regisztráljanak - mondta a miniszterelnök a Kossuth Rádió reggeli műsorában. Be kell oltanunk a pedagógusokat és az iskolai dolgozókat is mielőtt az iskolákat meg tudnánk nyitni. 102 ezer regisztrált iskolai dolgozó van, közülük 20 ezret már beoltottak, mert sor került rájuk. A többieket is be kell oltani, mielőtt megnyitják az intézményeket – magyarázta. (Forrás: Híradó)

2021. 03. 25. Az elhunytak több mint 80 százaléka idős. Ha az időseket beoltják, remélhetőleg csökken majd az elhunytak száma. 650 ezer nyugdíjas nem regisztrált az oltásra. Aki oltást kíván kapni – beleértve a legfiatalabbakat is - remélhetőleg május végéig megkaphatja legalább az elsőt. A CoviShield- és a CanSino oltóanyagokra még nem kötött szerződést a kormány. A Johnson & Johnson oltóanyagából Magyarország 4,36 millió dózist rendelt. Gulyás miniszter rámutatott: ha egy háziorvos már minden olyan 65 év felettit beoltott a körzetében, aki kérte a védőoltást, akár egy fiatalabb krónikus beteggel folytathatja, de ha ők is megkapták az oltást az általa ellátott körzetében, bárki mást beolthat. (Forrás: Híradó)

2021. márc. 25. A hagyományos és az új (pl. a COVID-19 elleni) védőoltások működése. /rajzfilmes megelevenítés/(Forrás: YouTube / SemmelweisEgyetem): https://tinyurl.com/5f6yr8sn
37 522 megtekintés

2021. 03. 24. Holnaptól új kormányrendelet lép hatályba, melynek értelmében a járóbeteg-ellátókat is be lehet vonni a koronavírus elleni intézményes védekezésbe az abban jelenleg is részt vevő megyei kórházak, egyetemi kórházak, valamint a fővárosi centrumkórházak mellett. Az oltás jó ütemben, tervezetten halad, a lakosság 16,8 százaléka kapta meg legalább az első védőoltást, szemben a 9,4 százalékos EU-s átlaggal. Eddig 1 696 110 embert oltottak be Magyarországon, 494 520-an már a második adagot is megkapták. Az oltás kizárólag kijelölt oltópontokon, orvosi rendelőkben zajlik. A kórházi oltópontokon Pfizerrel, a háziorvosoknál Sinopharmmal, AstraZenecával, és Modernával folytatódik az oltás. Veszélyeztetettségük miatt továbbra is a regisztrált idősek oltása van elől a sorban. Az eddig regisztrált 65 év felettiek 65 százaléka már megkapta az oltást, a többiek is hamarosan sorra kerülnek. Elhunyt 249 'többségében idős, krónikus beteg'. Újabb 7 587 magyar állampolgárnál mutatták ki a koronavírus-fertőzést, az aktív fertőzöttek száma 192 951-re emelkedett. A fertőzöttek átlagéletkora 'továbbra is' 55 év hazánkban. 11 805 koronavírusos beteget ápolnak kórházban, közülük 1 423-an vannak lélegeztetőgépen. A favipiravír nevű készítményből, ami gátolja a koronavírus szaporodását eddig már 37 ezer dobozt rendeltek a háziorvosok. Múlt éjszaka újabb 180 ezer adag, második oltáshoz szükséges Szputnyik V-vakcina érkezett Budapestre. A Janssen oltóanyag április második felében érkezhet meg hazánkba. Az operatív törzs úgy döntött, hogy megkezdi az infrastruktúrát üzemeltető fontos üzemek, cégek dolgozóinak oltását. Elkezdték a BKV dolgozóinak oltását, ma a Paksi Atomerőmű munkatársaink oltása is elkezdődik, a következő napokban a MÁV és a GYSEV munkatársainak oltásával folytatják. (Forrás: Híradó)

2021. március 23. A korai előrejelző rendszer SARS-CoV2 koronavírus-vizsgálatának eredménye a március 14-21.-i hétre vonatkozóan: a szennyvízben mért koronavírus örökítőanyag koncentráció országos szinten jellemző növekedése megállt, a legtöbb vizsgált település eredménye stagnál. A koncentráció 11 minta esetében az emelkedett kategóriában van, hét településen csökkent. /térképpel/ (Forrás: NemzetiNépegészségügyiKözpont): https://tinyurl.com/av4p52es

2021. 03. 22. Magyarországon tavaly 9 884 elhunytat soroltak hivatalosan a vírus áldozatai közé, míg a többlethalálozás ennél kevesebb, 8 331 fő volt – mondta Vukovich, a Központi Statisztikai Hivatal (KSH) elnöke. A 2015–2019. közötti időszak átlagos halálozási adatához képest ez 6,3 százalékos emelkedést jelent. Az EU-s tagállamok között nem egységes, mikor sorolnak egy elhunytat a koronavírus áldozatai közé. Németországban a halálesetek 7,5 százalékkal növekedtek 2020-ban, de a jelentett koronavírus-fertőzés miatti halálozás ennek alig a felét fedi le. (Forrás: Híradó / MTI)

2021. 03. 22.  A kínai CanSino Biologics bejelentette, hogy a koronavírus elleni oltóanyaga Magyarországon vészhelyzeti használati engedélyt kapott az Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézettől – számolt be a Reuters hírügynökség ma. Az Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet honlapján egyelőre nincs erre vonatkozó információ. A CanSino oltóanyagát már korábban vizsgálta a gyógyszerhatóság, de akkor a szakértők szerint még nem volt elérhető elegendő információ róla. A CanSino oltóanyaga virális vektoralapú. A második fázisú klinikai tesztek alapján 60 év fölöttieknek is biztonsággal beadható. Március elején engedélyezték Kínában. Akkor a kínai pártlap azt írta róla, hogy vizsgálatok alapján 65,7 százalékos hatásosságú, és 90,9 eséllyel előzi meg a komolyabb megbetegedést. (Forrás: Híradó)

2021. 03. 22.  A nyugati oltóanyagok vásárlására Magyarország nem tud szerződést kötni, mert a többi uniós állammal ezt a jogot átengedték az Európai Uniónak. Magyarország csak a keleti gyártókkal tárgyal és köt szerződéseket oltóanyag-szállítmányokról - mondta Müller, országos tiszti főorvos. Tegnap este újabb 250 ezer adag Szputnyik V oltóanyag érkezett hazánkba. 'Az elmúlt napokban' az OGYI két újabb oltóanyag behozatalát, illetve forgalmazását engedélyezte Magyarországon, a CanSino és CoviShield nevű vektor oltóanyagokét. Müller  arra kérte a háziorvosokat, hogy amikor enyhe vagy középsúlyos koronavírus betegekkel találkoznak, írják fel számukra a Favipiravir nevű gyógykészítményt, és ellenőrizzék a betegek kezelését, hogy megelőzzék a betegek állapotának súlyosbodását. Több kismama jelenleg súlyos állapotban van a vírusfertőzés miatt, ők kórházi ellátásra szorulnak – válaszolta újságírói kérdésre. Magyarország fel van készülve a koronavírus betegek ellátásra, van elég szabad kórházi ágy, elég szabad lélegeztetőgép, és minden más orvosszakmai készítmény – jelentette ki. Azonban az egészségügyi dolgozók emberfeletti munkát végeznek, ezért egyre fáradtabbak.  (Forrás: Híradó / M1)

2021. 03. 21.  Krivácsy, a Semmelweis Egyetem I. Számú Gyermekgyógyászati Klinikája Sürgősségi Betegellátó Osztályának vezetője elmondta: a klinika március 18-án jelentette be posztcovid ambulancia nyitását gyerekeknek. Azokat a koronavírus-fertőzésen átesett gyerekeket várják, akiknek a betegség után egy hónappal is tüneteik vannak. Ismertette: a Covid-19 hosszútávú tünetek közé tartozik a gyengeség, az iskolai teljesítménycsökkenés, a fejfájás, a hasi, a keringést és a légzést érintő panasz. Előfordulhat, hogy más probléma áll a tünetek hátterében. (Forrás: Híradó / MTI)

Ausztria
2021. 03. 28  Holnap, hétfőtől hat napig 24 órás kijárási korlátozás lép életbe, vesztegzár alá kerül több tartomány és az osztrák főváros is. Bécsben, Burgenland és Alsó-Ausztria tartományban az emberek csak munkába, élelmiszerboltba és patikába menet hagyhatják el otthonaikat. Az iskolákban és munkahelyeken heti egyszeri vírustesztet írtak elő, Napi több mint háromezer fertőzöttet regisztrálnak Ausztriában: az aktív fertőzöttek száma a legújabb fertőzéshullám kitörése óta több mint a kétszeresére nőtt. A kórházak koronavírusos betegekkel vannak tele, a helyzet országszerte egyre romlik. A kormány azt fontolja, hogy az egész országra kiterjesztik a keleti tartományokra kihirdetett óvintézkedéseket. (Forrás: M1 / Híradó)

* France
28/03/2021 Around 20 million people, including those in the greater Paris region, are classed as living in high-infection zones. They are not allowed to travel further than 10 kilometres from their home unless they have an essential reason. Checks at train stations, airports and toll-paying motorways began today to enforce the travel restrictions. Only shops selling food, and book and music stores are open and classrooms in high schools are only running at half the capacity. Daily cases in France have nearly doubled since the start of the month and there have been more than 200,000 new cases every week. The World Health Organization in 26 March appealed to richer nations to donate vaccines to help poorer ones start inoculations. The deployment of vaccines has been glaringly unequal, with the United States accounting for more than a quarter of the global total and poorer nations lagging far behind wealthier ones. While rich EU countries are still struggling to get their inoculations into overdrive, France made clear it sees vaccine policies feeding not just European, but global competition for influence. "We are looking at a new type of world war," President Macron said after an EU summit. "We are looking in particular at Russian and Chinese attacks and attempts to gain influence through the vaccine." But Berlin said it would be happy to use Sputnik V if it gets approval from EU regulators. Germany also classified the whole of France as a high-risk zone, which means travellers need to show a negative Covid test and quarantine upon arrival. (Source: RFI)

21 Mar 2021  Nothing says “lockdown” as loudly as hundreds of miles of traffic jams on all roads out of Paris and trains to the Mediterranean and Brittany full to bursting. And that was just what happened in 19 March after French prime minister Jean Castex announced that the capital and 15 other departments – out of a total of 94 – would face new restrictions. By evening, traffic congestion more than 250 miles long affected roads leading from the capital. By yesteray morning, the city centre looked deserted. Covid-19’s third wave was now making itself felt. About 21 million people – roughly a third of the French population – living in Paris and surrounding areas, as well as several departments in the north and south, are now affected. The measures are aimed at halting the “third wave” of Covid cases. Two-thirds of these are now the highly contagious “English variant”, that has seen admissions to hospital intensive care units soar. Worryingly, health chiefs report that many of the new patients are younger than in past Covid waves. The measures have been imposed at the end of a perplexing week. In 15  March, Macron announced France would temporarily halt AstraZeneca vaccinations as a “precautionary measure” following fears of possible side-effects. The pause lasted four days. In 18 March, PM Castex was back on television reassuring the sceptical French that the vaccine was safe, before rolling up his sleeve for a jab in 19 March. Such dithering is bad, especially in France where anti-vax feeling is rife. Medical authorities argue that France is on track to hit its target of 10 million vaccinations by mid-April and is not – as has been claimed –  “sitting on” vaccine supplies. (Source: TheGuardian)

**** Italy
March 24, 2021 Italian
authorities have discovered 29 million doses of Oxford/AstraZeneca vaccine that had been stocked at a manufacturing site in the country. The doses likely come from AstraZeneca's Halix plant in the Netherlands, which hasn't yet been approved for EU production. Those doses were originally destined to the U.K., but exports stopped after the bloc introduced a mechanism to restrict exports on vaccines. AstraZeneca hadn't alerted EU authorities to the doses, which were being stored in a fill-finish site run by Catalent in the town of Agnani. AstraZeneca comes under harsh criticism from the European Commission over shortfalls of vaccine deliveries, having widely missed its original delivery targets set in the EU's advance purchase agreement. Its most recent promise is to deliver in the first quarter of the year 30 million doses - nearly equal to the amount found at the Catalent site. The find coincides with the European Commission's move to introduce new rules that could slash EU vaccine exports for six weeks. The rules target places like the U.K. and U.S. - countries that are either receiving EU-made doses but not shipping back their own shots, or that have vaccinated more of their population than the EU. (Source: Politico)

Németország Germany
2021. 03. 28  Erősödik az új típusú koronavírus (SARS-CoV-2) által okozott betegségtől védő vakcináknak ellenálló vírusváltozatok megjelenésének veszélye, ha a napi új fertőződések számának gyors emelkedése mellett halad előre az oltási kampány – mondta a német kancelláriaminiszter. Németország a járvány legveszélyesebb szakaszában van, és a következő hetekben dől el, hogy sikerül-e belátható időn belül megszerezni az ellenőrzést a vírus terjedése felett – mondta Braun asszony, végzettségét tekintve orvos. Már januári nyilatkozataiban hangsúlyozta, hogy Németországban is a fokozottan fertőzőképes brit, B.1.1.7-es jelzésű mutáció lesz a meghatározó. Most kifejtette, hogy a napokban elindult újabb járványhullám pusztítóbb lehet az első kettőnél. Ezért a zárlat további enyhítése helyett vészfékrendszert kell alkalmazni, vissza kell állítani a március elején felfüggesztett korlátozásokat, be kell vezetni újabb szigorításokat azokban a tartományokban, járásokban vagy városokban, amelyekben tartósan – egymás után három nap – száz fölött van a megelőző hét napon regisztrált új fertőződések százezer lakosra vetített száma. Elmondta, hogy két hónapig kell még fokozott óvatossággal viselkedni, addigra lesz elég oltóanyag ahhoz, hogy Németország az egészségügyi ellátórendszer túlterhelése nélkül jusson ki a járványból. Az oltási kampány első eredményei májusban jelentkezhetnek majd, járványlassító hatása pünkösdkor lesz érezhető, de csak akkor, ha sikerül megakadályozni, hogy a járványhelyzet  teljesen kicsússzon az ellenőrzés alól. Javítana a helyzeten az esti és éjszakai kijárási tilalom, mert a magán-összejöveteleken a legnagyobb a fertőzési arány. Korlátozások lebontását alacsony fertőzésgyakoriság és hatékony tesztelési rendszer mellett lehet elkezdeni – mondta. A Robert Koch közegészségügyi intézet (RKI) adatai szerint a hétnapi fertőzésgyakoriság  országos szinten már március 21-én átlépte a 100-as határértéket, és ma, vasárnap reggel 129,70-en állt. 24 óra alatt 17 176 fertőződést szűrtek ki tesztekkel. Ez csaknem 25 százalékos növekedés az egy héttel korábbi 13 733-hoz képest. Az új regisztrált fertőződésekkel együtt 2 772 401 ember szervezetében mutatták ki a SARS-CoV-2-t. A járvány áldozatainak száma 75 870 Németországban. A mostani hullámot megakadályozni nem lehet, csak fékezni. Tíz-tizennégy napos kijárási korlátozásra van szükség Németországban a koronavírus-járvány harmadik hullámának megfékezéséhez – jelentette ki ma Spahn szövetségi egészségügyi miniszter. A Robert Koch közegészségügyi intézet (RKI) vezetőjével, Wielerrel tegnapi közös tájékoztatójukon figyelmeztettek, hogy a következő hetekben teljesítőképessége határára érhet az egészségügyi ellátórendszer a SARS-CoV-2 vírus új változatainak terjedése és a napi új fertőződések gyarapodása miatt. A miniszter mostani nyilatkozata szerint a húsvétot követő egy hétben is szükség lesz még a szigorú kijárási korlátozásokra. Nyilatkoztak az ügyben intenzív osztályon dolgozó orvosok; azt mondták, hogy csak kéthetes szigorú otthonmaradással kerülheti el a társadalom, hogy a kórházak intenzív osztályai összeomoljanak a teher alatt. Karagiannidis, az intenzív és sürgősségi orvoslás németországi szövetségének elnöke azt tanácsolta a politikusoknak, hogy egyelőre vessék el mindenféle nyitás tervét, ne hagyják cserben a kórházi személyzetet. (Forrás: Híradó / MTI)

24 Mar 2021 Angela Merkel took the unusual step of issuing a personal apology to the nation, as she performed a U-turn on plans to put Germany under a hard lockdown over Easter. Following an acrimonious summit between the chancellor and the heads of Germany’s 16 federal states in March 22, Merkel had announced an extension of the partial lockdown until 18 April, as well as a tightening of restrictions from 1-5 April. The proposals were immediately questioned by epidemiologists, business associations and members of Merkel’s own political bloc. Under the planned Easter lockdown, all shops and business would have been told to remain shut for five days in a row, while grocery stores were to briefly reopen on Holy Saturday – a proposal that many feared would lead to crowded aisles and super-spreader events in supermarket queues. Merkel’s interior minister, Seehofer, of the Christian Social Union (CSU), criticised the request for churches to hold Easter services online. Today morning the German chancellor said the plan to close churches and shops over a five-day period had been her mistake. An emergency break on further reopenings that will apply to areas exceeding 100 new cases per 100,000 inhabitants over a seven-day period remains in place. National elections will take place in September. (Source: TheGuardian)

23 March, 2021 Germany has announced that it will extend its lockdown for a further three weeks in response to a rapidly rising rate of coronavirus infections. The restrictions will be particularly tough over the Easter weekend. Chancellor Angela Merkel has said that the country is now in a “very serious” situation. Today the German leader said: “We basically have a new pandemic.” In Germany 7,485 infections have been reported in the past 24 hours and 250 deaths have been recorded. Lockdown measures will include Germans being asked to stay at home for five days, from 1 April. A so-called “emergency brake” will prevent further reopenings in areas of the country where infection numbers reach more than 100 new cases per 100,000 people, for a period of seven days. As of Sunday, March 21, in Germany around 4 per cent of the population had received both doses of a coronavirus vaccine, with 9 per cent having had their first dose. (Source: Independent)

March 22, 2021 Germany may buy the Russian-made Sputnik V vaccine if no alternative sources of vaccines are found soon. "As far as the Russian vaccine is concerned, I share the opinion that we should use any vaccine approved by the European Medicines Agency. But I would rather prefer European purchases. If there are no European purchases and no signs indicating their possibility, we will have to take the German path alone," Angela Merkel told on March 18 after a meeting with heads of German regions to discuss anti-coronavirus vaccination in the country. "I think that we have very good chances of fulfilling our promise to give every citizen an opportunity of becoming vaccinated [against COVID-19]  by the end of this summer," she said, adding that a lot depends on how many doses of vaccines will be supplied to the country. The EU started the certification process of the Sputnik V vaccine in mid-January. Russia finally sends all the documentation required and the COVID-19 vaccine is expected to be approved  for use in the EU by the European Medical Agency by the end of May. In the background the preparations for manufacturing Sputnik V in Europe are well underway. The Russian Direct Investment Fund (RDIF), the Russian sovereign wealth fund that is behind the vaccine’s development, reached agreements with companies from Italy, Spain, France and Germany to jointly produce Russia’s Sputnik V vaccine, RDIF CEO Dmitriev told on March 16. Russia came up with a high quality vaccine very quickly and in meantime has developed two more. Russia has approved CoviVac, its third coronavirus vaccine, for domestic use, Prime Minister Mikhail Mishustin said, although large-scale clinical trials have not started yet, which scientists say could be even more effective than Sputnik V which has a 91% efficacy score. The epidemic is now in retreat, Russia is expected to reach “herd immunity” levels of 70% of the population with anti-bodies as soon as August. Russia has entered into agreements to set up production in multiple counties including Turkey and Belarus which should come online shortly. (Source: IntellyNews)

2021. 03. 21.  Sok országban a nyár végéig tarthat a járványügyi korlátozások időszaka az új típusú koronavírus elleni védekezésben, de legalább egy évig tart még, mire világszerte sikerül megszerezni az ellenőrzést a kórokozó terjedése felett – mondták a német BioNTech cég alapítói. A török származású Türeci és férje, Sahin elmondta: helyi járványkitörések továbbra is lesznek és új vírusváltozatok is kifejlődnek, de nagy valószínűséggel nem okoznak majd nagy veszélyt. Rendre szükség lesz majd emlékeztető oltásra, de még nem tudni, hogy évente vagy ötévente. Egyelőre azt sem lehet pontosan látni, hogy mekkora átoltottság kell a járvány megállításához. A két kutatóorvos a napokban megkapta Steinmeier szövetségi elnöktől az egyik legmagasabb német állami elismerést, a Nagy Érdemkereszt Csillaggal kitüntetést, illetve a lapkiadó Axel Springer német multinacionális vállalat díját. (Forrás: Híradó / MTI)

European Council
26 March 2021  In February, the EU executive launched an export mechanism to ensure transparency by better tracking where vaccine exports are directed. Under these rules, companies manufacturing vaccines in Europe require authorisation from national authorities – which can be denied under certain conditions – before shipping vaccines outside the EU. While European Council President Michel lauded a very strong consensus among the member states on the issue of the mechanism and France, Italy and Spain showed strong support for it, the Netherlands, Sweden and Ireland asked the Commission to refrain from blocking shipments without consulting national authorities and vaccine manufacturers. Since the start of the mechanism on 1 February, more than 380 export requests were, and one has been stopped. The data shows the EU as open, reliably exporting region in the world, mentioning that the US and their executive order prioritise US citizens and the fact that the UK has not shared the same figures on exports. Troubles are mounting at home, as the EU’s supply chain is still undermined by the lack of deliveries that affect the roll-out of vaccines. It has had 88 million doses delivered so far, of which 62 million doses have been administered. 18.2 million people have been fully vaccinated so far, almost 4.1% of the population. “We want to make sure that Europe gets its fair share of vaccines because we must be able to explain to our citizens that if companies export their vaccines to the whole world, it is because they are fully honouring their commitments without putting at risk the security of supply in the EU,” Commission President Ursula von der Leyen told. In 24 March the Commission tightened up the mechanism including new criteria which could deny export to countries that have already ensured a certain vaccination rate, if it is higher than the one in the EU. Missing deliveries from the Anglo-Swedish company AstraZeneca remains a major issue, with questions remaining over whether it is prioritising the UK supply over the EU one. EU officials remain frustrated by the behaviour of AstraZeneca pharmaceutical - which is still struggling to deliver the expected doses of the COVID-19 vaccine to EU - and are set to use all the tools at their disposal to secure further doses for EU citizens. A change of tack is expected in the second quarter of the year, although AstraZeneca has committed again to a lower number of doses than was contracted – 70 million instead of 180 million. “There are some concerns serious concerns with regard to this one company,” said Michel, calling for AstraZeneca to ensure predictability of their vaccine production and respect contractual delivery deadlines. The situation could still change if the export mechanism is used. Von der  Leyen made clear that the company has to honour the contract it has with the EU member states, before it can engage again in exporting vaccines. Italian Prime Minister Mario Draghi reserved harsh words for AstraZeneca, saying European citizens felt “disappointed” and “fooled” by the company. BioNtech/Pfizer and Moderna are, however, expected to deliver doses of their vaccinese, with the possibility of even increasing the doses produced, von der Leyen told EU leaders. The single-shot Johnson&Johnson vaccine will increase the array of vaccine available in the second quarter. Accelerating the production, delivery and deployment of vaccines remains essential and urgent to overcome the crisis, the EU leaders agreed during the summit. They confirmed the deadlock over the distribution of the additional 10 million BioNTech-Pfizer doses. Countries more exposed by the shortfalls in the supply of the cheaper AstraZeneca vaccine have asked for these extra doses not to be distributed pro-rata but following criteria that take into account infections and the current quantity of vaccines in a certain member state. This coalition of countries was lead by Austria, who threatened to veto the Council’s final statement at a certain point of the meeting. The EU leaders passed the issue to the EU ambassadors asking them to solve the issue “in a spirit of solidarity” but confirming “the pro-rata population key for the allocation of vaccines.” (Source: euractiv)
Note: According to the source, EU is the region that exports the highest number of vaccines worldwide. According to the Commission’s figure, the total number of exports from the EU amounts to approximately 77 million doses to 33 different countries, including the poorer nations included in the COVAX initiative.

Európai Unió     European Union
2021. 03. 28.  Breton, a belső piacért felelős Európai Uniós biztos, EU oltási stratégiáért is felelős francia politikus
megerősítette, hogy az EU nyárra elérheti a koronavírus-elleni kollektív immunitást a területén gyártott oltóanyag-mennyiségnek köszönhetően. „Megvan a kapacitásunk arra, hogy a negyedév végéig legyártsunk és leszállítsuk európai honfitársaink számára az ígért 360 millió dózist, július végéig pedig mintegy 420 milliót. Ez a szükséges mennyiség ahhoz, hogy kollektív immunitásról beszélhessünk” – mondta. Egy héttel ezelőtt azt mondta, hogy Európa július 14-re érheti el a közösségi immunitást. Elmondta, hogy a közös EU-s egészségügyi igazolás június 15-től lesz érvényes digitális és papír változatban is mind a 27 tagállam számára. „Attól a pillanattól kezdve, hogy biztosak lehetünk abban, hogy minden európai, aki szeretné magát beoltatni, egyformán hozzáférhet az oltáshoz, kell lennie egy dokumentumnak, amely igazolja mindenki állapotát” – fogalmazott a biztos. A QR kóddal ellátott igazoláson szerepelni fog a tulajdonos neve, születési dátuma, az útlevele száma, illetve az, hogy kapott-e oltást és hogy milyen típusút, valamint, hogy átesett-e a fertőzésen és vannak-e antitestjei. (Forrás: Híradó / MTI)

March 27 2021  Yesterday, the European Medicines Agency (EMA) approved three new sites for the production of the AstraZeneca, Pfizer-BioNTech and Moderna jabs for the EU supply chain. Everyone will hope this can help relieve shortages across all member states. (Source: Independent.ie)

25 March 2021 EU leaders to discuss boosting vaccine supplies. Last week, European Commission President Ursula von der Leyen complained that the EU had exported more than 10 million doses to the UK, but the UK had so far exported none in return. The tougher export controls are most likely to affect vaccine-exporting countries that have higher vaccination rates than the EU, such as the UK and US. The key criteria for the proposed regulations are "reciprocity" and "proportionality": the EU says there is no reciprocity if a country importing vaccines from the EU restricts exports itself - so it may review exports to this country; member states and the Commission will also consider the state of the pandemic in that country, its vaccination rate and vaccine supplies. (Source: BBC)

March 24, 2021  EU curbs vaccine exports - introduced emergency legislation that would allow it to control exports of COVID-19 vaccines. The legislation is aimed chiefly at halting exports of vaccines from AstraZeneca PLC to the rest of the world, and is expected to disrupt supply to the U.K. Last week, European Commission President Ursula von der Leyen threatened to use emergency powers to curb exports, as she pointed out the EU has allowed for 41 million doses to be sent to 33 countries since early February. She said that AstraZeneca has overpromised and underdelivered on its contract with the EU. EU officials have been criticized for allowing vaccines to be exported, while other countries, notably the U.S. and U.K., have moved fast  to secure domestic production for their own citizens. In the U.S. 164 million doses had been distributed to states, 128.2 million doses had been administered and 83.9 million people had received at least one dose, equal to 25.3% of the population. So far, 45.5 million Americans have received two doses and are fully vaccinated, equal to 13.7% of the population. (Source: MarketWatch)

March 21, 2021  The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands. Two factories in Britain run by Oxford Biomedica and Cobra Biologics are listed as suppliers to the EU in the contract with AstraZeneca, but no vaccine has so far been shipped from Britain to the EU, despite Brussels’ earlier requests. Officials have said that Cobra is not fully operational.  AstraZeneca told EU officials that the UK is using a clause in its supply contract that prevents export of its vaccines until the British market is fully served. “The Brits are insisting that the Halix plant in the Netherlands must deliver the drug substance produced there to them. That doesn’t work,” an official told. “What is produced in Halix has to go to the EU,” the official added. The Leiden-based plant which is run by sub-contractor Halix is listed as a supplier of vaccines in both the contracts that AstraZeneca has signed with Britain and with the European Union. AstraZeneca has declined to comment on the amount of vaccines that are currently stockpiled at Halix. (Source: Reuters)

Szerbia    Serbia
2021. 03. 28. vasárnap. Tülekedés ingyenes oltóanyagért. A szerb kormány lehetővé tette, hogy az AstraZeneca koronavírus elleni oltóanyagát akár külföldiek is megkapják a kijelölt oltópontokon. Ingyenesen és előzetes regisztráció nélkül is fel tudják venni a hétvégén a védőoltást, akár külföldiek is. Tegnap, szombaton a legnagyobb sorok a bosnyák–szerb, valamint az észak-macedón–szerb határon alakultak ki, nagyon sokan érkeztek Montenegróból is azért, hogy Belgrádban vagy Újvidéken megkapják az oltást. Szombaton a legnagyobb sorok a boszniai-szerb, valamint az észak-macedón-szerb határon alakultak ki, de nagyon sokan érkeztek Montenegróból is azért, hogy Belgrádban vagy Újvidéken megkapják az oltást. A Szerbiában regisztrált koronavírus-fertőzöttek száma mára 4497-tel 581 617-re, Koszovóban 873-mal 87 027-re, Észak-Macedóniában 1320-szal 126 230-ra, Montenegróban 369-el 89 732-re, Bosznia-Hercegovinában pedig 1843-mal 163 875-re növekedett. A járvány halálos áldozatainak száma az utóbbi 24 órában Szerbiában 37-tel 5151-re, Koszovóban 11-gyel 1834-re, Észak-Macedóniában 35-tel 3642-re, Montenegróban 7-el 1241-re, Bosznia-Hercegovinában pedig 60-al 6322-re nőtt. (Forrás: Híradó / MTI)

27-Mar-2021  Serbia is the second stop on China's defense minister General Wei's four-country journey through central and southeastern Europe. As Serbian Defense Minister Stefanovic announced after meeting with General Wei, China's military will donate COVID-19 vaccines to Serbia's soldiers and their families. General Wei also met Serbian President Vucic and attended Serbian military special forces drills. 'My visit here is with the support of President Xi,' said Wei. 'The aim is to realize the consensus between President Xi and President Vucic about deepening friendly relations between our two armies.' The emphasis on friendly ties not just relevant 'to defense and military' cooperation: economic ties are the backbone of the relationship between the two countries. Since the COVID-19 pandemic started, the medical collaboration became the most important area for the two nations, as Wei emphasized in talks with his Serbian counterpart Stefanovic, who said the Serbian Military Medical Academy would soon open a Center of Chinese traditional medicine. The two defense ministers spent more than two hours talking behind closed doors, after which they signed an agreement on the Chinese military's donation of 'military aid' to Serbia. Stefanovic gave the public just a glimpse of the other topics discussed. One more topic was shared yesterday in Belgrade: China will help the Serbian defense industry's efforts to perfect its indigenous attack drone, the Pegasus. Defense Minister Wei continues his four-country tour today when he'll visit Greece before his last stop in North Macedonia. (Source: cgtn)

** United Kingdom
March 28, 2021  To combat the ever-changing virus. On March 4, 2020, when there were just 84 confirmed cases of COVID-19 in the U.K., professor Peacock, 62 recognized that the country needed to expand its capacity to analyze the genetic makeup of the virus. The Cambridge University microbiologist understood that genomic sequencing would be crucial in tracking the disease, controlling outbreaks and developing vaccines. So she began working with colleagues around the country to put together a plan. Within a month, the government had provided 20 million pounds ($28 million) to fund their work. The initiative helped make Britain a world leader in rapidly analyzing the genetic material from large numbers of COVID-19 infections, generating more than 40% of the genomic sequences identified to date. These days, their top priority is finding new variants that are more dangerous or resistant to vaccines. This is the first time authorities are using genomic sequencing to provide real-time surveillance of a global pandemic. She, "the variant-hunter-in-chief" is executive director and chair of the COVID-19 UK Genomics Consortium, known as COG-UK, the group she helped create a year ago. During the first week of this month, COG-UK sequenced 13,171 viruses, up from 260 during its first 12 days of operation in March last year. Positive COVID-19 tests from hospitals and community testing programs around the country are sent to a network of 17 laboratories where scientists spend their days extracting the genetic material from each swab and analyzing it to identify that virus’ unique genetic code. The sequences are then cross-referenced with public health data to better understand how, where and why COVID-19 is spreading. When mutations in the virus correspond with an otherwise unexplained increase in cases, that’s a clue that a new variant of concern is circulating in the area. The importance of genomic sequencing became obvious late last year as the number of new infections began to spike in southeastern England. Combing through data from genome sequencing, scientists identified a new variant that included a number of mutations that made it easier for the virus to hop from one person to another. More than 120 countries are submitting sequences to GISAID, a data-sharing hub originally created to track influenza viruses. Iceland, Australia, New Zealand and Denmark actually sequence a higher percentage of their COVID-19 cases than Britain, and Denmark does the work faster. The U.K. has submitted 379,294 of the almost 898,000 sequences in the GISAID database. Representatives from COG-UK took part in a recent call with American researchers and the Rockefeller Foundation aimed at building capacity in the United States. The U.K.’s sequencing success was built on  the foundation of groundbreaking genetic science in Britain, stretching back to the work of Watson, Crick and Franklin, who were credited with discovering the chemical structure of DNA.  Success attracted investment, such as the Wellcome Trust’s 1992 decision to create the Sanger Centre to help map the human genome, further expanding the pool of expertise in Britain. (Source: AP)

March 28, 2021  U.K. expects to receive first Moderna vaccines in coming weeks. The arrival of the shot comes as the European Union toughens restrictions on exports and Britain faces a significant reduction in supplies in April due to a delayed delivery from India. The economy had its deepest contraction last year for more than three centuries. The government is on track to offer first doses of a vaccine to all over 50s by the middle of April and to the rest of the adult population by the end of July. There is also no danger of people unable to get their second dose of the same jab within 12 weeks, the culture secretary spoke. The aim is to remove remaining restrictions on social contact from June 21. Britain and the EU are in talks to resolve a standoff over vaccine sharing as the bloc attempts to get its own immunization program back on track. Last week, the two sides indicated progress in defusing the spat. (Source: Bloomberg)

27 March 2021 Vaccines Minister Zahawi said people aged over 70 could start receiving Covid booster jabs from September to protect them from new variants. Mr Zahawi also confirmed drive-thru vaccine sites are being considered to persuade younger people to take a Covid jab. Mr Zahawi also told that the government was hoping to have up to eight vaccines available by the autumn - with several made in the UK - including one that could guard against three different variants via a single jab. The UK is currently using two vaccines - developed by Oxford-AstraZeneca and Pfizer-BioNTech - to protect people against Covid-19. A third - the Moderna vaccine - has been approved by the UK's medicines watchdog. All have been shown to be effective at preventing people from becoming seriously ill and dying from Covid. The Oxford vaccine offers a good level of protection against the "Kent" variant now dominant in the UK. Early research on other vaccines, including Pfizer, suggest they also protect against this variant. There are concerns vaccines may not work as well against variants first spotted in South Africa and Brazil, and some UK variants too, but they can be updated. Despite ministers warning that the UK's vaccine supplies would fall in April, No 10 said all adults in the UK  will still receive a first Covid jab by the end of July. (Source: BBC)

26 Mar 2021 Embattled scientists at AstraZeneca feel they have been unfairly targeted for trying to do something that goes against the profit-driven grain in the pharmaceutical industry – produce a low-cost, easy to use vaccine that will work well for low and middle-income countries but will not make them money in the short-term. Sir Bell, the Oxford University professor who helped drive the vaccine’s development, suggested morale at AstraZeneca is plummeting and that it had never received due credit for its decision to take no profit. Others are making fortunes –  Moderna expects $18bn in revenue this year from the vaccine and Pfizer/BioNTech $15bn. (Source: TheGuardian)

23 Mar 2021 A research led by scientists at the MRC-University of Glasgow Centre for Virus Research (CVR) found that human rhinovirus (the virus that causes the common cold) triggers an innate immune response that seems to block SARS-CoV-2 replication in cells of the respiratory tract. Professor Murcia explains: “This means that the immune response caused by mild, common cold virus infections, could provide some level of transient protection against SARS-CoV-2, potentially blocking transmission of SARS-CoV-2 and reducing the severity of COVID-19. “The next stage will be to study what is happening at the molecular level during these virus-virus interactions, to understand more about their impact on disease transmission. The study, ‘Human rhinovirus infection blocks SARS-CoV-2 replication within the respiratory epithelium: implications for COVID-19 epidemiology’ is published in the Journal of Infectious Diseases. (Source: UniversityofGlasgow)

21 March 2021 Professor Bell, leading member of Oxford-AstraZeneca vaccine team criticised France for refusing to administer the AstraZeneca vaccine to under-55s after the country previously said the jab was unsuitable for older people. He has slammed the EU's 'completely hopeless' efforts to track outbreaks of coronavirus variants. Lack of genome sequencing on the continent means importing the South African variant from Europe is now the 'biggest risk' facing the UK, he said. (Source: DailyMail)
A comment: "Reading between the lines. If the South African variant hits the UK, and it will, the AZ vaccine won't work".

21 Mar 2021  Waging war over vaccines can only end in tragedy for Britain and the EU. Gloating over Europe’s travails is a stupid and shortsighted way for the UK to respond. A government with an enlightened perspective on the long-term interests of Britain would see value in offering expressions of sympathy and gestures of solidarity with the EU at its time of severe trial. That could generate a lot of goodwill among European voters and leaders. It might be the more effective in winning friends for Britain for being so unexpected from a Brexiter government.  Raab, the foreign secretary, instead prefers to play tit for tat. He responded to Ms von der Leyen by accusing her of the “kind of brinkmanship” usually practised by dictatorships, an echo of those Brexiter tropes which insultingly compared the EU with Nazi Europe or the Soviet bloc. Other cabinet members huff and puff that threats to curtail vaccine exports show that the EU can’t be trusted to honour contracts. There is a problem with this attempt by ministers to seize the title deeds to the moral high ground. Their behaviour has robbed them of any claims on it. No one is worse qualified to lecture others about contract-breaking than a member of Mr Johnson’s government. It is not so long ago that he was brazenly threatening to break international law by tearing up clauses of the withdrawal agreement that he signed. More recently, the government abandoned attempts to renegotiate aspects of the agreement which are working badly in Northern Ireland and announced a reneging on previous commitments. “My word is my bond” has not exactly been the motto by which Boris Johnson has lived his life. Bermann concluded her time as French ambassador in London with a valedictory assessment of Mr Johnson which described him as “an unrepentant and inveterate liar”, a view widely held among European leaders. The chances of avoiding a mutually destructive struggle with the EU over vaccine supplies would be much better had Britain a prime minister who was regarded as a trustworthy international partner by his peer group. An escalation into a full-blown “vaccine war” between Britain and the EU would be a disaster for both on many levels. The production of vaccines depends on intricate multinational supply chains. Take the Pfizer dose. Ingredients for that vaccine are shipped from the UK to the company’s plant in Belgium before some of the finished product is exported across the Channel. A round of beggar-my-neighbour export bans will be self-defeating. The EU’s problems will deepen, while the government will find it harder to realise its ambition to get a shot into every adult by July. Vaccine nationalism is already a dimension of this crisis. It would set a terrible example to the world if countries that advertise themselves as mature, sophisticated and internationalist democracies were to unleash a vaccine war in Europe. Britain and her near neighbours are going to have to live and work with each other long after Covid-19 has become history. The UK’s security and prosperity still depend in great part on what happens within the EU. It cannot be in the EU’s interests to have permanently toxified relations with such a substantial country on its border. A vaccine war would be a conflict without a winner, only many losers. Any words or actions that further inflame very raw nerves are highly dangerous. Careless talk costs lives. (Source: TheGuardian)

.

Szólj hozzá!

Címkék: kína térkép magyarország máv vírus franciaország olaszország india németország oroszország törökország mexikó sweden virus szerbia brazília who belgium koszovó europe montenegró denmark ireland austria spain greece egyesültkirályság australia iceland belarus európaiunió boszniahercegovina egyesültállamok központistatisztikaihivatal europeancommission sovietunion thenetherlands europeancouncil északmacedónia nemzetinépegészségügyiközpont

2021. III. 21-28. Vírusfertőzés és védőoltás adatok. II. Kína - China, India, United States, Brazil - Brazília, Mexico, globalization

2021.03.21. 23:35 Eleve

 

2021. III. 28.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
127 014 568

Országonként:

Egyesült Államok * 30 255 303
Brazília ** 12 490 326
India *** 11 971 624
Franciaország 4 606 185
Oroszország 4 469 327
Egyesült Királyság 4 347 010

...
Magyarország 633 861

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 780 749

Országonként:

Egyesült Államok 549 288
Brazília 310 550
Mexikó 201 429
India 161 552
Egyesült Királyság 126 832
Olaszország 107 933

...
Magyarország 19 972

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
71 958 415

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 11 323 762
Brazília 10 948 382
Oroszország 4 092 015
Törökország 2 957 093
Olaszország 2 850 889

...
Magyarország 395 790

-----------------------------------------

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/28/2021 10:26 p. m."

------------------------------------------------

Kína    China
2021. 03. 25. Több tízmillió adagot kínált fel a COVAX-programnak
a CanSino Biologics kínai gyógyszergyártó vállalat az általa gyártott egydózisú oltóanyagból „versenyképes áron”; azt 2021 második felétől 2022 végéig szállítaná, hozzátéve, hogy készek 2022 után is szállítani, ha igény lesz rá. Peking korábban bejelentette, hogy 10 millió dózist ajánl fel az oltóanyagok méltányos elosztására létrehozott COVAX programnak, bár a szállítás dátumát nem említette. A CanSinoBIO mellett a Sinovac Biotech és a Sinopharm kínai gyártó is jelentkezett a programra. "A CanSino adenovírus-vektor alapú oltóanyagát, amelyet a vállalat a kínai Katonai Orvostudományi Akadémiával közösen fejlesztett, Kínán kívül mostanáig Pakisztánban, Magyarországon és Mexikóban engedélyezték'. (Forrás: Híradó / MTI)

March 22, 2021 China’s CanSino Biologics Inc (CanSinoBIO) said today its COVID-19 vaccine has been authorised for emergency use in Hungary, the second Chinese vaccine to receive approval in that nation. The Hungarian National Institute of Pharmacy and Nutrition granted the approval for its vaccine, with the trade name Convidecia, based on the interim results of its phase III trial, the company said in a statement. CanSinoBIO’s vaccine is a single-dose vaccine that is currently also approved in China, Pakistan and Mexico. Hungary’s daily coronavirus infections on Friday, 19 March were hitting a record of 10,759, while the daily death toll also hit a record at 213 in the central European country of 10 million. (Source: Reuters)

*** India
March 24, 2021
India’s health ministry said today that a new “double mutant variant” of the coronavirus and other 771 “variants of concern” have been detected among 10,787 positive samples in a survey across 18 of the country’s states and union territories, saying that such variants “have not been detected in numbers sufficient to either establish a direct  relationship or explain the rapid increase in cases in some states”. 736 samples have tested positive for the UK variant, 34 the South African variant and one sample was found positive for the Brazilian variant. The country recorded 47,262 new cases in the previous 24 hours, the largest daily spike in months. Total number of Covid cases rose above 11.7 million. The health ministry said only five states - Maharashtra, Punjab, Karnataka, Chhattisgarh and Gujarat - account for about 77 per cent of the new cases. India became the fifth country in the world to sequence the genome of the novel coronavirus. India ramped up its genomic sequencing efforts amid concerns about the arrival of the UK variant into the country in December. The health ministry revealed an increase in incidences of both the E484Q and L452R mutations, as compared to December 2020. “Such mutations confer immune escape and increased infectivity. These mutations have been found in about 15-20 per cent of samples and do not match any previously catalogued variants of concern, it said. These mutations have also been detected in other countries; E484Q has been found in 11 countries, while L452R mutation has been detected in about 22 countries. Several states have announced a ban on gatherings ahead of the festival of Holi next week to curb the rising number of Covid-19 cases. The government of Delhi said “public celebrations and all gatherings and congregations during upcoming festivals should not be allowed in public places.” (Source: Independent)

* United States
March 27, 2021  About 49 million Americans are now fully vaccinated, and about 1 in 3 have received at least one dose. 71% of seniors have received one shot, because that age group accounts for roughly 80% of the Covid deaths up to this point. With the increase in vaccine supply, there will be enough vaccine doses for every adult in the US by the end of May and the three manufacturers who have received emergency use authorization for their  vaccines in the US - Pfizer, Moderna and Johnson & Johnson - "are setting and hitting targets." (Source: CNN)

March 25, 2021 The Pfizer/BioNTech and Moderna Covid-19 vaccines are effective in pregnant and lactating women, who can pass protective antibodies to newborns, according to research published today in the American Journal of Obstetrics and Gynecology. Researchers at Massachusetts General Hospital, Brigham and Women’s Hospital and the Ragon Institute of MGH, MIT and Harvard looked at 131 women who received either the Pfizer/BioNTech or Moderna Covid-19 vaccine. Among the participants, 84 were pregnant, 31 were lactating and 16 were not pregnant or lactating. Samples were collected between Dec. 17, 2020 and March 2, 2021. The vaccine-induced antibody levels were equivalent in pregnant and lactating women, compared to non-pregnant women. The antibody levels were “strikingly higher” than those resulting from coronavirus infection during pregnancy, the team noted. In addition, the team found that women passed protective antibodies to their newborns, measured in breast milk and the placenta. Additional research is needed to understand how long those protective antibodies last in newborns.  (Source: CNN)
Note: Pregnant and lactating women were not included in the initial clinical trials of the vaccines.

March 24, 2021  An assortment of hand cleaners that flooded into the market contain high levels of benzene, according to Valisure, a New Haven, Connecticut-based online pharmacy that tests products for quality and consistency. Benzene causes cancer, according to the U.S. Department of Health and Human Services. The World Health Organization’s cancer research arm puts it in the highest risk category, on par with asbestos. Valisure analyzed 260 bottles from 168 brands and found 17% of the samples contained detectable levels of benzene. Twenty-one bottles, or 8%, contained benzene above two parts per million, a temporary limit the FDA set for liquid hand sanitizers to ease the supply squeeze. That level “can be tolerated for a relatively short period of time,” the FDA said in June. Fifteen brands were represented among the 21 bottles with the highest levels of contamination. Most hand sanitizers Valisure found and tested were gels. The pharmacy’s test results were verified by Yale University’s Chemical and Biophysical Instrumentation Center and Boston Analytical, a private lab. It isn’t clear how benzene became present in the products. It may have been introduced during the manufacturing process when germ-killing alcohol is purified. In certain chemical industries the material is used to make plastics and rubber. Benzene has been linked to certain blood cancers, such as leukemias. Skin absorption and ingestion are also possible. Focusing on hand-sanitizer safety, the U.S. Food and Drug Administration (FDA) in January blocked imports of products from Mexico after many were found to contain methanol, a form of alcohol that’s poisonous to humans. Most of the products Valisure found to contain high levels of benzene were made in China or the U.S. One Scentsational product that tested for high levels of benzene held 14 times the limit of methanol, which is 630 parts per million. Alcohol-based hand sanitizers typically should not contain methanol; they’re usually made with ethanol, or grain alcohol. (Source: msn)
See also: March 24, 2021 "Valisure’s citizen petition to the FDA, including a list of brands identified with high benzene levels" (Source: Valisure): https://tinyurl.com/c6v4pjf2

March 24, 2021  GlaxoSmithKline fired ex-chief scientist of the U.S. government’s Covid vaccine development effort Operation Warp Speed during the Trump administration Slaoui, as Galvani Bioelectronics board chairman, over ‘substantiated’ sexual harassment claims. Slaoui, 61, had spent 30 years at GSK, overseeing vaccine development at that pharmaceutical giant. Slaoui’s firing came 10 months after then-President Trump tapped him to oversee the U.S. effort to development vaccines to fight the coronavirus pandemic. At the time he was appointed, he was on the board of Moderna. Slaoui last month joined Centessa Pharmaceuticals as chief scientific officer and advisor. 'Slaoui also has been advising the European Union on its coronavirus vaccine rollout. ' (Source: cnbc)

March 23, 2021  To have access to therapeutic options, Pfizer Inc. said it has begun human safety testing of a new pill to treat the coronavirus that could be used at the first sign of illness. If it succeeds in trials, the pill could be prescribed early in an infection to block viral replication before patients get very sick. The drug binds to an enzyme called a protease to keep the virus from replicating. Protease-inhibiting medicines have been successful in treating other types of viruses, include HIV and Hepatitis C. The study could generate results within weeks. The new protease inhibitor is the second such medicine Pfizer has brought into human trials to treat Covid-19. Pfizer’s oral protease inhibitor, code-named PF-07321332, had a number of potential advantages. In lab tests, it worked against many coronaviruses, including the original SARS virus and MERS. Additionally, the coronavirus protease doesn’t mutate much, which means the therapy is likely to work equally well against numerous variant strains. In theory, the protease inhibitor could also be combined with other antiviral drugs, such as the one Merck is developing. Pfizer is testing another given intravenously to hospitalized virus patients. Pfizer could begin a much larger combined phase 2-phase 3 trial early in the second quarter, potentially allowing it to apply for emergency-use authorization from the Food and Drug Administration by the end of this year, depending on how the pandemic evolves. The drug is likely to be given twice a day for about five days. Pfizer also plans to explore whether the drug works to protect healthy people who have been exposed to the coronavirus, such as family members or roommates who live with someone who got sick. Easy-to-use treatments are lacking for early-stage Covid-19 patients. While antibody therapies from EliLilly & Co. and Regeneron Pharmaceuticals Inc. are authorized in the U.S. for Covid patients who haven’t yet been hospitalized but are at high risk of developing severe symptoms, they  must be infused in the hospital or at a doctor’s office. For sicker people Gilead Sciences Inc.’s antiviral drug remdesivir must be infused over several days and is approved only for hospitalized patients. Merck & Co. has one of the few coronavirus pills that is far along in human testing. Its experimental antiviral drug molnupiravir works by a different mechanism than the Pfizer drug and is in late-stage human trials. Merck is developing its drug in collaboration with Ridgeback Biotherapeutics LP. (Source: msn)

March 23, 2021  Late yesterday the Data and Safety Monitoring Board (DSMB) notified the National Institute of Allergy and Infectious Diseases (NIAID), the Biomedical Advanced Research and Development Authority (BARDA) and AstraZeneca that it was concerned by information released by AstraZeneca on initial data from its COVID-19 vaccine clinical trial. The DSMB expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data. "We urge the company to work with the DSMB to review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible". (Source: NationalInstitutesofHealth)

March 22, 2021  Companies sponsoring drug or vaccine trials typically wait for the monitoring board to review analyses and conclude that the study has yielded an answer before they announce trial results. In recent days, the monitoring board’s analysis of the AstraZeneca trial was delayed several times because the board had to ask for revised reports from those handling trial data on behalf of the company. The monitoring board ultimately conveyed the results of the study to AstraZeneca in a meeting over the weekend, leading to the company’s announcement yesterday morning. It was highly irregular to see such a public display of friction between a monitoring board and a study sponsor, which are typically in close concordance. Many millions of people have received the AstraZeneca shot worldwide, including more than 17 million in Britain and the European Union, almost all without serious side effects. In an effortto increase public confidence, many European political leaders have gotten the injections in recent days. The AstraZeneca vaccine has also been administered in the past week to leaders in South Korea, Taiwan and Thailand. (Source: TheNewYorkTimes)

** Brazil    Brazília
March 27, 2021  Home to 212 million people, the country trails only the U.S. in the virus’ toll. Brazil has become the epicenter of the pandemic, recently reporting records of more than 100,000 cases and 3,650 deaths a day. While vaccinations have picked up in the last week, the 19 million shots deployed so far have only covered 7% of the population with one dose, and fully vaccinated about 2%. The national death toll crossed 300,000 this week, two-and-a-half months after hitting 200,000, half the time it took to go from 100,000 to 200,000. Brazil is facing a rising number of deaths among the young. So far this month, about 2,030 Brazilians aged 30 to 39 have died from Covid, more than double the number recorded in January. Among those in their 40s, there have been 4,150 fatalities in March, up from 1,823 in January, and for those 20-29, deaths jumped to 505 from 242. The explanation for the growing infection rate among the young - in a country that is largely young - remains unclear although officials and medical experts suggest several possibilities. First, throughout 2020, local and regional restrictions hampered socializing. That changed with the holidays, the new year and the loosening of lockdowns. Second, a variant first spotted in the Amazonian city of Manaus is probably partly to blame. Patients are largely getting sick with that variant or the U.K. one, which is also more contagious. A study carried out in Sao Paulo found one of the two variants in 71% of cases. Third, vaccines are limited in Brazil and there is no time line for inoculating the young. The mutation of the virus into a much more contagious version with a viral load that makes people sick in a  faster and more aggressive way has meant young people have gone from mostly asymptomatic cases to being gravely affected. (Source: Bloomberg)

2021. 03. 26. Brazília ma bejelentette, hogy elkészült a koronavírus elleni első saját gyártású, Butanvac nevű oltóanyaga, amelyet az Instituto Butantan nevű állami biológiai kutatóközpont fejlesztett ki, s amelyet jóváhagyás esetén azonnal elkezdenek embereken tesztelni. Az Instituto Butantan gyártja Brazíliában a Sinovac Biotech kínai gyógyszergyártó CoronaVac nevű oltóanyagát is, amellyel az emberek túlnyomó többségét oltják a dél-amerikai országban. A koronavírus-járvány által sújtott, 210 millió lakosú Brazíliában eddig 12 320 169 fertőzöttet és a fertőzéshez köthető 303 462 halálesetet regisztráltak, a gyógyultak száma 10 808 499. (Forrás: Híradó / MTI)

Mexico
Mar 28 2021  The government has acknowledged that the country's true death toll from the coronavirus pandemic now stands above 321,000, almost 60 per cent more than the official test-confirmed number of 201,429. Mexico does little testing, many Mexicans died at home without getting a test. The only way to get a clear picture is to review excess deaths and review death certificates. Yesterday, the government quietly published such a report, which found there were 294,287 deaths linked to Covid-19 from the start of the pandemic through February 14. Since February 15 there have been an additional 26,772 test-confirmed deaths. Mexico has a population of 126million. Suggestive were the overall number of excess deaths since the pandemic began, around 417,000. A review of death certificates found about 70.5 per cent of the excess deaths were Covid-19 related, often because it was listed on the certificates as a suspected or contributing cause of death. But some experts say Covid-19 may have contributed to many of the other excess deaths because many people couldn't get treatment for other diseases because hospitals were overwhelmed. (Source: TheU.S.Sun)

Globalization
March 26, 2021 Ending
the pandemic will require vaccinating children too. Children’s infection rates are low - they make up about 13% of COVID-19 cases documented in the U.S. 268 have died from COVID-19 in the U.S. alone and more than 13,500 have been hospitalized, according to a tally by the American Academy of Pediatrics. That’s more than die from the flu in an average year. Additionally, a small number have developed a serious inflammatory condition linked to the coronavirus. Apart from their own health risks, there still are questions about how easily  children can spread the virus. Last month in Britain, AstraZeneca began a study of its vaccine among 6- to 17-year-olds. Johnson & Johnson is planning its own pediatric studies. In China, Sinovac recently announced it has submitted preliminary data to Chinese regulators showing its vaccine is safe in children as young as 3. In the first phase of the Pfizer study, a small number of children receive different doses of vaccine as scientists winnow out the best dosage to test in several thousand kids in the next phase. (Source: AP)

26 March 2021  More than 500 million doses of vaccines have been given around the world as of yesterday. Israel still leads the race by far, with nearly six out of 10 of its population  having received at least one dose. More than half of Israelis have received a second dose. Next is the United Kingdom (43 percent of the population has received at least one dose), the United Arab Emirates (more than 39 percent), Chile (32 percent), Bahrain (27 percent), the United States (26 percent), Serbia (19 percent) and Hungary (19 percent). The US is way ahead  with 133 million jabs given, followed by China with 91 million and India (55.5 million). European Union countries have given 65 million doses between them to 10 percent of the bloc's population. The vaccines produced by US-German Pfizer/BioNTech and the American Moderna are more expensive and harder to store. They are mainly used in rich countries. The American Johnson & Johnson vaccine, the first to require just one dose, has so far only been rolled out in the US and South Africa though it has been approved in Canada and the EU. Russia's Sputnik V and China's Sinopharm and Sinovac jabs have been administered mostly in their home markets as well as emerging and developing countries. The vaccine developed by AstraZeneca and Oxford University has been administered in rich countries and India, as well as poorer ones, notably thanks to Covax of which it is the main supplier. '0.1 percent of the doses injected around the world were given in poor countries, home to nine percent of the global population'. Several of the world's poorest countries have started their vaccination campaigns using doses delivered for free under the Covax scheme launched by the WHO, the Gavi vaccine alliance and the Cepi coalition. (Source: Yahoo / AFP)

.

Szólj hozzá!

Címkék: kína térkép magyarország chile vírus franciaország russia olaszország india oroszország taiwan törökország mexikó pakisztán virus brazília bahrain who germany israel canada thailand egyesültkirályság serbia europeanunion egyesültállamok southkorea southafrica globalization unitedarabemirates

2021. március 19. Magyarország. Lekötött, illetve már beszerzett - Covid-19 koronavírus elleni - oltóanyag mennyiség

2021.03.20. 01:12 Eleve

 

                                 Forrás: Híradó / MTI / koronavirus.gov.hu

 

 

Szólj hozzá!

Címkék: magyarország vírus

2021. III. 13. - III. 20. Vírusfertőzés és védőoltás adatok. I. Magyarország - Hungary, Denmark, France, Ireland, Németország - Germany, Európai Bizottság - European Commission

2021.03.15. 00:14 Eleve

 

2021. III. 20.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
122 639 917

Országonként:

Egyesült Államok 29 774 306
Brazília 11 871 390
India 11 555 284
Oroszország 4 397 816
Egyesült Királyság 4 304 839
Franciaország * 4 277 182

...
Magyarország ** 560 971

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 705 934

Országonként:

Egyesült Államok 541 738
Brazília 290 314
Mexikó 197 219
India 159 558
Egyesült Királyság 126 359
Olaszország 104 642

...
Magyarország 18 068

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
69 464 058

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 11 107 332
Brazília 10 470 969
Oroszország 4 014 770
Törökország 2 807 572
Olaszország 2 686 236

...
Magyarország 366 774

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/20/2021 11:26 p. m."

------------------------------------------------

** Magyarország     Hungary
2021. III. 20. Eddig 66 333 079 adag koronavírus elleni oltóanyag érkezett az Európai Unióba, amelyből 53 057 739-et oltottak be. A legtöbbet lakosság-arányosan Málta és Magyarország oltott – derült ki az Európai Betegségmegelőzési és Járványvédelmi Központ (ECDC) legfrissebb, tegnapi összesítéséből. Az ECDC szerint az Európai Unió lakosságának 10,7 százaléka kapta meg valamelyik koronavírus elleni oltóanyag legalább első adagját, míg a második adag a lakosság átlagosan 4,2 százalékához jutott el. Magyarországon az oltás első adagját a lakosság 17,9 százaléka, a második adagját 5,3 százaléka kapta meg. Lakosság-arányosan a legtöbb adag oltást Magyarország szerezte be: 31,8 adag oltóanyag jut 100 felnőtt (18 évnél idősebb) lakosra. (Forrás: Híradó / MTI)

March 19, 2021  Hungary can start the first stage of easing coronavirus restrictions once a further one million citizens have been vaccinated, Prime Minister Viktor Orbán said today.  Around 1.5 million Hungarians have been inoculated so far, and he said curbs could start to be eased once that number rose to 2.5 million - equivalent to a quarter of the population. Orbán reiterated his backing for Hungary’s use of Chinese and Russian vaccines, which it was the first European Union country to authorise and deploy. Orbán said the daily tally of coronavirus-related deaths stood at a record 213, with more than 10,000 people in hospitals, which were managing to cope with a record wave of infections. Orbán aims to get as many people immunised as quickly as possible to reopen and jump-start the economy, which shrank by 5.1% last year. Fidesz yesterday submitted its resignation from the European People’s Party (EPP), the mainstream conservative grouping in the European Parliament. He said his Fidesz party would team up with like-minded parties in Italy and Poland to reorganise European right-wing politics. He would soon meet with Salvini, who heads Italy’s League party, and Poland’s Prime Minister Mateusz Morawiecki. “We will plan the future together.” (Source: Reuters)

2021. III. 19.  Magyarország az eddigi 6,5 millió adagról 10,9 millióra növelte a lekötött Pfizer-BionTech oltóanyag mennyiségét, így már összesen 31 millió adag oltóanyagot kötött le. Ebből 24 millió adag oltóanyagot várunk az Európai Uniós beszerzésből, ennek eddig a 7 százaléka érkezett meg három gyártótól (Pfizer, Moderna, AstraZeneca). A Johnson & Johnson oltóanyagának szállítása várhatóan csak április második felében kezdődik. A Janssen egydózisú oltóanyagból 4,36 millió adagot vár Magyarország, amely ugyanennyi ember oltását teszi lehetővé. A kínai oltóanyagból eddig három szállítmány érkezett, az első több mint félmillió adagos szállítmányt a háziorvosok gyakorlatilag mára beoltották a regisztrált idősek körében, a második 450 ezer adagos szállítmányt jövő héten kezdik felhasználni a már beoltott idősek második körös oltására. Az ezen a héten érkezett 100 ezer adag kínai oltóanyaggal a szükséges hatósági vizsgálat után lehet majd oltani, ezt szintén a regisztrált idősek első és második körös oltására használják majd. Az eddig érkezett Szputnyik-oltóanyaggal a regisztrált idősek oltását  végezték a kórházi oltópontokon, a legutóbb érkezett 180 ezer adag első dózisú oltóanyag alkalmazását a Nemzeti Népegészségügyi Központ t(NNK) március 15-én engedélyezte, és ezt a hét második felében szállították ki a kórházi oltópontokra, ahol a háziorvosok által beküldött regisztrált időseket oltják vele. Márciustól a Pfizer-BionTech második adagját a korábbi 21 nap helyett 35 napos különbséggel, az AstraZeneca második adagját a korábbi 4 hét helyett 12 hetes különbséggel adják be. Az eddig csak 18-59 év közöttiek oltására engedélyezett AstraZeneca alkalmazása is megváltozott, már a 60 év felettieket is olthatják vele a háziorvosok. Az operatív törzs kifejezetten azt kérte a háziorvosoktól, hogy a még be nem oltott regisztrált időseket oltsák ezzel az oltóanyaggal is. (Forrás: Híradó / MTI / koronavirus.gov.hu)

2021. március 19. Az immun-válasz kialakulása és későbbi hatása /video/ (Forrás: MTA): https://tinyurl.com/ecajmkzz

2021. III. 18. A beoltottak száma 1 441 706, ebből 421 915 fő már a második oltását is megkapta. A brit vírus-mutáns nagyon gyorsan terjed, jelentősen nő az aktív fertőzöttek és a kórházi betegek száma. A járvány kezdete óta összesen 539 080 főre nőtt a beazonosított fertőzöttek száma, az elhunytaké 17 628 főre emelkedett. A gyógyultak száma 360 895 fő, az aktív fertőzöttek száma 160 557 főre emelkedett. 10 386 koronavírusos beteget ápolnak kórházban, közülük 1170-en vannak lélegeztetőgépen. Müller, országos tiszti főorvos elmondta: több vírusvariáns van, amit a PCR-tesztek nem tudnak kimutatni. A Magyarországon használt PCR-tesztek háromféle antigént is ki tudnak mutatni. Az oltási program rendben, ütemezetten zajlik, a veszélyeztetettségük miatt továbbra is a regisztrált idősek oltása van elől a sorban. A következő napokra ehhez a háziorvosoknak átlagosan 10 fő oltására elég AstraZeneca oltóanyag jut, további 44 idős embert tudnak kórházi oltópontra szervezni, ahol Szputnyik és Pfizer oltóanyagok vannak. Ma 54 ezer Moderna oltóanyag érkezett, valamint 21 600 AstraZeneca, amiből 74 ezernek kellett volna érkeznie. ​Várhatóan a jövő héten is kevesebbet kapunk majd. Ahogy beérkeznek az oltóanyagok, azokat be is adják. (Forrás: Híradó)

2021. 03. 13.  Kínai oltóanyag üzlet; 55 milliárdos beszerzés, cégalapítás, tulajdonosváltások, kapcsolati háló. A kínai Sinopharm-oltóanyag beszerzésére egy 'rendkívül zavaros hátterű céggel" kötött szerződést a magyar állam, miközben közvetlenül a gyártóval is megállapodhatott volna. Az orosz oltóanyagokért 19,9 dollárt, míg a Sinopharmért 30 euro + 5 százalék áfát fizet az állam - utóbbiért utalnak majd 57 milliárd forintot a beszerzést lebonyolító Danubia Pharma Kft.-nek. Ez az 2009-ben alapított, gyógyszer-nagykereskedelemmel foglalkozó cég 2020. november 27-én új tulajdonoshoz, a Syntonite Med Zrt.-hez került, amelynek a vezérigazgatója, Tuza, a Danubia Pharmát is vezeti. A Syntonite Med-et 2020. november 24-én hozták létre, két magánszemély alapította, a budapesti Gergely, valamint egy dunakeszi lakos, Kovács. Három nap múlva a Syntonite Med-et már be is jegyezte a cégbíróság - ugyanazon a napon, amikor a Zrt. megszerezte a Danubia Pharma 100 százalékos tulajdonrészét. A cég bejegyzésével kapcsolatos eljárásokban Kovalenko egyéni ügyvédet bízta meg az egyik alapító, Kovács. Az ilyenkor fizetendő illetéket – ami 50 ezer forint volt – egy negyedik személy, dr. Vámosi-Nagy fizette. Dr. Vámosi-Nagy egyik alapítója az SRF Silk Road Zrt.-nek, amelynek vezérigazgatója Szeverényi  gyógyszerkereskedő lett, aki egyidejűleg résztulajdonosává vált az 'üzletviteli, egyéb vezetési tanácsadás' főtevékenységű Fourcardinal Tanácsadó Kft-nek. Ez utóbbi azon cégek egyike volt, mellyel a Külgazdasági és Külügyminisztérium szerződést kötött lélegeztetőgépek beszerzésére. 'Az 1000 darabos beszerzésre szóló kontraktus értéke 17 milliárd forint volt, vagyis gépenként 17 millió forint'. Szeverényi testvérét Áder a külgazdasági  és külügyminiszter előterjesztésére rendkívüli és meghatalmazott nagykövetté nevezte ki 2020. júliusában. 'Az innovatív termékeket és szolgáltatásokat exportálni kívánó magyar vállalkozások külföldi piacra jutásának segítése' a nagykövet Budapestről végzett feladata. Diplomata férje Szabó - volt külügyminiszter-helyettes és amerikai nagykövet - jelenleg a kormánypárti sajtótermékeket kiadó Mediaworks elnök-vezérigazgatója. Szabó 2020 áprilisában, a lélegeztető-beszerzések kellős közepén hagyta hátra a washingtoni missziót, lépett ki a külügy kötelékéből. Az indok: 'elfogadott egy felkérést a gazdasági szférából'. Sógora, Szeverényi épp ezzel egyidőben kötötte meg a 17 milliárdos lélegeztetőgép-szerződést a külüggyel. 2021. február 5-én, bő két hónappal a Syntonite Med alapítás és egy héttel a kínai oltóanyag szerződés aláírása után változás történt a tulajdonosi szerkezetben; kiszállt a cégből Kovács, tulajdonrészét Tuzának adta át. Gergely és Tuza jelenleg fele-fele részben birtokolja a Danubia Pharma mögött álló Syntonite Med Zrt.-t. (Forrás: 24.hu)

Denmark
March 18, 2021   People over 65 who have recovered from COVID-19 have a 50-50 chance of a second attack within six months of their first illness, a new Danish study published in the Lancet medical journal has found. About 80 percent of healthy people under age 65 did not suffer a second attack within six months of a first COVID-19 illness. The study looked at 4,000 test subjects Dr. Ethelberg from the Statens Serum Institute in Denmark said. (Source: NewYorkPost)
The study /at 17 March 2021/: "Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study" (Source: TheLancet): https://tinyurl.com/3m8anv7k

* France
18/03/2021 French Prime Minister Jean Castex has announced a limited month-long lockdown for Paris and several other regions to combat surging Covid-19 cases. Non-essential businesses will close and movement outside will be restricted in the affected regions. Schools will stay open and outdoor exercise allowed up to 10 kilometres from home. Some 1,200 people are in intensive care in the Paris region alone. Residents in affected regions will not be allowed to leave, except for essential business. The curfew that has been in place nationwide will be relaxed all over France so it ends at 7:00 pm rather than 6:00 pm. (Source: Reuters)

March 16, 2021  France has discovered a new COVID-19 variant that appears to be able to escape detection by standard tests for the virus. The French Health Ministry said yesterday that a cluster of cases of the new variant was detected at a hospital in Lannion, in the Brittany region. Several of the patients tested negative on PRC tests. Researchers at the Institut Pasteur are looking into whether the variant has genetic modifications that make it more difficult to detect. Though potentially harder to trace, the variant does not appear to be more serious or transmissible than others. The latest coronavirus surge has seen averages of more than 20,000 new cases a day. “The situation is not getting better, there is a higher and higher number of infections and hospitals are very burdened with many patients, whose average age is getting lower and who don’t always have comorbidities,” Prime Minister Jean Castex said. (Source: NewYorkPost)

Ireland
13 Mar, 2021 The monkey with the biggest stick gets all the coconuts. 34m doses of vaccine have been exported from the EU, including 9m to the UK and 1m to the US. This tremendous figure, despite queues of anxious citizens across Europe, is put in context by the fact that Ireland will get only a further 46,500 doses of the Pfizer-BioNTech vaccine as part of a new EU deal. Had those 34m vaccines gone to the world's poor countries, then it might be a moment to concede to greater needs, but they have gone to rich countries. March 9 figures show that of 34,090,287 doses exported from the EU to 31 countries, 9,106,162 went to the UK, 3,917,640 to Canada, 3,134,204 to Mexico, 2,720,210 to Japan, and 1,368,900 to Saudi Arabia. Other destinations included Hong Kong (1.3m), Singapore (967,030), the US (953,723), Chile (942,825), and Malaysia (751,140). Challenging figures that demand a plausible explanation. This week by Washington telling the EU that it should not expect AstraZeneca Covid-19 vaccines manufactured in the US any time soon. One of the reasons Germany is working to produce at least 360m doses a year within the EU. We are asked, time and time again, to be patient. (Source: IrishExaminer)

Németország     Germany
2021. 03. 21. Sok országban a nyár végéig tarthat a járványügyi korlátozások időszaka az új típusú koronavírus elleni védekezésben, de legalább egy évig tart még, mire világszerte sikerül megszerezni az ellenőrzést a kórokozó terjedése felett – mondták a német BioNTech cég alapítói. A török származású Türeci és férje, Sahin elmondta: helyi járványkitörések továbbra is lesznek és új vírusváltozatok is kifejlődnek, de nagy valószínűséggel nem okoznak majd nagy veszélyt. Rendre szükség lesz majd emlékeztető oltásra, de még nem tudni, hogy évente vagy ötévente. Egyelőre azt sem lehet pontosan látni, hogy mekkora átoltottság kell a járvány megállításához. A két kutatóorvos a napokban megkapta Steinmeier szövetségi elnöktől az egyik legmagasabb német állami elismerést, a Nagy Érdemkereszt Csillaggal nevű kitüntetést, illetve a lapkiadó Axel Springer német multinacionális vállalat díját. (Forrás: Híradó / MTI)

15 March 2021 The Paul-Ehrlich-Institut informss temporary suspension of vaccination with COVID-19 vaccine AstraZeneca following intensive consultations on the serious thrombotic events that have occurred in Germany and Europe. Cases have been reported in Germany. The experts now see a striking accumulation of a special form of very rare cerebral vein thrombosis (sinus vein thrombosis) in connection with a deficiency of blood platelets (thrombocytopenia) and bleeding in temporal proximity to vaccinations with the COVID-19 vaccine AstraZeneca. The data are being further analysed and evaluated by the European Medicines Agency (EMA). (Source: pei.de)

Európai Bizottság      European Commission
2021. 03. 21. Az Európai Bizottság az uniós tagállamok megbízásából és egyetértésükkel csak előzetes beszerzési megállapodásokat kötött a koronavírus elleni oltóanyagokat gyártó hat vállalattal, a konkrét mennyiségi és szállítási szerződéseket a tagállamok írták alá – közölte az Európai Bizottság magyarországi képviselete. Ezek a megállapodások a közös oltóanyag-beszerzés alapvető feltételeit szabják meg. A tagállamok bármelyike dönthetett volna úgy, hogy nem vesz részt ebben a megállapodásban, de egyik sem élt a lehetőséggel – közölték. Az EU-s szintű előzetes beszerzési megállapodások alapján a tagállamok egyénileg kötik meg a konkrét megrendelési szerződéseket a gyártócégekkel; az adott államra vonatkozó  gyakorlati szállítási és mennyiségi feltételeket ezek a szerződések tartalmazzák. A szerződéses feltételek bizalmas kezelését az oltóanyag-gyártók kötötték ki üzleti érdekeikre hivatkozva. Az Európai Bizottság a szerződések közül hármat – AstraZeneca, CureVac, Sanofi-GSK – már nyilvánosságra hozott az érintett cégek egyetértésével, bizonyos bizalmas üzleti adatok kitakarásával– írták. Az Európai Bizottság eddig a Johnson & Johnson (Janssen, 400 millió adag), a Pfizer–BioNTech (600 millió adag), a Moderna (460 millió adag), az AstraZeneca (400 millió adag), a CureVac (405 millió adag) és a Sanofi–GSK (300 millió adag) vállalattal írt alá szerződést védőoltás-beszerzésről. (Forrás: Híradó / MTI)

19 March 2021  European Commission president Ursula Von der Leyen has said the EU will consider restricting vaccine exports to the UK. She has called for reciprocity on vaccine exports amid an ongoing row with the UK and US over jab deliveries. An average of just 10 per cent of Europeans have received their first dose of a Covid vaccine. That compares to 25.7m people who have received their first injection in the UK -  equivalent to almost 39 per cent of Britain’s population.     More than fifteen countries issued a temporary ban on the Astrazeneca vaccine this week over reports of blood clots among patients in several countries. The European Medicines Agency (EMA) said yesterday it remains 'firmly convinced' that the benefits of the Astrazeneca vaccine outweigh the small risk of side-effects, as it gave the jab the green light for use across the bloc. France, Spain, Italy and Germany are among the European countries that confirmed last night they will resume rolling out the Astrazeneca vaccine following the EMA’s ruling.      Von der Leyen confirmed this morning that Russia’s Sputnik vaccine was still under review, though it would need to be approved by the EMA before being rolled out across Europe. (Source: cityam)

16 March 2021   EU Commission agrees delivery top-up with Pfizer/BioNTech. The agreement would see an accelerated delivery of additional 10 million doses being delivered to member statesover the next three months. This will bring the total EU deliveries of this vaccine to 200 million for that quarter. These additional doses are to be drawn forward from the option of 100 million doses in the second contract with Pfizer/BioNTech, foreseen for the third and fourth quarters of this year. (Source: TheJournal.ie)

.

Szólj hozzá!

Címkék: video térkép magyarország chile vírus franciaország olaszország india oroszország japan törökország mexikó virus brazília málta germany denmark singapore canada malaysia ireland poland spain egyesültkirályság európaiunió egyesültállamok európaibizottság magyartudományosakadémia europeanparliament saudiarabia

2021. III. 13. - III. 20. Vírusfertőzés és védőoltás adatok. II. European Union, Europe, United Kingdom, India, Australia, United States, globalization

2021.03.14. 15:51 Eleve

 

2021. III. 20.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
122 639 917

Országonként:

Egyesült Államok * 29 774 306
Brazília 11 871 390
India ** 11 555 284
Oroszország 4 397 816
Egyesült Királyság *** 4 304 839
Franciaország 4 277 182

...
Magyarország 560 971

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 705 934

Országonként:

Egyesült Államok 541 738
Brazília 290 314
Mexikó 197 219
India 159 558
Egyesült Királyság 126 359
Olaszország 104 642

...
Magyarország 18 068

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
69 464 058

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 11 107 332
Brazília 10 470 969
Oroszország 4 014 770
Törökország 2 807 572
Olaszország 2 686 236

...
Magyarország 366 774

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/20/2021 11:26 p. m."

------------------------------------------------

European Union
16 Mar  The majority
of countries in Europe are falling short on tracking coronavirus variants, such as those first detected in the UK, South Africa and Brazil - meaning more contagious strains are spreading undetected. The so-called UK variant, which up to 75 percent more transmissible, is spreading significantly across Europe - with some 24,000 cases officially registered in EU/EAA countries. It continues to predominate in new cases reported in the UK, Ireland, Italy, Portugal, and Denmark, among others. In Germany, it is now responsible for 22 percent of new infections. Only Ireland, Italy, Germany, Luxembourg, Belgium, Denmark, and Finland, together with non-EU Iceland and Norway, have increased genome sequencing to at least 10 percent of positive test results - the level recommended for detecting and monitoring the emergence and dominance of these strains. To identify changes in genes is considered crucial to understanding the progress of the virus behaviour, and, accordingly, the role of adapted vaccines. Meanwhile, the European Centre for Disease Prevention and Control (ECDC) is itself sequencing genomes on behalf of those member states that have very limited or none genome-sequencing  capacity - such as Bulgaria, Malta, Cyprus, Greece, Slovakia and Slovenia. Under its new HERA Incubator programme, the European Commission wants to mobilise €75m to support member states with genomic sequencing. The commission will soon propose speeding up the regulatory approval for adapted vaccines. Companies will not be obliged to submit an entire file from scratch as the new shot would be approved as "a kind of variation" of doses that have been already approved by the EU agency. Moreover, manufacturers will be able to ask for the approval of different modified vaccines under the same marketing authorisation application. (Source: Reuters)

March 15, 2021  The EU has signed deals with six Western vaccine makers and launched talks with two more. It has approved four vaccines so far but production glitches have slowed its inoculation campaign and some member states are seeking their own solutions. Hungary and Slovakia have already bought the Russian shot, the Czech Republic is interested, and the EU official said Italy was considering using the country’s biggest vaccine-producing bioreactor at a ReiThera plant near Rome to make Sputnik V. On Feb. 25, when Mario Draghi made his debut at an EU summit as Italy’s new prime minister, the former European Central Bank chief, who is highly regarded in Brussels for saving the euro from its worst crisis years earlier, took an assertive stand on vaccines to quicken the pace of both inoculations and production in Europe. He told fellow leaders the EU must buy more doses, including from outside the bloc, and expand vaccine production. Italy, traditionally supportive of a softer stance on Moscow, is now pushing EU governments to consider Sputnik V. At a meeting of EU diplomats in 10 March, Italy’s representative urged the EU to broaden its supply of vaccines, including with the Russian shot. EU governments were considering launching talks with Sputnik V developers and it would take requests from four EU states to start the process. If Sputnik V were to join the EU’s vaccine arsenal, it would be a diplomatic triumph for Russia, whose trade with the bloc has been hamstrung for years by sanctions.. A spokesman for the European Commission, which coordinates talks with vaccine makers, said the EU was not required to launch talks with Sputnik V developers, even if the bloc’s drug regulator approves the vaccine. The EU official said no decision had yet been made about whether to approach Sputnik V developers following internal talks on the matter. Even last week, Michel, who chairs summits of EU leaders, again cast doubt on Russia’s motives for promoting Sputnik V. 'We should not let ourselves be misled by China and Russia, both regimes with less desirable values than ours, as they organise highly limited but widely publicised operations to supply vaccines to others,' he said. “Europe will not use vaccines for propaganda purposes.” On March 4, the EMA launched a rolling review of Sputnik V, the first step in a  process that could lead to its EU-wide approval. A decision on possible authorisation could come as early as May. (Source: Reuters)

*** United Kingdom
20 March 2021  Half of all adults in the UK have received their first dose of the COVID-19 vaccine. The UK health services vaccinated a total of 26.8 million people between 8 December and 19 March with first doses, while 2.1 million people - around 4% of the adult population - have had their second dose so far. The UK is on track to achieve the target of offering the vaccine to all over-50s by 15 April, as well as all adults by the end of July. During April around 12 million people will receive their second doses. Through the government’s Vaccines Taskforce, the UK has secured early access to 457 million doses of 8 of the most promising vaccine candidates, including: BioNTech/Pfizer for 40 million doses; Oxford/AstraZeneca for 100 million doses; Moderna for 17 million doses; GlaxoSmithKline and Sanofi Pasteur for 60 million doses; Novavax for 60 million doses; Janssen for 30 million doses; Valneva for 100 million doses; CureVac for 50 million doses. Both the Pfizer and Oxford-AstraZeneca vaccines are highly effective in reducing COVID-19 among older people aged 70 years and over. The Moderna vaccine has also been approved by the MHRA and will be deployed from the spring. Rolling reviews are also underway by the MHRA to assess the Janssen and Novavax vaccines. To date, the government has invested over £300 million into manufacturing a successful vaccine to enable a rapid roll out.  (Source: gov.uk)

18 March 2021  A semi-retired British ex-Pfizer scientist became an anti-vax hero. He co-authored a petition to Europe's medicines regulator. The petitioners made the demand COVID-19 vaccine clinical trials to be halted. They speculated that the vaccines could cause infertility in women. The document appeared on a German website on Dec.1. Within weeks, doctors and nurses in Britain began reporting that concerned women were asking them whether it was true. In January, a survey by the Kaiser Family Foundation (KFF) found that 13% of unvaccinated  people in the United States had heard that 'COVID-19 vaccines have been shown to cause infertility.' One of the petition's co-authors spent 16 years at Pfizer. He joined Pfizer in 1995 and rose to become a vice president and head of allergy and respiratory research. A blog with an alarmist headline – 'Head of Pfizer Research: Covid vaccine is female sterilization' – was shared thousands of times on Facebook. The visage and views of him are widely identified as an "Ex-VP of Pfizer,' and can be seen on social media in languages including German, Portuguese, Danish and Czech. On Feb. 3, his Twitter account had a message for his 91,000 followers: "A tweet recently appeared under my ID, which was horribly offensive. As a result my account was locked. I of course deleted it. I want you to know of course that I didn't write it." He didn't make clear what tweet he was referring to. But shortly after, several Twitter users and a blog called Zelo Street posted screenshots of numerous offensive anti-Muslim tweets from his account from about a year ago. Many were captured at the time by archive.org. On Feb. 4, he cryptically mentioned in a tweet, "I'll soon be gone." Two days later, he was off Twitter. His followers were greeted with this message: "This account doesn't exist." His LinkedIn profile also soon changed, now stating that he is "Fully retired." Craig, a British pathologist, compared his treatment on Twitter – where some users derided his views as nonsense and dangerous – to medieval societies burning heretics at the stake. "There is no other way to see it than the burning of the witches," said Craig, who has  criticized lockdowns and COVID-19 tests. "Science is always a series of questions and the testing of those questions and when we are not allowed to ask those questions, then science is lost." "He will have a think about how he will contribute in the future," she said. (Source: Reuters)

16 Mar 2021 The Covid-19 Bereaved Families for Justice group has told Downing Street it wants a statutory public inquiry led by a senior judge to “determine a definitive, official, evidence-based narrative of what did and did not happen, independent of political influence” during the pandemic. Frontline health workers also want a wide-ranging inquiry to provide a platform for their experiences, while minority ethnic leaders believe an inquiry can only determine what went wrong if wider societal inequalities relating to work, health and housing are investigated. The Covid-19 Bereaved Families for Justice group cites the inquiry into the Hillsborough disaster, which produced an interim report in less than four months. It argues that, for the bereaved, a public inquiry is “likely to be the only way they can obtain answers to what happened to their loved ones, and whether the death could have been prevented”. It says the government has a duty to investigate under the European convention on human rights which demands it in cases where there is an arguable case that there has been a breach of the duty to protect life. (Source: TheGuardian)

March 16, 2021  The coronavirus variant B.1.1.7, which was first identified in the United Kingdom, is associated with an estimated 64% higher risk of dying from Covid-19, according to the study published in the medical journal The BMJ in March 10. The greater risk of death associated with the variant emerges around two weeks in the course of a patient's Covid-19 illness. Could it be that they're getting bacterial infections, because they're in the hospital longer? Blood clots? What complication is causing that delay in death?  B.1.1.7 is projected to become the dominant variant in the US by the end of this month or early April. (Source: CNN)
The study (Source: BMJ): https://tinyurl.com/d7uadux7

Europe
19 Mar, 2021  Excess deaths in UK were among highest levels in Europe for under-65s last year. By the week ending December 18 deaths for this age group were 7.7% higher than the equivalent average figure for the years 2015 to 2019. Only Bulgaria recorded a higher rate of cumulative excess mortality (12.3%). The individual rate for England stood at 8.7%, higher than the figures for Scotland (7.7%), Wales (5.0%) and Northern Ireland (4.1%). For deaths among all ages, Poland ended 2020 with the greatest cumulative excess mortality (11.6% above the five-yearaverage), followed by Spain (10.6%) and Belgium (9.7%). Central and eastern European countries were worse hit in the second half of the year. Cities of central and eastern Europe suffered particularly high excess mortality in the autumn and winter period, with Sofia (112.5%) and Warsaw (103.8%) having the highest weekly excess mortality rates. But these were much lower than those cities affected during the spring of 2020, such as Madrid (452.0%), Barcelona (266.0%) and London (228.4%). (Source: IrishExaminer)

16 Mar  The majority of countries in Europe are falling short on tracking coronavirus variants, such as those first detected in the UK, South Africa and Brazil - meaning more contagious strains are spreading undetected. The so-called UK variant, which up to 75 percent more transmissible, is spreading significantly across Europe - with some 24,000 cases officially registered in EU/EAA countries. It continues to predominate in new cases reported in the UK, Ireland, Italy, Portugal, and Denmark, among others. In Germany, it is now responsible for 22 percent of new infections. Only Ireland, Italy, Germany, Luxembourg, Belgium, Denmark, and Finland, together with non-EU Iceland and Norway, have increased genome sequencing to at least 10 percent of positive test results - the level recommended for detecting and monitoring the emergence and dominance of these strains. To identify changes in genes is considered crucial to understanding the progress of the virus behaviour, and, accordingly, the role of adapted vaccines. Meanwhile, the European Centre for Disease Prevention and Control (ECDC) is itself sequencing genomes on behalf of those member states that have very limited or none genome-sequencing  capacity - such as Bulgaria, Malta, Cyprus, Greece, Slovakia and Slovenia. Under its new HERA Incubator programme, the European Commission wants to mobilise €75m to support member states with genomic sequencing. The commission will soon propose speeding up the regulatory approval for adapted vaccines. Companies will not be obliged to submit an entire file from scratch as the new shot would be approved as "a kind of variation" of doses that have been already approved by the EU agency. Moreover, manufacturers will be able to ask for the approval of different modified vaccines under the same marketing authorisation application. (Source: Reuters)

** India
March 16, 2021   Poonawalla, chief executive of the world’s largest vaccine producer Serum Institute of India (SII), repeated warnings that just half of global population will be vaccinated in the next two years. Export curbs by the US on raw materials critical for Covid-19 shots will slow global efforts to inoculate people, he said. He expressed concern that his company and others would face shortages of vital supplies after the U.S. administration placed export controls on them to boost domestic vaccine production. Filters, bags, key raw materials are only sourced from the US. Last week, the White House said it had used the Korean War-era US Defence Production Act, which prevents the export of materials to prioritise local production, to help drugmaker Merck make Johnson & Johnson’s Covid-19 vaccine. SII is producing the vaccine developed by the University of Oxford and AstraZeneca at its factory in Pune, western India. By January, the company has already released 95 million doses, half of them for local use, with monthly production set to increase from May to 100 million doses, from 60 million. Mr Poonawalla said he had begun building a factory to produce vaccines for Covid-19 variants and as forward planning for the next pandemic. SII has plans for a factory that could make a billion doses within months, but needs major funding from governments. “I will eventually go to governments and offer this to different regional governments so they don’t have to build  their own facilities which might become too costly and impossible for them to do,” Mr Poonawalla said.  (Source: TheNational.uae)

Australia
March 17, 2021  Australia will donate 8,000 locally produced COVID-19 vaccines to Papua New Guinea (PNG). Canberra will suspend all travel to and from PNG from today midnight. Australia said today it will ask the European Union to release 1 million doses of a COVID-19 vaccine to help PNG - parts of which are just a short boat ride from Australian territory - to battle a dangerous outbreak that authorities fear could spread to other parts of the region. PNG, the impoverished country of almost nine million people has officially recorded over 2,300 cases since the pandemic began, a figure experts say vastly underestimates the true outbreak. Prime Minister James Marape earlier this week warned local hospitals would soon be overwhelmed. Australian Chief Medical Officer Kelly said the limited coronavirus testing being done in PNG was showing alarming results. Thousands of people gathered to mourn the death of Michael Somare, PNG’s first prime minister after independence from Australia. (Source: euobserver)

* United States
March 16, 2021  Moderna to launch COVID-19 vaccine trial on children. The move makes Moderna the first U.S. vaccine maker to test its vaccine on infants - Moderna's trial will enroll nearly 7,000 children from ages 6 months to 12 years in the U.S. and Canada. The first age group to start in the trial will be children ages 6 to 11, followed by children ages 2 to 6 and then children 6 months to 2 years of age. Both the Moderna and Pfizer pharmaceutical companies have enrolled children 12 and older in clinical trials of their vaccines and hope to have results by the summer. Last month, the administration announced a revised timeline for children to receive COVID-19 vaccines, telling in Feb. 19 that high school students may receive vaccines in the fall, but elementary school children won't receive them until early 2022. More than 70 million adults in the U.S. have now received at least one dose of a COVID-19 vaccine, or nearly 28% of the adult population. (Source: GoodMorningAmerica)

Globalization
March 13 2021  Flu numbers are down all over the world. And when we emerge from the Covid crisis and start to relax public-health measures - in particular, allowing international air travel to resume - more dangerous agents could surprise us with a violent resurgence. In 1980, a measles outbreak killed some 2.6 million people worldwide. By 2014, vaccinations had brought yearly deaths down to 100,000. The disruption to measles vaccinations, including cancellations, during the current pandemic mean that measles may be set for a massive global outbreak just as the world wakes from the Covid nightmare. The measles vaccine is composed of two doses - known as MCV1 and MCV2 - and the vaccination rate needs to be above 95 percent with both doses to prevent outbreaks. Unfortunately, MCV1 coverage has been stuck at around 85 percent for more than a decade, and MCV2 coverage, while rising, is still only at 71 percent. This is why, after measles cases fell steadily from 2010 to 2016, numbers again began growing - reaching 89,000, 109,000, 142,000 and 207,000 deaths in the following years. In 2020, during the first six months of the coronavirus pandemic, some 50 countries canceled mass vaccination campaigns for various viruses. Routine immunizations were also disrupted with millions of children missing out on important vaccinations. This is like priming an explosive: the measles, is a fierce infectious agent. The reproductive number for measles is 12 to 18, making it one of the world’s most contagious known viruses. We’ve had effective measles vaccines for decades. The challenge is how to achieve sufficient vaccine coverage. (Source: Bloomberg)

.

Szólj hozzá!

Címkék: térkép magyarország vírus franciaország wales olaszország india oroszország törökország mexikó korea china virus brazília belgium germany europe england denmark canada scotland bulgaria poland slovakia portugal spain egyesültkirályság australia europeanunion egyesültállamok europeancentralbank europeancommission czechia globalization papuanewguinea

11 March 2021. Europe. Covid-19 infections - increase over past fortnight

2021.03.12. 03:13 Eleve

 

                                            Source: TheU.S.Sun

 

Szólj hozzá!

Címkék: hungary sweden virus map france germany europe italy austria poland portugal spain greece serbia estonia thenetherlands

7 March 2021. Europe. Covid-19 vaccine doses administered per 100 people

2021.03.07. 22:17 Eleve

 

                                               Source: DailyMail / OurWorldinData)

 

Szólj hozzá!

Címkék: hungary sweden virus france belgium germany europe denmark italy ireland austria poland portugal greece unitedkingdom thenetherlands

2021. III. 5. - III. 12. Vírusfertőzés és védőoltás adatok. I. Magyarország, Bulgaria, Csehország, Italy, Szlovákia, European Union - Európai Unió

2021.03.06. 01:58 Eleve

.

2021. III. 12.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
118 867 662

Országonként:

Egyesült Államok  29 330 642
India 11 308 846
Brazília 11 277 717
Oroszország 4 321 588
Egyesült Királyság 4 261 393
Franciaország 4 050 680

...
Magyarország * 498 183

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 634 979

Országonként:

Egyesült Államok 532 151
Brazília 272 889
Mexikó 193 142
India 158 306
Egyesült Királyság 125 578
Olaszország 101 564

...
Magyarország 16 627

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
67 329 604

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 10 953 303
Brazília 10 031 732
Oroszország 3 928 114
Törökország 2 670 273
Olaszország 2 564 926

...
Magyarország 346 904

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/12/2021 10:23 p. m."

------------------------------------------------

* Magyarország
20210311 Az állam a Danubia Pharma Gógyszerkereskedelmi és Szolgáltató Kft közvetítőn keresztül vásárolja meg a kínai oltóanyagot. A vevő - a Nemzeti Népegészségügyi Központ (NNK), azaz a magyar állam - 30 euro +5% áfá-t fizet darabonként az eladónak, valamint a vám, illetéki, szállítási, biztosítási és egyéb költségek is az államot terhelték. Gulyás, Miniszterelnökséget vezető miniszter a Facebook-on tette közzé az orosz és kínai oltóanyagok beszerzéséről szóló szerződést. A kínai oltóanyagra vonatkozó szerződésből nem derül ki, hogy az eladó milyen áron szerzi be azt. A szerződés tartalmazza a leszállítás idejét: 500 000 adagot március 15-ig, valamint azután minden hónap tizenötödik napjáig leszállít májusig; június 15-ig pedig 3 500 000 darab oltóanyagot kell leszállítania a gyártónak, és az oltóanyagnak legalább a leszállítást követő hatodik hónapig felhasználhatónak kell lennie. Ha az oltóanyagot késéssel szállítják le, akkor a vevő az eladóval szemben nem alkalmaz szankciókat a szerződés szerint. A beérkezett oltóanyagok minőségiellenőrzése az NNK által meghatározott körülmények között történik, és ehhez az eladónak (a Danubia Pharmának) kötelessége a gyártótól az OGYÉI vizsgálatához szükséges dokumentumokat beszereznie és az NNK részére biztosítania. A februárra és márciusra szerződött  teljes vételár, valamint az április és májusi mennyiség vételára együtt 66 millió euro, amit a  szerződés megkötése utáni 3. napig az államnak ki kell(ett) fizetnie az eladó felé. A fennmaradó összeg 70%-át (azaz 84 millió euro-t) március 31-ig fizeti ki az állam. "A kínai vakcinák beszerzési összege így összesen 150 millió forint (Sic!) + áfa volt'. Ha a szerződés meghiúsul (mert például közben kivonják a forgalomból az oltóanyagot), akkor az eladó 20%-ot fizet kötbérként a vevőnek a még be nem tárolt mennyiség arányában. "További részletek hamarosan.' (Forrás: portfolio)

2021. 03. 11 Érkezett Kínából  összesen egymillió adag oltóanyag már. A beoltottak száma 1 millió 150 ezer, 327 ezren már a második oltást is megkapták. Az emberek kevesebb mint 50 százaléka kér oltást, el kellene érni a 60-70 százalékos arányt. A szabad ágyak száma 13 244, a szabad lélegeztetőgépeké 1918. A szükséges humánerőforráshoz kellő döntéseket a kormány meghozta, az átvezénylésekről az egészségügyben az Országos Kórházi Főigazgatóság dönt. Rendelkezésre állnak a jogszabályok ahhoz is, hogy a magánszolgáltatók is bekapcsolódjanak az ellátásba. Több mint hétezer kijelölt oltópont van az országban. Az egészségügyi jogviszonyra vonatkozó szerződéseket az egészségügyi dolgozók 96,3 százaléka írta alá. 727 olyan orvos volt, aki nem szignálta. 420 új belépő volt, így mintegy 300-zal csökkent az orvosi létszám. Gulyás, Miniszterelnökséget vezető miniszter azt mondta: az orosz oltóanyagból  a két oltás ára 19,90 dollár, mintegy 17 euro, a kínai vakcinából pedig a két dózis 63 euro. Hozzátette: az Európai Uniós beszerzésből származó oltóanyagok valamivel olcsóbbak, van amelyik sokkal, van amelyik valamennyivel. Ezek árát az EU-nak kellene nyilvánosságra hoznia – tette hozzá. Kitért arra is: Magyarország 4 millió 360 ezer adagot kötött le a Johnson and Johnson oltóanyagából, amelyet a gyártókapacitásnak megfelelően szállítanak majd. Ebből az oltásból, a többivel ellentétben, csak egyet kell beadni. Közölte: a kormány egy napon belül nyilvánosságra hozza az orosz és a kínai oltóanyagokra kötött szerződéseket, hozzátéve: levélben fordul az illetékes biztoshoz, hogy az Európai Bizottság által a tagállamok nevében kötött oltóanyag-szerződéseket is nyilvánosságra lehessen hozni. Brüsszel megtiltja a tagállamoknak ezek nyilvánosságra hozatalát – jelentette ki, Mindenkinek joga van tudni, hogy a Bizottság melyik oltóanyag-gyártóval mikor kötött szerződést, mi az oka, hogy számtalan ország, amely előbb szerződött, lényegesen jobban áll a beszerzésben, milyen feltételek és ütemezés mellett szerződött a brüsszeli testület – hangsúlyozta. (Forrás: Híradó / M1)

2021. 03. 11  Újabb 55 200 adag AstraZeneca oltóanyag érkezett. Előzetes jelzések szerint ebből az oltóanyagból kevesebbet fognak szállítani a következő héten. Érkezett további 450 ezer Sinopharm-oltóanyag is. Az oltóanyag-szállítmányok adatait közzéteszik a koronavirus.gov.hu oldalon is, mindenki számára nyomon követhető. Müller, országos tiszti főorvos a múlt heti járványügyi adatokat ismertetve elmondta: a 9. héten 35 802 koronavírusos betegek regisztráltak, átlagéletkoruk 44,5 év, és 55 százalékuk nő, 45 százalékuk férfi. A betegek 23 százaléka a 40-49 éves korosztályhoz, 17 százaléka az 50-59 éves  korosztályhoz, 15 százaléka a 30-39 éves korosztályhoz tartozott. A 20-29 évesek és a 65 év felettiek aránya 12-12 százalék volt. (Forrás: Híradó / M1)

2021. 03. 10. Készülnek a védettséget igazoló színes plasztikkártyák, jobb felső sarkukban a magyar címerrel. Név, útlevél- és személyazonosító szám szerepel rajtuk, valamint egy adattároló kód, amelyet informatikai eszközzel lehet leolvasni. Megjelölik az oltás időpontját, a fertőzéséből felgyógyultak esetében pedig az érvényességi időt. Az információkat magyarul és angolul is feltüntetik. (Forrás: Híradó / M1)

2021. 03. 09. Kásler a koronavírus-fertőzés kórházi kezelésében már igen hatásosnak bizonyult favipiravir hatóanyagú gyógyszer - tabletta - ambuláns alkalmazásáról döntött. A gyógyszer a tapasztalatok szerint megakadályozhatja a tünetek súlyosabbra fordulását. Mostantól már a háziorvos is felírhatja, az otthonukban gyógyuló enyhe vagy  középsúlyos tüneteket mutató járóbetegek számára, kezelésükre, ezzel is elősegítve a betegség könnyebb lefolyását és csökkentve a kórházi kezelést igénylő betegek számát. A gyógyszeres terápia javasolt hossza 5 nap; magzatkárosító hatása miatt várandósság alatt nem alkalmazható. A gyógyszer kizárólag magyar orvosi vény ellenében adható ki, térítésmentesen. (Forrás: Híradó / MTI)

2021. 03. 08., Hétfő. Érvénybe léptek a március 22-ig érvényben lévő szigorított járványügyi szabályok. A Magyar Közlönyben megjelentek szerint nyitva tarthatnak az élelmiszerboltok, a drogériák, a patikák, a posták és a bankok. A plázákban csak ezek lehetnek nyitva. Nyyitva tarthatnak az építőipar működéséhez szükséges üzletek és a mezőgazdasági boltok is. Működhetnek a benzinkutak, nyitva lehetnek a piacok, március 8-án a virágboltok is. A bölcsődék nem zárnak be, mivel az új szabályok az óvodákra és az iskolákra vonatkoznak. A szolgáltatások helyszínei zárnak be (például a fodrászat vagy a kozmetika). De egy vízvezetékszerelő kimehet a munkavégzés  helyére. Az éttermekben elviteles vásárlásra lesz továbbra is lehetőség. A hivatalokban lesz ügyfélfogadás, a postai és csomagküldő szolgáltatások is működhetnek. A játszóterek nyitva lehetnek, de maszkot kell viselni ott is, mint minden közterületen. Az esti kijárási tilalom érvényben marad - este 8 és reggel 5 óra között továbbra is csak különösen indokolt esetben (pl. munkavégzés) lehet az utcán lenni. Kutyasétáltatás lehetséges. Kell tartani a legalább másfél méter védőtávolságot. Ahol lehetséges, otthoni munkavégzést javaslnak. Müller, országos tiszti főorvos elmondta: Magyarországon a brit vírusmutáció okozza a megbetegedések nagy részét. 'Ez a vírustörzs inkább a faitalokat (sic!) támadja meg, és első tüneteként köhögés és magas láz jelentkezik". (Forrás: Híradó / M1)

Bulgaria
8 March 2021 An unprecedented
“doctorisation”. Bulgarian doctors who gained media prominence during the COVID-19 health crisis are now being courted by political parties ahead of the 4 April general elections. Minister of Health, Angelov, a medical doctor and a former head of clinic will head the ticket of the ruling GERB party in the cities of Varna and Veliko Tarnovo. Angelov is known from the TV screen for presenting the “official” views about the pandemic. But in Varna, Angelov will face off against another doctor, Mangarov, the most ardent critic of the official government line, who gained notoriety by preaching herd immunity instead of confinement. Mangarov will lead the lists of a smaller political force, the leftist ABV, in Varna and in Sofia. Chorbanov, head of the Laboratory of Experimental Immunology at the Bulgarian Academy of Sciences joined the political party of TV showman Trifonov, called “There is such a people”. The centre-right Democratic Bulgaria will also feature a popular doctor – pulmonologist Simidchiev, who will compete in the capital, Sofia. Critics of Prime Minister Boyko Borissov say he is trying to boost his public support by lifting pandemic restrictions. Despite the growth in morbidity rates and the delayed vaccination process, restaurants in the country reopened on 1 March, and from 1 April, night clubs will open. Over the past week, Bulgaria has been recording around 2,500 infections per day, and the numbers of hospitalisations and deaths are also increasing. Additionally, Bulgaria ranks last among all 27 EU members in terms of the number of vaccinated people, with about 4.2% of the total population vaccinated with at least one dose. (Source: euractiv)

Csehország
2021. 03. 10 Zeman, köztársasági elnök
közölte: Csehország ajánlatot kapott, hogy Németországgal és Oroszországgal együtt részt vegyen a Szputnyik gyártásában egy általa meg nem nevezett német tartományban. Csehországban ma estig 903 ezer személy kapott koronavírus elleni oltást, a beoltottak száma a héten túllépi az egymilliót. Az egészségügyi miniszter közölte, hogy az oltóanyagok 70 százalékát a Pfizer/BioNTech-oltóanyag teszi ki. Lassulni látszik a koronavírus-járvány terjedése Csehországban. Az új igazolt fertőzöttek száma ma meghaladta a 15 ezret, de ez mintegy 1600-al kevesebb, mint egy hete volt. A kórházak leterheltsége továbbra is kritikus. (Forrás: Híradó / MTI)

Italy
March 9, 2021  Russia’s RDIF sovereign wealth fund has signed an agreement with Swiss-based pharmaceutical company Adienne to produce the Sputnik V vaccine against COVID-19 in Italy, with plans for Italian production to begin in June. It hoped that 10 million doses of Sputnik V could be produced in Italy by the end of the year. (Source: Reuters)

March 5, 2021 When you’re exposed to high pollution levels, your body has been under stress. For decades, Bergamo and other picturesque cities in the Po River Valley in northern Italy have suffered some of the worst air quality in Europe. Pollution has long been considered a leading cause of cancer in the area, which is full of factories and highways crowded with truckshauling commercial goods. Many of the homes are off the main gas  grid, meaning that, in winter, wood-burning and pellet stoves release particulate matter into the stagnant air. Now, scientists are investigating whether one longstanding health crisis has played a role in making a new one worse. Early research suggests that long-term exposure to microscopic particles abundant in Bergamo’s dirty air is associated with greater risk of death from COVID-19, which is, after all, a respiratory disease. A year later, Italy’s COVID-19 fatality rate remains the fourth-highest in the world, after Mexico, Peru and Hungary, according to Johns Hopkins University. Of the country’s 99,000 deaths, almost a third were concentrated in the wealthy northern region of Lombardy. Researchers in Europe quickly noticed that coronavirus hot spots seemed to correspond to relatively polluted areas around the world, such as Bergamo, New York and parts of China, and began investigating. A study published in the December issue of the journal Cardiovascular Research concluded that exposure to tiny particles 2.5 micrometers or smaller, known in scientific shorthand as PM2.5 particles, was correlated with a higher percentage of avoidable deaths from COVID-19 among those who came down with the disease. In North America and Europe every cubic meter of air has, on average, 10 to 20 micrograms of PM2.5 particles. In that range, studies have found that each additional microgram correlates to an additional 8% risk of death for COVID-19 patients. In 2019, Bergamo averaged 18.5 micrograms of PM2.5 particles per cubic meter of air. Beijing residents breathe an especially toxic soup that averaged a whopping 42.1. (Source: Yahoo)

Szlovákia
2021. 03. 05. Matovic Igor szlovák miniszterelnök
ma nyilvánosan köszönetet mondott Magyarországnak, hogy segítséget nyújtott Szlovákiának a kétmillió, koronavírus elleni Szputnyik V orosz oltóanyag beszerzéséhez. (Forrás: Híradó / MTI)

European Union     Európai Unió
March 12, 2021 The EU began to relax its ban on non-essential travel from the rest of the world last July by drawing up a roster of countries with low infection rates from where people would be allowed in. But that list, which doesn’t include the U.S. or the U.K., has steadily shrunk and now totals just seven nations. The issue could be discussed by EU leaders at a summit later this month. Discussions among EU states haven’t yet considered what rules should apply for example if someone from a third country was to enter the bloc via one state and then seek to  travel directly to another. (Source: Bloomberg)

March 12, 2021 Severe allergies should be added to the possible side effects of AstraZeneca's coronavirus vaccine after likely links were found to a number of cases in Britain, the EU's drug regulator said today. "The update is based on a review of 41 reports of possible anaphylaxis seen among around 5 million vaccinations in the United Kingdom," it said. The AstraZeneca vaccine's product information already said that people should be kept under "close observation for at least 15 minutes" after getting the jab in case of allergic reactions. (Source: MedicalXPress)

March 12, 2021 AstraZeneca. The German institute that oversees vaccine safety said in a statement that there have been 11 reports of instances of blood clotting - and four deaths - from a pool of about 1.2 million  who have received the shot in the country. There’s no evidence the clotting resulted from the vaccine, leading the institute to echo the European Medicines Agency’s position that the benefits of the shot outweigh the risks. French Health Minister Veran said yesterday that only 30 people have had clotting issues out of about 5 million who’ve received the shot across Europe. There’s no evidence of causality, he added, and “no reason to suspend the AstraZeneca vaccinations.” To be sure, Denmark and other countries aren’t claiming a direct link between the Astra vaccine and unwanted side effects - they’re calling for more research to be carried out before continuing administering the shot. Countries including Italy have only banned  supplies that came from a particular production batch. AstraZeneca said that analysis of more than 10 million records has shown no evidence of an increased risk of pulmonary embolism or deep vein thrombosis in any age group, gender, batch or country. (Source: msn)

2021. 03. 11. Az Európai Gyógyszerügynökség (EMA) ma közleményében jelezte, hogy a feltételes forgalomba hozatali engedély megadásával alkalmazásra ajánlja az amerikai Johnson & Johnson oltóanyagát, amelyet a Janssen leánycég fejlesztett ki. Uniós alkalmazása elősegíti az oltási kampány fokozását már 2021 második negyedévében. Az Európai Bizottság október 8-án kötött megállapodást a Johnson & Johnson vállalattal 200 millió adag oltóanyag beszerzéséről, további 200 millió dózis vásárlásának lehetőségével. Az Egyesült Államokban február végén engedélyezték a szert, amelyből Magyarország mintegy 4,3 millió dózist kötött le. Az Európai Bizottság a Novavax amerikai vállalattal 100 millió adag, a Valneva európai biotechnológiai vállalattal 30 millió dózis, és további 30 millió adag beszerzésének lehetőségével zárta le a tárgyalásokat. Az EU-s beszerzések révén ez idáig 60,7 millió adag oltóanyagot szállítottak a tagállamokba, amelyekből 43,1 millió adagot adtak be az embereknek. (Forrás: Híradó)

11 March 2021  The European Union has allowed the export of 34 million doses of Covid-19 vaccines over recent weeks, despite shortages at home. More than 9.1 million doses were exported to the UK at a time when diplomatic tensions rose over vaccine exports and the implementation of the Brexit divorce agreement. The exports were only for the producers that respect their contract commitments towards the EU. (Source: IrishExaminer)

A 2021. március 5. - március 12. közötti előzmények itt érhetőek el / About the period of 5 March - 12 March 2021:

https://tinyurl.com/77hnh83u

.

Szólj hozzá!

Címkék: kína térkép magyarország franciaország peru szlovákia csehország olaszország india németország oroszország törökország mexikó virus brazília mexico europe denmark bulgaria switzerland egyesültkirályság európaiunió egyesültállamok európaibizottság northamerica nemzetinépegészségügyiközpont

2021. III. 5. - III. 12. Vírusfertőzés és védőoltás adatok. II. European Union, Oroszország, England, United Kingdom, Europe, China, Dubai, Iran, Izrael - Israel, United States, Brazil.

2021.03.05. 23:50 Eleve

.

2021. III. 12.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
118 867 662

Országonként:

Egyesült Államok * 29 330 642
India 11 308 846
Brazília ** 11 277 717
Oroszország *** 4 321 588
Egyesült Királyság **** 4 261 393
Franciaország 4 050 680

...
Magyarország 498 183

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 634 979

Országonként:

Egyesült Államok 532 151
Brazília 272 889
Mexikó 193 142
India 158 306
Egyesült Királyság 125 578
Olaszország 101 564

...
Magyarország 16 627

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
67 329 604

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 10 953 303
Brazília 10 031 732
Oroszország 3 928 114
Törökország 2 670 273
Olaszország 2 564 926

...
Magyarország 346 904

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/12/2021 10:23 p. m."

------------------------------------------------

European Union
11/03/2021  Denmark has suspended use of AstraZeneca’s Covid-19 vaccine after several patients developed blood clots. The Danish Health Agency said it was not certain the blood clots were linked to the vaccine. In 8 March Austria stopped administering a batch of vaccines produced by the Anglo-Swedish laboratory, after a 49-year-old nurse died of "serious clotting disorders" days after being immunised. Four other European countries – Estonia, Lithuania, Latvia and Luxembourg – also suspended vaccinations of doses from the same batch, which was delivered to 17 countries and included one million vaccines. A preliminary investigation by the European Medicines Agency found there was no link between the AstraZeneca vaccine and the death in Austria. (Source: rfi)

8 March 2021  Biden and Ms von der Leyen spoke on phone call in March 5 to discuss their joint efforts in the pandemic. Following that conversation, Breton, the EU's internal market commissioner was tasked with working with Zients, the US Covid tsar, on vaccine supply chains. Brussels, which hopes for stronger ties with the White House with Biden in charge, is reliant upon the States for some of the raw materials needed to make jabs. By February 26, the bloc with a population of 446 million people had received 51.5 million doses, according to official EU data. The EU would receive 'in the second quarter an average of around 100 million doses a month, in total 300 million by end June', Ms von der Leyen told the Stuttgarter Nachrichten newspaper. (Source: DailyMail)

March 5, 2021  France could follow Italy in blocking Covid vaccine exports. EU rules mean shipments can be stopped if delivery targets are not met. Italy, backed by the European Commission, stopped the export of some 250,000 doses of AstraZeneca’s vaccine to Australia after the country’s new Italian Prime Minister Mario Draghi called for stronger measures against manufacturers that failed to meet delivery commitments. Under rules brought in by the European Commission in January, vaccine exports can be curbed. Australian Prime Minister Scott Morrison said today he could understand the decision, with his country reporting fewer than 1,000 deaths from the virus. Australia began its vaccination programme last week and is expected to begin local production next month. Recent studies showing the AstraZeneca vaccine does provide strong protection in the elderly have prompted a reversal of that policy in countries such as Belgium, Denmark, France, Germany, Greece and Sweden. (Source: TheNationalNews.uae)

*** Oroszország
2021. 03. 10.  Oroszországban az újonnan diagnosztizált betegek száma második napja van 10 ezer alatt van, ez a legalacsonyabb szám október 1. óta. Ezzel a fertőzöttek száma 4 351 553-ra, a felépülteké 3 945 527-re emelkedett. Az R-szám 0,9, az új esetek 10,7 százaléka tünetmentes. Az aktív fertőzöttek száma 315 751-re csökkent, míg a halálos áldozatoké 466-tal 90 275-re nőtt. Új koronavírusos fertőzés gyanújával 510 534 embert tartanak orvosi megfigyelés alatt. 48-ra nőtt a Szputnyik V-vel való oltást engedélyező országok száma s az engedélyező államok összlakossága meghaladja az 1,2 milliárdot az orosz oltóanyagok fejlesztését finanszírozó Oroszországi Közvetlen Befektetési Alap (RFPI) szerint. Az orosz oltóanyag alkalmazását ma Kenyában és Marokkóban engedélyezték. (Forrás: Híradó / MTI)

**** England
11 March 2021  The number of people waiting for hospital treatment in England has hit a record high after January's coronavirus peak. Some 4.66 million people were waiting to begin treatment at the end of January, according to NHS England. The number waiting more than a year was 304,044 in January. In comparison, the number in January 2020 was just 1,643. In early 2020 all non-urgent operations were postponed ahead of the first wave of the pandemic. With lockdown in force and many hospitals dealing with record numbers of COVID patients, January also saw a 54% drop in people admitted for routine treatment. (Source: SkyNews)

**** United Kingdom
March 12, 2021   AstraZeneca has again cut down its forecast for coronavirus vaccine deliveries to the European Union in the first quarter of 2021, telling the EU officials it expects to only provide about 30 million doses by the end of March, according to a document dated March 10. AstraZeneca CEO Soriot had told MEPs on February 25 that the company would try and deliver 40 million doses by the end of March, already a stark drop from the target of 80 to 100 million doses written in the contract between the European Commission and the firm. The EU can expect a further 20 million doses of the Oxford/AstraZeneca jab in April. As of March 7, AstraZeneca has delivered slightly more than 11 million doses to the EU. (Source: Politico)

Europe
Mar 11 2021  Earlier this week the EU’s bungled jab rollout suffered yet another serious setback: another 55 million doses have been delayed. Johnson & Johnson has told it is facing supply issues that may complicate plans to deliver all the vaccines - 55 million doses - the bloc has ordered for the second quarter of the year. It comes after Pfizer also cut supplies to the bloc, vowing to make up for it with larger-than-expected deliveries later this year. The British/Swedish firm AstraZeneca has also slashed its delivery to the EU in the first quarter of this year. The EU has given first doses to just six per cent of its population so far compared to 33 per cent in the UK. Much of the third wave has been fuelled by the new “British variant” of the virus that was first detected in Kent. In Italy, infections jumped by 50 per cent in a fortnight with about 300 deaths each day. In Hungary infections have more than doubled in 14 days. Scientists in the Czech Republic believe the country could achieve herd immunity without jabs because infection rates are now so high. Germany, which Angela Merkel declared was in the grip of a third wave a week ago, has not yet seen a big rise in cases. France has been in a third wave since the start of the year, the infection rate has flattened since late January. Spain and Portugal appear to be past the third wave, with infections dropping steeply. (Source: TheU.U.S.Sun)
A comment: "This is what happens when you become unhealthy reliant on tourism economy".

March 6, 2021  Variants power virus surge sweeping Europe. The highly contagious coronavirus variant first identified in England was racing through. The variants also include versions first identified in South Africa and Brazil. Europe recorded 1 million new COVID-19 cases last week, an increase of 9% from the previous week. It is dominant in Britain, Denmark, Italy, Ireland, Germany, France, the Netherlands, Spain and Portugal. In Lombardy, Italy more than two-thirds of new positive tests are of the UK variant. Cases in Milan schools alone surged 33% in a week. The Czech Republic registered a record-breaking total of nearly 8,500 patients in the hospital with COVID-19 this week. Poland is opening temporary hospitals as the variant has grown from 10% of all infections in February to 25% now. In Britain cases were soaring in December. Cases have since plummeted, from about 60,000 a day at the peak in early January to about 7,000 a day. The rate of decline is slowing. Infection rates are highest in people ages 13 to 17.  The U.K. variant is dominant in France, forcing lockdowns in the French Riviera city of Nice and the northern port of Dunkirk. The variant first detected in South Africa has emerged as the most prevalent in the Moselle region, which borders Germany and Luxembourg. It represents 55% of the virus circulating there. The South Africa variant also is predominant in a district of Austria that extends from Italy to Germany. Austrian officials were announcing plans to vaccinate most of the 84,000 residents. The Brazilian variant, which appears capable of reinfecting people, has been detected in 15 European countries. (Source: AP)

Dubai
March 10, 2021  UAE Covid vaccine: modified third dose of the Covid-19 vaccine to help those with weak immunity. A small number of people in the UAE have received a third Covid-19 vaccine ‘booster’ shot which aims to kick in an immune response against the virus. The third dose of Sinopharm vaccine can be taken by those who have less immunity against diseases, people with chronic illnesses and who belong to the high-risk group, UAE doctors have said. The third dose of Sinopharm vaccine is not in the national policy. The practice is in the trial phase. Third dose should be taken by those having comorbid conditions like diabetes, hypertension, severe asthma, chronic renal or cardiac diseases. (Source: KhaleejTimes)

China
9 Mar, 2021  China has launched a digital health certificate for its citizens that they might one day be able to use as a “vaccine passport”. The certificates, which work though the WeChat social media platform, include details of users’ coronavirus and antibody test results and whether they have been vaccinated against Covid-19. All of the information is encrypted in a QR code that can be verified, decrypted and read using a public key provided by the issuing authority. Chinese President Xi proposed the introduction of a global QR code system at a G20 summit in November, saying it would help countries to 'further standardise policies and establish fast tracks to facilitate the orderly flow of people'. Beijing has already implemented a “green health code” system for use within China. Several countries are considering the introduction of “vaccine passports” to accelerate the reopening of their borders. The concept has already been discussed by the Group of 7 nations, while the European Union is expected to put forward a legislative proposal later this month for a digital green pass that shows if a traveller has been vaccinated against the coronavirus. The World Health Organization, however, has questioned the use of such documents while many countries are struggling to secure sufficient doses of Covid-19 vaccines. Dr Ryan, who heads the WHO’s emergencies programme, said in Geneva yesterday that there were “real practical and ethical considerations”  for countries thinking of using vaccine certification as a condition for travel. Such a scheme would not be fair to those who could not be vaccinated and requiring a vaccine passport to travel might allow “inequity and unfairness [to] be further branded into the system”, he said. (Source: SouthChinaMorningPost)

Iran
11 Mar 2021   Iran says received 150,000 doses of India's Covid jab Covaxin. The country of more than 80 million has lost more than 61,000 lives out of over 1.7 million cases of Covid-19 infection. Iran is in its second month of a vaccination campaign, and it is to receive another 375,000 doses from India next week. Tehran, using multiple sources, started its national vaccination campaign on February 9. It has bought a total of two million doses of Russia's Sputnik V. Tehran plans to launch the local manufacture of the Russian jab before the start of the new Iranian year on March 21. "36 to 40 million doses of Sputnik V will be produced and distributed" in the upcoming year, Jahanpour, the health ministry's public relations head said. Iran also received 250,000 doses of China's Sinopharm vaccine on February 28, donated by the Chinese government. Health Minister Namaki has said Iran will likewise receive 4.2 million doses of the vaccine developed by Anglo-Swedish firm AstraZeneca and Oxford University, purchased via the international vaccine mechanism Covax. Three homegrown vaccine projects have reached the clinical trials phase since December. (Source: BusinessRecorder)

Izrael     Israel
2021. 03. 11. A beoltott szoptató édesanyák az anyatejjel koronavírus ellenanyagot juttathatnak kisbabáik szervezetébe, s ezzel őket is védik. Az Izraelben és az Egyesült Államokban végzett közös kutatás szerint a Pfizer és a BioNTech által közösen fejlesztett oltóanyaggal, valamint a Moderna készítményével beoltott édesanyák olyan antitesteket termeltek a koronavírus ellen, melyek a szoptatásnál átkerültek gyermekeik szervezetébe anélkül, hogy maga az oltóanyag genetikai anyaga is a csecsemőkbe jutott volna.     A mostani járványhullám visszavonuló szakaszában 36 712 aktív fertőzöttet tart nyilván az egészségügyi minisztérium, a koronavírus okozta szövődményekkel 1045 embert ápolnak kórházakban, közülük 645-en súlyos esetnek számítanak, 211-en lélegeztetőgép segítségére szorulnak. A SARS-CoV-2 vírus okozta betegségben tavaly február óta 5955-en haltak meg Izraelben. (Forrás: Híradó / MTI)

March 9, 2021  40 percent of Israel’s entire population of 9 million people has been fully inoculated via the two-shot Pfizer-BioNTech vaccine, including 90 percent of those over the age of 50 who are most at risk. Health authorities have even begun vaccinating teenagers in a bid to fully stop transmissions that increasingly skew younger. (Source: TheDailyBeast)

* United States
March 12, 2021  A continuation of “America First” approach. Drug manufacturers that received federal assistance in developing or expanding vaccine manufacturing of doses were required to sell their first doses to the U.S. In the case of AstraZeneca, whose vaccine was initially expected to be the first to receive federal emergency use authorization, the U.S. government ordered 300 million doses - enough for 150 million Americans. The two-dose vaccine from AstraZeneca has received emergency approval from the European Union and World Health Organization, but not in the U.S. Now U.S. partners are prodding President Biden to release the supply, noting that the administration has lined up enough doses of the three already-approved vaccines to cover every American adult by the end of May and the entire U.S. population by the end of July. AstraZeneca said that the U.S.-produced vaccines are “owned” by the U.S. government and that sending them overseas would require White House approval. The company said this month it believes it will have roughly 30 million doses available to the U.S. government by the end of March, and another 20 million by the end of April. As foreign regulators have moved ahead with approval for the shot, the U.S. has not dropped its contractual claim on the initial doses produced in the U.S. The administration has purchased enough doses of Moderna, Pfizer and Johnson & Johnson to be able to inoculate 150 million more people than its population by the end of the year. The U.S. has also ordered 110 million doses of vaccine from Novavax, which is expected to file for emergency approval as soon as next month. The U.S. administration did move to have the U.S. contribute financially to the United Nations and World Health Organization-backed COVAX alliance, which will help share vaccine with more than 90 countries with lower and  middle-income nations, but it has yet to commit to sharing any doses. Israel has vaccinated more than half of its population with Pfizer vaccines produced in Europe and has also attempted to use vaccine diplomacy to reward allies. Despite shortages at home and often being accused of vaccine protectionism, the 27-nation European Union bloc has allowed the export of well over 34 million doses of COVID-19 vaccines over the past weeks, including 953,723 shots to the United States. (Source: AP)

12 March 2021  More than half of U.S. adults who have previously been infected with COVID-19 have symptoms of depression, a new study published in JAMA Network Open suggests. The team looked data of surveys conducted between June 2020 and January 2021. Researchers found that 54.2 percent of patients who had  recovered from their illness met criteria for 'moderate or greater symptoms of major depression.' Many reported difficulty sleeping or concentrating, a loss of appetite, feeling tired or finding little pleasure in life. The team, led by Massachusetts General Hospital and Harvard University, also found that people who report their case of coronavirus was severe were five times more likely to have symptoms linked with depression. Younger people were more likely to be depressed than older adults with the risk of symptoms rising 24 percent with every decade.  Women who had COVID-19 were about 28 percent less likely to have depressive symptoms compared to men. Those who suffered headaches while infected were 33 percent more likely be depressed afterwards. (Source: DailyMail)
A comment: "More than half of adults who haven't had COVID also have symptoms of depression".

March 12, 2021   Novavax vaccine is 96 per cent effective against mild, moderate and severe symptoms of the original virus. It is 86 per cent effective against the UK strain of coronavirus,mthe variant which is spreading across the world and is likely to become the dominant strain. The UK trial enrolled more than 15,000 people aged 18 to 84. In a smaller trial conducted in South Africa - where volunteers were primarily exposed to another newer, more contagious variant widely circulating there and spreading around the world - the Novavax vaccine was 55 per cent effective, based on people without HIV, but it still fully prevented severe illness. The company expects to use the data to submit for regulatory authorisation in various countries. It is not clear when it will seek US authorisation or whether regulators will require it to complete an ongoing trial in the US. Novavax is still planning to file for authorisation from UK regulators early in the second quarter of 2021. The vaccine could be cleared for use in the US as soon as May if US regulators decide the UK data is enough to make a decision. Novavax plans to produce its two-shot vaccine at eight manufacturing locations, including the Serum Institute of India. The Maryland-based company has received $1.6 billion from the U.S. government in funding for the vaccine trial and to secure 100 million doses. (Source: TheNationalNews)

March 9 2021   With the U.S. vaccination effort picking up speed, new coronavirus cases in the U.S. rose 1.5% in the week ended in March 7, Sunday, the slowest increase since the pandemic began almost a year ago. The U.S. reported 420,285 infections for the week, after recording 471,198 cases in the prior seven days. In the past week, an average of 2.16 million vaccine doses per day were administered in the U.S., with the total number of s hots reaching 90.4 million. U.S. cases remain “very high” and a rush to lift virus-related restrictions risks triggering another surge. (Source: msn / Bloomberg)

Mar 8 2021   “As clinicians develop care plans for COVID-19 patients, they should consider the risk for severe outcomes in patients with higher body mass indexes (BMI), especially for those with severe obesity,” the Centers for Disease Control and Prevention (CDC) wrote. About 78% of people who have been hospitalized, needed a ventilator or died from Covid-19 have been overweight or obese, CDC said in a new study today. Over 42% of the U.S. population was considered obese in 2018, according to the agency’s most recent statistics. Overweight is defined as having a body mass index of 25 or more, while obesity is defined as having a BMI of 30 or more. Among 148,494 adults who received a Covid-19 diagnosis during an emergency department or inpatient visit at 238 U.S. hospitals from March to December, 71,491 were hospitalized. Of those who were admitted, 27.8% were overweight and 50.2% were obese. The risk for hospitalizations, ICU admissions and deaths was lowest among individuals with BMIs under 25. The risk of severe illness “sharply increased,” however, as BMIs rose, particularly among people 65 and older. Obesity is linked to impaired immune function and decreased lung capacity that can make ventilation more difficult. Obesity is a common and costly chronic disease in the U.S. Non-Hispanic Black adults have the highest prevalence of self-reported obesity in the U.S., followed by Hispanic adults and non-Hispanic white people. (Source: cnbc)

March 8, 2021  Some children's hospitals see a surge in rare Covid-19 complication MIS-C. The novel coronavirus doesn't usually cause severe disease in children, but for those few kids that do go on to develop multisystem inflammatory syndrome (MIS-C), the condition seems to inflame different parts of the body, and it can be serious. In an update released in March 5, the US Centers for Disease Control and Prevention said there have been 2,617 MIS-C cases in the United States before March 1, and 33 children have died. More than half the reported MIS-C cases,  59%, were in males and most are in children and adolescents ages 1 to 14, the CDC said. 66% of reported cases are in children who are Latino, 842 cases, or non-Hispanic Black, 746 cases. Typically, a surge in MIS-C follows a surge in Covid-19 cases. A study released in March 5 in JAMA Neurology said that neurologic symptoms are common among children hospitalized for Covid-19 or MIS-C; although symptoms resolved for most patients, some developed into life-threatening conditions. A study published in March encourages doctors to follow-up with these patients to make sure there aren't any cognitive, developmental or physical issues. (Source: CNN)

Mar 7 2021  One of the truly immense tasks of spiritual formation isn’t so much communicating the truth but preparing a heart to receive the truth and respond accordingly. America’s Evangelical Christian communities are often full of the most radically generous people you’ll ever meet. We must understand that they’re trusting voices they truly believe love them, care for them, and have their best interests at heart. You can’t berate them into trusting institutions they may perceive to be distant, elitist, and hostile. According to a recently released Pew Research Center survey, 69 percent of Americans have indicated that they’ve either already taken the vaccine or will definitely or probably take it in the future. That’s up from 60 percent last November. But hesitancy is so profound in white Evangelical communities that it could disrupt the quest for herd immunity. On a partisan basis, white Republicans are among those least likely to take the vaccine. Only 54 percent of white Evangelicals will “definitely” or “probably” take the vaccine. The next-closest numbers belonged to black Protestants and religiously unaffiliated Americans at 64 percent. By contrast 77 percent of Catholics will take the vaccine and a whopping 90 percent of atheists. Evangelical vaccine hesitancy is both an information problem and a spiritual problem. We need to flood the zone with better and more effective spiritual teaching about loving our neighbors and - critically - about trust, faith, and courage. Too many people believe that the refusal to wear a mask in appropriate settings (indoors or in close proximity to others) is a sign of their personal fearlessness. It’s a declaration either that they have faith that God will protect them from the disease or that they don’t fear the consequences of catching the virus.  Yet it’s well-established that the primary purpose of wearing the mask is to protect those around you more than it is to protect yourselves. When I’m standing next to an unmasked family in church, I’m not thinking they’re brave or bold. I’m seeing instead a tangible disregard for the health and safety of those around them. Many people now see the refusal to take the vaccine as a concrete demonstration of their own courageous assertion of individual autonomy. The sad consequence of large-scale rejection of the vaccine (especially given the geographic clustering of Evangelical communities) may well be entire counties and towns that suffer needless sickness and death.  We can perhaps persuade people that taking risks (or enduring inconvenience) on behalf of others should be a cardinal Christian characteristic when making a choice to take a shot or wear a mask. (Source: thedispach)

March 5, 2021  The factory that Pfizer Inc. plans to use to boost production of its covid-19 vaccine for the massive U.S. inoculation effort was cited by federal inspectors last year for repeated quality-control violations. Food and Drug Administration inspectors visited the McPherson, Kansas plant at the end of 2019 into January 2020. They found the drug giant released medications for sale after failing to thoroughly review quality issues that arose in routine testing, the inspection report shows. Inspectors found bacteria and mold in supposedly sterile areas, an issue seen in previous visits to the facility by regulators. And the plant failed to properly sample drug products to ensure they didn't have excessive levels of certain toxins, the inspectors wrote. The company plans to supply the U.S. with 200 million doses of its two-shot vaccine regimen by the end of May. The FDA halted all inspections of drugmaking facilities at the beginning of the Covid-19 pandemic, though it has since resumed some domestic visits. Pfizer's plant in Kansas is also authorized to make the Covid-19 treatment remdesivir for Gilead Sciences Inc. Pfizer will conduct the final stage of vaccine production at the Kansas factory, in which the shot is put into vials, packaged and shipped for distribution.  (Source: SFGate / Bloomberg)

** Brazil
10 March 2021  Very concerning. Health systems in most of Brazil's largest cities are close to collapse because of Covid-19 cases. More than 80% of intensive care unit beds are occupied in the capitals of 25 of Brazil's 27 states. Two cities - Porto Alegre and Campo Grande - have exceeded capacity. The country has recorded more than 266,000 deaths and 11 million cases since the pandemic began. Yesterday, the country recorded more than 70,000 cases, a 38% increase on last week. The surge in cases has been attributed to the spread of a highly contagious variant of the virus - named P1 - which could be up to twice as transmittable as the original version of the virus. The new variant could evade immunity built up by having had the original version of Covid. The chance of reinfection is put at between 25% and 60%. Last week, the leading health institute Fiocruz said that P1 was just one of several "variants of concern" that have become dominant in six of eight states studied by the Rio de Janeiro-based organisation. The 'natural laboratory' will continue to affect all the neighbourhood there and beyond, where people can see what happens when coronavirus goes relatively unchecked fuelled by vaccine shortages. The worry is that the P1 variant is a looming threat over the progress made in the region and the wider world. Brazil has ordered more than 200 million doses of the AstraZeneca and CoronaVac vaccine. So far, more than eight million people have had their first dose, representing just 4% of the population. The Oxford team behind the vaccine earlier said it offers less protection - but should still protect against severe illness. Another Brazilian study has indicated the CoronaVac vaccine, made by China's Sinovac biopharmaceutical company, is effective against the same variant. The Pfizer-BioNTech vaccine has been able to combat the Brazil variant, according to laboratory research published yesterday by the New England Journal of Medicine. The Pfizer vaccine has not yet been rolled out in the country. Economy Minister Guedes said Pfizer had agreed to deliver 14m doses by June after a video call with President Bolsonaro. (Source: BBC)

March 9, 2021  Latin America's largest country long ago succumbed to denialism, disorganization, apathy, hedonism and medical quackery - and buried more than 265,000 people along the way. The ICU occupation rate is at least 80 percent in most states, much higher in some. Patients are being transferred from state to state - sometimes traveling hundreds of miles - in a nationwide hunt for hospital resources. Without ventilators, nurses have pumped infected patients' lungs manually. Cemeteries are running out of space to put the bodies. Refrigerated containers wait outside hospitals to take the overflow. People all over the country are dying at home, unable to get treatment. The situation is unpredictable for both Brazil and the world. There's little national coordination. The vaccine rollout has been bogged down in delays, vaccine shortages and political infighting. It has left the country in disarray: Every city, every state, every Brazilian has taken their own direction. As things stand now, few scientists think the country will be able to stop the carnage. The question is whether the failure to control the virus poses an international threat that will undermine the hard-won gains other countries have made against the virus. The virus will mutate to get around obstacles and barriers. That might have happened with the P.1 variant: preliminary research based on modeling and cell cultures has suggested it can dodge a certain amount of immunity in people who have recovered from a previous infection. The country that doesn't control its outbreak is a risk for other countries in that it's a breeding site for new variants. (Source: TheWashingtonPost)

March 5, 2021  A huge storm forming in Brazil. Sao Paulo, the country ’s financial hub and center of wealth, is where the virus first made landfall one year ago in Brazil, transported  unwittingly by returning skiers and holiday-makers from Spain, Italy and the U.S. From them, it spread to household help and employees.The continent-sized nation of 212 million is facing  more Covid deaths and cases than ever, its hospitals overflowing, its policy in disarray, its vaccine supply severely limited. In addition to a president who scoffs at the disease, rejects masks and leaves each state on its own, the country plays host to a variant that’s more contagious and possibly deadlier which emerged in the Amazonian city of Manaus. Brazil has lost more than 260,000 to the virus. Elsewhere in the country, shots are available only to health-care professionals and those 75 or older, plus priority groups including the indigenous population. The country has only a few doses at hand, not enough to cover even the priority groups. Cities are going off on their own to try and buy them. The government’s cash handouts which helped tie over 66 million Brazilians last year and even reduced poverty levels, ran out in December. Lawmakers debated a new round of aid, which was approved just this week. State health secretaries issued a statement calling on the government to recognize the seriousness of the pandemic. It lamented the lack of a national, coherent policy and asked for more stringent rules for non-essential businesses, including forbidding sports and religious activities and all in-person classes and closing bars and beaches. It also called for authorities to consider shutting airports and suspending interstate travel, as well as imposing a national curfew from 8 p.m. to 6 a.m. during the week and all day on weekends. The concern is that Bolsonaro himself will bar any such initiative. The president raged against governors for creating panic in the population. "We have to face our fears. No more fussiness, no more whining. Are people going to cry forever?," he told a crowd of supporters in 4 March. (Source: Bloomberg)

A 2021. február 25 - március 4.-i előzmények itt érhetőek el / About the period of 25 February - 4 March:

I.:    https://tinyurl.com/4chrhh8u

II.:    https://tinyurl.com/2nxw63bm

.

Szólj hozzá!

Címkék: video térkép magyarország vírus franciaország dubai olaszország india izrael oroszország törökország mexikó sweden china virus iran brazília who belgium germany latvia europe denmark ireland lithuania austria poland portugal spain greece egyesültkirályság australia estonia europeanunion egyesültállamok unitednations europeancommission southamerica czechia thenetherlands

2021. II. 25. - III. 4. Vírusfertőzés és védőoltás adatok. I. Magyarország, Czechia, France, Germany, European Union, Russia

2021.02.25. 22:44 Eleve

2021. III. 4.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
115 467 624

Országonként:

Egyesült Államok 28 808 978
India 11 156 923
Brazília 10 718 630
Oroszország * 4 241 970
Egyesült Királyság 4 213 733
Franciaország 3 895 423

...
Magyarország ** 446 178

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 565 369

Országonként:

Egyesült Államok 519 967
Brazília 259 271
Mexikó 188 044
India 157 435
Egyesült Királyság 124 259
Olaszország 98 974

...
Magyarország 15 476

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
65 296 409

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 10 826 075
Brazília 9 573 696
Oroszország 3 826 183
Törökország 2 601 137
Olaszország 2 453 706

...
Magyarország 328 136

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/4/2021 9:25 p. m."

------------------------------------------------

** Magyarország
2021.03.03.  Újabban 4211 magyar állampolgárnál mutatták ki a koronavírus-fertőzést, meghalt 136, 'többségében idős, krónikus beteg'. 6367 fertőzött van kórházban, már 622-en szorulnak lélegeztetőgépre. Az elmúlt 24 órában 7411 hatósági házi karantént rendeltek el, így most 37 005-en vannak vesztegzár alatt. (Forrás: Híradó)

2021.03.02.  Csaknem 115 ezer adag Pfizer-BioNTech-oltóanyag érkezett Magyarországra ma. Ez "a tizenegyedik magyarországi szállítmány a Comirnaty nevű oltóanyagból". A gyártó által eddig Magyarországra szállított dózisok mennyisége meghaladja a 850 ezret. (Forrás: Híradó / MTI)

2021.03.02.  György, a Miniszterelnökség területi közigazgatásért felelős államtitkára, az oltási munkacsoport vezetője szerint Magyarország a harmadik az átoltottság tekintetében. Az első oltást több mint 721 ezren, a másodikat 252 847-en kapták meg. A praxisok arányában s a regisztráltak arányában biztosítják a 'megyei' háziorvosi praxisok számára, illetőleg a kórházak számára az oltóanyag szállítmányokat. A cél, hogy április 11-ig minden regisztrált megkapja az oltást és a lakosság minél szélesebb rétege szerezzen védettséget. A beoltottak a második adag oltóanyagot a Pfizer estében 21 nap helyett 35 nap, az AstraZeneca esetén 4 hét helyett 12 hét különbséggel kapják meg. Ezzel érhető el, hogy felgyorsuljon az első oltások üteme – emelte ki. A ma érkező 14 ezer adag Pfizer-oltóanyagot, valamint a kínai Sinopharm-szállítmány második részét első oltásként adják be. A múlt heti 275 ezer után ezen a héten 250 ezer Sinopharm oltóanyagot kapnak a háziorvosok – közölte. György ismertette a holnaptól egy hétig tartó oltási tervet. Folytatódik a regisztrált idősek oltása. Több mint 395 ezer időst tudnak beoltani a következő hét napban; 250 ezren a kínai oltóanyagot, 115 ezren a Pfizer oltóanyagát kapják. 38 ezer Moderna védőoltást  'szintén' a 60 évesek kapnak. Szociális otthonok lakóinak mintegy 11 ezer adag Moderna oltóanyagot szállítanak ki. A 60 évnél fiatalabb krónikus betegek - 74 ezer fő - oltása AstraZeneca oltóanyaggal március 6-án és 7-én a kórházi oltópontokon folytatódik. Akik nem jelennek meg, későbbi időpontban juthatnak hozzá az oltáshoz. Müller, országos tiszti főorvos ismertette az egyes oltóanyagokhoz köthető tudományos eredményeket. Az AstraZeneca oltóanyagának hatékonysága  a 35. nap után eléri a 73 %-ot. Ennél az oltóanyagnál a 80 év feletti korosztályban a harmadik-negyedik héten 80 %-os hatékonyságot mértek a betegség súlyos lefolyásának megelőzésében. A Pfizer saját adatai szerint 83 %-al csökkenti a halálozások számát az első védőoltás beadása után. (Forrás: Híradó)

2021.03.02.  Galgóczi, a Nemzeti Népegészségügyi Központ járványügyi osztályvezetője elmondta: klinikai, tudományos és szakmai ismeretek alapján igyekeznek kitolni a második oltás időpontját, a Pfizer oltóanyag esetén, a korábbi 21 helyett 35 napra. Karikó, a Pfizer oltóanyagának kifejlesztésében kulcsszerepet játszó biokémikus szerint az is megfelelő, ha három hét helyett 35 nap telik el az első oltás után a második beadásáig. Hangsúlyozta, hogy már az első oltás is véd. (Forrás: Híradó / MTI)

2021.03.02.  A járvány harmadik hullámának felszálló ágában vagyunk, egyre nő az aktív fertőzöttek és a kórházi betegek száma. Meghalt 130, 'többségében idős, krónikus beteg'. Kórházban 6701 fertőzött van. Az elmúlt napon 2764 új fertőzöttet regisztráltak, a járvány kezdete óta összesen 435 689 főre nőtt a beazonosított fertőzöttek száma. A szakemberek napok óta azt hangsúlyozzák, hogy az elkövetkező három hét olyan kihívás elé állíthatja, nemcsak az egészségügyet, hanem a társadalmat is, amelyet még a vírus megjelenése óta egyszer sem tapasztalhattunk meg. (Forrás: Híradó)

2021. 03. 01.  A járványügyi készültségi időszak utazási korlátozásairól szóló kormányrendelet alapján a külügyminiszter felhatalmazást kapott arra, hogy a belügyminiszterrel közösen rendeletben állapítsa meg azokat az államokat, ahonnan gazdasági vagy üzleti célból Magyarország területére korlátozás nélkül léphetnek be. Ezek: az Amerikai Egyesült Államok, Kína, Oroszország, India, Indonézia, Izrael, Japán, Koreai Köztársaság, Törökország, Ukrajna, Szingapúr, Bahrein és az Egyesült Arab Emírségek. (Forrás: Híradó / MTI)
Megjegyzés: 'Korlátozás nélkül'.  Nem tesztelik az érkezőket? Vesztegzár alá helyezik-e őket! 10 napra?

2021.02.28.  A koronavírus-fertőzésen átesett betegek utógondozására post-Covid szakambulancia-hálózatot indít a Debreceni Egyetem (DE) klinikai központja. A leggyakoribb a fáradtság, légszomj, koncentráció- és memóriazavarok megjelenése, azonban szerteágazó panaszok – különféle légúti, szív- és érrendszeri, véralvadási, idegrendszeri, mozgásszervi, pszichiátriai, emésztőrendszeri, fül-orr-gégészeti vagy bőrgyógyászati problémák – alakulhatnak ki. A post-Covid szakambulancia hálózatban infektológus, gyermekgyógyász, kardiológus, tüdőgyógyász, reumatológus, neurológus, pszichiáter szakorvosok, és szakpszichológusok részvételével a Covid-19-fertőzéssel összefüggésbe hozható panaszokkal küzdő betegek kivizsgálását, gondozását és rehabilitációját végzik március elsejétől. (Forrás: Híradó / MTI)

2021.02.27.  Eddig 563 601 embert oltottak be, közülük 244 407-en már a második oltást is megkapták. (Forrás: Híradó / MTI)

2021.02.26.  Tegnap 74 400 adag AstraZeneca és 40 800 Moderna oltóanyag érkezett az országba. Magyarországon is megjelent a dél-afrikai mutáns; tegnap a Neumann Diagnosztikai Laboratórium mutatta ki egy férfinál. Február 25-ig 418 esetben mutatták ki a brit mutánst. 34 főnél mutattak ki különböző variánsokat, és kilenc embernél a "cseh mutánst'. (Forrás:  Híradó / M1)

2021.02.26.  A KOVIDők egy táblázattal segíti az embereket abban, hogy kiigazodjanak a különböző oltóanyag-típusok közt. (Forrás: Híradó / FaceBook): https://tinyurl.com/yrpthy26

2021.02.25.  'Minden Magyarországon elérhető oltóanyagot a magyar hatóságok megvizsgáltak, és a magyar állam teljes felelősséggel áll amögött, hogy ezek az oltóanyagok megbízhatóak és hatékony védelmet jelentenek a koronavírussal szemben" – jelentette ki Gulyás miniszter. Azt teljesen kizártnak tartotta, hogy magánellátásban pénzért lehessen majd oltást beadatni. A magyar államnak van oltási programja, szerez be oltóanyagot, ennek megfelelően oltanak, a Nemzeti Népegészségügyi Központ másra biztosan nem fog majd engedélyt kiadni – jelentette ki. Hozzátette: hogyha ma Magyarország területén oltóanyag lenne szabadon, akkor azt az állam azonnal lefoglalná, ugyanúgy ahogy egyébként azt más államok is teszik. (Forrás: Híradó / M1)

2021.02.25.  Mivel ismét emelkedik a fertőzöttek száma, a kormány úgy döntött, hogy a fennálló járványügyi szabályokat meghosszabbítja március 15-ig. Eddig 508 073 fő kapott oltást,  közülük 211 073 fő már a második oltását is megkapta. (Forrás: Híradó / M1)

2021.02.25. Az egész eddigi koronavírus-járvány legnehezebb két hete előtt áll az ország – közölte a miniszterelnök. Az újfajta mutációk megjelenése miatt a fertőzések száma erősen nő és nőni fog – fogalmazott. Hozzátette: olyan terhelés lesz a kórházakon, mint amilyen még nem volt. Minden orvosra, minden ápolónőre, minden lélegeztetőkészülékre szükség lesz – mondta.  (Forrás: Híradó / MTI)

2021.02.25. Magyarország részt vehet egy harmadik klinikai fázisban lévő török oltóanyag tesztelésében – jelentette be Szijjártó külgazdasági és külügyminiszter, miután találkozott török kollégájával. Azt mondta: Törökországban jelenleg 17 oltóanyag fejlesztésén dolgoznak. Mivel az illegális bevándorlás most már egészségügyi kockázatot is hordoz, Szijártó arra kérte az európai, brüsszeli politikusokat, hogy ennek tudatában nyilatkozzanak kritikusan Törökországról. Cavusoglu török külügyminiszter azt mondta, hogy Magyarország stratégiai szövetségese Törökországnak. Jelezte, hogy Orbán Viktor miniszterelnökkel is találkozik még a nap folyamán. (Forrás: Híradó / MTI)

2021.02.25.  A jövő év végén megkezdődik a koronavírus elleni oltóanyag hazai gyártása Debrecenben – jelentette be az innovációs és technológiai miniszter. Nemzeti Koronavírus-Oltóanyaggyárat hoznak létre, amely a Debreceni Egyetem (DE) és a Nemzeti Népegészségügyi Központ együttműködésében fejlesztés alatt álló oltóanyagot gyárt majd. Szilvássy, a DE rektora jelezte:konzervatív technológiával inaktiválják a vírust, ebből már négy liter áll rendelkezésükre, és túl vannak az állatkísérleteken. Nemcsak antivirális, hanem antibakteriális otóanyagokat is gyártanak majd Debrecenben. Szavai szerint a magyar gyár nemcsak az országot, de Kelet-Közép-Európa lakosságát is képes lesz ellátni oltóanyagokkal. A beruházások teljes költsége várhatóan 55 milliárd forint, ebből a koronavírus oltóanyaggyár mintegy 6,7-7 milliárdba kerül. Az oltóanyaggyárat a Debreceni Egyetem által e célra alapított gazdasági társaság fejleszti, a gyár egyetemi tulajdonban marad. Az idei feladatokra mintegy 17 milliárd forint költségvetési forrást biztosítanak. Palkovics kitért arra is, hogy 'a szolgáltatások színvonalának növelése és azokhoz való jobb hozzáférés érdekében' tárcájánál hamarosan elkészül a hazai magánegészségügy továbbfejlesztésének stratégiája. (Forrás: Híradó / MTI)

Czechia
04-Mar-2021   China is to send the Sinopharm vaccine to badly hit Czechia after an agreement between the two countries, according to President Zeman's office. The President of the Republic granted this request and wrote to the President of the People's Republic of China. The office of Prime Minister Andrej Babic has not yet confirmed the request. Czechia, a country of 10 million people, has reported more than 20,000 deaths from COVID-19 and has one of the worst per capita infection rates in the world. (Source: cngt)

France
25/02/2021  ‘Mafia-type’ groups often based in eastern Europe but not just limited to there likely behind cyber attacks on French hospitals. Criminal organisations would typically demand ransom money from victims to restore their computer systems, after paralysing their software. Hospitals at Dax and Villefranche-sur-Saône were still working with pen and paper after their computer systems were hit. France's cybersecurity watchdog said on Feb. 15 that hackers had spent up to three years breaking into organizations by targeting monitoring software made by  French company Centreon. French motorhome company Trigano and boatmaker Beneteau also announced this month that they had suffered cyber attacks. (Source: France24)

Germany
March 3, 2021  Last month, Prof Wieler – president of the Robert Koch Institute – said Muslims comprised more than 50% of those in intensive care, despite making up less than 5% of Germany’s population. On the conference call on February 14, Voshaar of the Lung Clinic at the Bethanien Hospital in Moers, western Germany, reportedly said: "According to my analysis, more than 90% of the intubated, most seriously ill patients always had a migrant background.” “We agreed among ourselves that we should describe these people as 'patients with communications barriers,' he said. “There are parallel societies in our country. You can only put that right with proper outreach work in the mosques, but we're not getting through. And that sucks.” The country has recorded more than 71,000 deaths linked to Covid-19. About 5.3 per cent of the Germany’s population have been given at least once vaccine dose but the government has been criticised for not doing more. The authorities are also under pressure to reverse a decision not to use the AstraZeneca vaccine on over-65s amid fears about its effectiveness. It has led to a build-up of unused doses of the AstraZeneca vaccine, with about two thirds of the 1.4 million delivered still in storage. (Source: TheNationalNews.uae)

European Union
04/03/2021   EMA starts review of Russian-developed Sputnik V COVID vaccine. The announcement comes just days after Slovakia became the second European Union member state, after Hungary, to receive deliveries of the Russian-made vaccine despite it not being approved by the regulator, deepening a political crisis in the eastern European country. (Source: euronews)

02.03.2021  The European Commission has signed a contract with Moderna pharmaceutical company to supply an additional batch of 300 mln doses of COVID-19 vaccines. The first contract with the company provided for the delivery of 160 mln doses. 150 mln additional doses of Moderna vaccines are to be delivered to the EU this year and the other half next. In total, the Commission contracted 2.6 bn doses. (Source: Polandin)

2 March 2021  The AstraZeneca jab has found itself shunned by some societies amid controversy. Numerous European countries, responding to limited clinical trial data on its  efficacy among elderly people, have restricted its use to populations under the age of 70, 65 or even 55. Four-in-five AstraZeneca doses remained unused across Europe over two weeks following their delivery. In Germany, appointment openings for the shot, meanwhile, are being left vacant.  Scottish data revealed that it has been 94 percent effective in preventing hospitalisations in the country. The World Health Organization, furthermore, has recommended it for all adults.  Slovakia has reported among the highest-per-capita fatality rates in the world in recent weeks and its hospitalisations have hit record peaks. Estonia, meanwhile, has recorded the second-highest rate of new coronavirus cases in Europe. Estonia has managed to completely exhaust its AstraZeneca supply and Slovakia has made significant headway in doing the same.  Slovakia has launched a mass vaccination programme aimed at teachers and childcare workers. Estonia has begun inoculating frontline workers including teachers, police officers and members of the armed forces ahead of schedule. In Slovakia more than 26,000 teachers under the age of 55 alone were vaccinated with their first dose within twoweeks. The initiative is now being expanded to include public transportation employees, taxi drivers and some retail workers who are engaged in regular social interaction as part of their jobs. Estonia's programme has proven similarly popular, with a reported 70-percent uptake among its police forces. In Germany, several regional prime ministers are indeed now calling on authorities to loosen the country's prioritisation scheme to allow younger individuals, even if they are farther down the priority list, to be administered unclaimed doses. (Source: euobserver)

* Russia
4 March 2021  Russia has said it expects several European Union countries to approve the use of its Sputnik V coronavirus vaccine this month, and that Moscow could provide vaccines for 50 million Europeans from June if the shot wins EU-wide approval. The European Medicines Agency (EMA) said it had started a rolling review of the jab, monitoring ongoing clinical trials. Slovakia received 200,000 doses of the Russian vaccine in 1 March, the first of 2 million doses set to be shipped in the coming months. In Europe, Sputnik V vaccine has been approved in  Slovakia, Hungary, San Marino, Serbia, Montenegro, Republika Srpska, Belarus and Russia. (Source: TheIndependent)

Előzmények / Previously:

A 2021. február 25 - március 4.-i előzmények itt érhetőek el / About the period of 25 February - 4 March:

https://tinyurl.com/2nxw63bm

A 2021. február 17-24.-i előzmények pedig itt  / About the period of 17 - 24 February 2021:

https://tinyurl.com/umfbjhy9

.

Szólj hozzá!

Címkék: magyarország vírus franciaország csehország olaszország india oroszország európa törökország mexikó china virus brazília who germany montenegro scotland slovakia egyesültkirályság serbia sanmarino belarus debreceniegyetem europeanunion egyesültállamok europeancommission nemzetinépegészségügyiközpont

2021. II. 25. - III. 4. Vírusfertőzés és védőoltás adatok. II. United Kingdom, China, Izrael, Turkey, United States, South America, globalization.

2021.02.25. 21:54 Eleve

2021. III. 4.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
115 467 624

Országonként:

Egyesült Államok * 28 808 978
India 11 156 923
Brazília ** 10 718 630
Oroszország 4 241 970
Egyesült Királyság *** 4 213 733
Franciaország 3 895 423

...
Magyarország 446 178

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 565 369

Országonként:

Egyesült Államok 519 967
Brazília 259 271
Mexikó 188 044
India 157 435
Egyesült Királyság 124 259
Olaszország 98 974

...
Magyarország 15 476

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
65 296 409

Országonként:

Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 10 826 075
Brazília 9 573 696
Oroszország 3 826 183
Törökország **** 2 601 137
Olaszország 2 453 706

...
Magyarország 328 136

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 3/4/2021 9:25 p. m."

------------------------------------------------

*** United Kingdom
March 4, 2021  Previously authorized vaccines that are modified to combat new variants “will not need a brand new approval or ‘lengthy’ clinical studies,” Britain’s Medicines and Healthcare Products Regulatory Agency said today. “The clear goal is that future vaccine modifications that respond to the new variants of coronavirus can be made available in the shortest possible time to U.K. recipients without compromising at any stage on safety, quality or effectiveness,” Dr. Raine, the head of the agency, said. "To date we don’t have evidence that the vaccines in use in the U.K. are significantly lacking in effectiveness,” Raine said. The new guidance is based on the model already used to modify the seasonal flu vaccine to keep up with annual changes in the virus and was issued jointly by regulators in the U.K., Australia, Canada, Singapore and Switzerland. The U.S. Food and Drug Administration and European Medicines Agency have issued similar guidance. Developers will be required to carry out small-scale trials on a few hundred people. (Source: AP)

4 Mar 2021  Being overweight increases the risk of becoming ill with Covid. About two-thirds of adult Britons are overweight or obese. The Department of Health and Social Care is giving the NHS and local councils in England £70m to pay for up to 700,000 overweight or obese people to go on weight management courses to help them shed unwanted pounds. Citizens are offered cash payments if they do a certain amount of physical activity, such as walking and running, and their progress is measured through wearable devices. Meanwhile, the UK could be flooded with cheap junk food as part of post-Brexit trade deals. Several nations with which the UK is negotiating trade deals – the US, Canada and Australia – are home to multinational food corporations and so have a strategic interest in increasing their junk food - biscuits, pizza, waffles and confectionery - sales. (Source: TheGuardian)

1 March 2021  A new pre-print of a study published by Public Health England today shows that just one dose of both the AstraZeneca and Pfizer vaccines is more than 80 per cent effective at preventing hospitalisations among the over-80s, three to four weeks after the shot. (Source: Spectator)

March 1, 2021  By yesterday, over 20 million people in Britain had been given a first dose of COVID-19 vaccine - just over 30% of the population, while around 800,000 had had a second dose. (Source: Reuters)

China
March 3, 2021  China has been slow to vaccinate its people relative to other countries, administering 3.56 doses per 100 people so far, in a population of 1.4 billion, according to Zhong, the head of an expert group attached to the National Health Commission. Chinese health experts say the country has enough vaccine supply for its population, although the country has pledged to provide close to half a billion doses abroad, roughly 10 times the number it has delivered at home. Developers of China’s four currently approved vaccines have said they could manufacture up to 2.6 billion doses by the end of this year. Still, vaccinating China’s massive population will be a daunting task. Fu, the head of China’s Center for Disease Control, predicted that life could return to an “approximate normal” in summer next year. (Source: IndiaToday)

March 2, 2021  Despite fears over the efficacy and safety of China's COVID vaccines, Beijing's vaccine diplomacy campaign has been a success: it has pledged more than half a billion doses of its vaccines to more than 45 countries and territories.  Just four of China’s many vaccine makers are claiming they are able to produce at least 2.6 billion doses this year. A large part of the world’s population will end up inoculated with China’s humble, traditionally made shots. Amid a dearth of public data on China’s vaccines, hesitations over their efficacy and safety are still pervasive in the countries depending on them, along with concerns about what China might want in return for deliveries. China has said it is supplying “vaccine aid” to 53 countries and exports to 27. Inoculations with Chinese vaccines already have begun in more than 25 countries, and the Chinese shots have been delivered to another 11. It’s a potential face-saving coup for China, which has been determined to transform itself from an object of mistrust over its initial mishandling of the COVID-19 outbreak to a savior. Like India and Russia, China is trying to build goodwill, and has pledged roughly 10 times more vaccines abroad than it has distributed at home. Some of them donated, some of them sold, and some of them sold with debt financing associated with it. Beijing has denied vaccine diplomacy, it said China considered the vaccine a “global public good.” China has targeted the low- and middle-income countries largely left behind as rich nations scooped up most of the pricey vaccines produced by the likes of Pfizer and Moderna. And despite a few delays of its own in Brazil and Turkey, China has largely capitalized on slower-than-hoped-for deliveries by U.S. and European vaccine makers. Like many other countries, Chile received far fewer doses of the Pfizer vaccine than first promised. In the month after its vaccination program began in late December, only around 150,000 of the 10 million Pfizer doses the South American country ordered arrived. Chinese company Sinovac Biotech Ltd. swooped in with 4 million doses in late January that Chile began inoculating its population of 19 million with impressive speed. The country now has the fifth highest vaccination rate per capita in the world. In Jakarta, Indonesian President Widodo was the first person in the Southeast Asian country to get the Chinese shot, 140 million doses of which he has ordered for his people. The choices are limited for Indonesia and many other low- and middle-income countries clobbered by COVID. China’s vaccines, which can be stored in standard refrigerators, are attractive to countries like Indonesia, a sweltering nation that straddles the equator and could struggle to accommodate the ultracold storage needs of vaccines like Pfizer’s. Vaccine deployment globally has been dominated by wealthier countries, which have snapped up 5.8 billion of the 8.2 billion doses purchased worldwide. The bulk of Chinese shots are from Sinovac and Sinopharm, which both rely on a traditional technology called an inactivated virus vaccine. Some countries view it as safer than the newer, less-proven technology used by some Western competitors that targets the coronavirus’ spike protein, despite publicly available safety data for the Pfizer, Moderna and AstraZeneca vaccines and none for China’s. The Ministry of Health in Azerbaijan has ordered 4 million Sinovac doses. In Europe, China is providing the vaccine to  countries such as Serbia and Hungary - a significant geopolitical victory in Central Europe and the Balkans, where the West, China and Russia are competing for political and economic influence. This stretch of Europe has offered fertile ground for China to strengthen bilateral ties with Serbia and Hungary’s leaders, who often criticize the EU. Serbia became the first country in Europe to start inoculating its population with China’s vaccines in January. The country has so far purchased 1.5 million doses of Sinopharm’s vaccine, which makes up the majority of the country’s supply, and smaller amounts of Russia’s Sputnik V and Pfizer’s vaccines. Neighboring Hungary, impatient over delays in the European Union, soon became the first country in the EU to approve the same Chinese vaccine. On Sunday, February 28, Hungarian Prime Minister Viktor Orbán got the Sinopharm shot, after recently saying he trusted the Chinese vaccine the most. In the Indian Ocean island nation of the Seychelles, the president recently received a Sinopharm shot on camera. There were started giving out the vaccines to leaders,  religious leaders and health workers. Beijing’s vaccine diplomacy efforts are good for both China and the developing world. Because of the competition for influence, the poor countries can get earlier access for vaccines, assuming that all the vaccines are safe and delivered in the right way. China’s vaccine diplomacy will only be as good as the vaccines it is offering, and it still faces hurdles. None of China’s three vaccine candidates used globally have publicly released their late-stage clinical trial data. China’s pharmaceutical business practices have raised concerns. In 2018, it emerged that one of China’s biggest vaccine companies falsified data to sell its rabies vaccines. That same year, news broke that a Sinopharm subsidiary, which is behind one of the COVID-19 vaccines now, had made substandard diphtheria vaccines used in mandatory immunizations.  People have less trust in products made outside the Western world. A December YouGov poll of 19,000 people in 17 countries and regions on how they felt about different vaccines found that China’s received the second-lowest score, tied with India’s. There are concerns among receiving countries that China’s vaccine diplomacy may come at a cost, which China has denied. In the  Philippines, where Beijing is donating 600,000 vaccines, China’s Foreign Minister, Yi, gave a subtle message to tone down public criticism of growing Chinese assertiveness in the disputed South China Sea. It was clear he wanted “friendly exchanges in public, like control your megaphone diplomacy a little.' Opposition legislators in Turkey are accusing Ankara’s leaders of secretly selling out Uyghurs to China in exchange for vaccines after a recent shipment delay. The legislators and the Uyghur diaspora community fear Beijing is trying to win passage of an extradition treaty that  could see more Uyghurs deported to China. Concerns have been exacerbated by confusion around the efficacy of Sinovac’s shot. In Turkey, where Sinovac conducted part of its efficacy trials, officials have said the vaccine was 91% effective. However, in Brazil, officials revised the efficacy rate in late-stage clinical trials from 78% to just over 50% after including mild infections. An expert panel in Hong Kong assessed the efficacy of the vaccine at about 51%, and the city approved its use in mid-February. Sinovac’s  trials were conducted separately in Turkey and Brazil, and the differences in efficacy rates arise from differences in the populations, a spokesman for the company said. (Source: AP)

(2021. II. 25.) Betegtájékoztató - a Sinopharm gyógyszer kínai nyelvű termékismertetőjének magyar nyelvű adaptációja, iránymutatás az alkalmazáshoz. Feltételes - sürgősségi - jóváhagyás alapján felhasználásra kerülő, COVID-19 megelőzésére alkalmazandó, YBS10362020 azonosítójú oltóanyag, 18-59 éves személyek oltására. " A 60 éves vagy annál idősebb népesség aránya alacsony volt a klinikai vizsgálatokban (0,63%)." "A védőhatásra vonatkozó értékeléshez a végső adatok egyelőre nem állnak rendelkezésre, a hatásosság és a biztonságosság még további ellenőrzésre szorul.' Alapimmunizálás: 2 alkalommal – az egyes alkalmak között 21-28 nap különbséggel. Ellenjavalt - mások mellett - a terhes, illetve szoptató nőknek. A védőoltás által biztosított immunvédelem tartósságára vonatkozó adatok egyelőre nem állnak rendelkezésre. Felhasználhatósági időtartama: 2 év. "A kiindulási alapul szolgáló termékismertető utolsó áttekintésének dátuma: 2020. december 30." (Forrás: OrszágosGyógyszerészetiésÉlelmezés-egészségügyiIntézet): https://tinyurl.com/3jatyx2a

Izrael
2021.03.03.  New York-i - Izraelben eddig ismeretlen változat koronavírus-variánst hordozókat találtak egy család három tagjánál. Feltételezik róluk, hogy New Yorkból visszatért személlyel kerültek kapcsolatba, így fertőződtek meg. Két, a dél-afrikai variánshoz hasonló esetet is találtak, amelyről már bebizonyosodott, hogy az oltás kevésbé hatékony vele szemben. Izraelben a rendkívül fertőző brit mutáció okoz ma már szinte minden új koronavírus-fertőzést. Ezért is javasolták a tel-avivi Ben Gurion repülőtér lezárását január 25-én. Azóta „kivételezési bizottság” döntötte el, mely izraeliek léphetnek be az országba a reptér zárlata ellenére. Március 7-től naponta 3000 beutazást engedélyeznek, és ehhez ezentúl nem szükséges a bizottság engedélye. A grémium csak a nem izraeli állampolgárok számára biztosíthatja a belépést. De: az országba érkezőket tesztelni fogják, s karanténbe kell vonulniuk, amit elektromos követővel fognak ellenőrizni, mert korábban a visszatérők jelentős része nem tartotta be a rendelkezéseket. Tavaly március óta 787 211-en fertőződtek meg koronavírussal a mintegy 9,3 millió lakosú országban. Az oltási kampány kezdete, december 20. óta az ország lakosságának több mint 51,74%-a kapta meg az első dózis védőoltást. Jelenleg 42 733 aktív fertőzöttet tartanak nyilván, 1195 beteget ápolnak a kórházakban, közülük 717-en súlyos állapotban vannak, és 224 ember van lélegeztetőgépen. A SARS-CoV-2 vírus okozta betegségben tavaly február óta 5797-en haltak meg Izraelben. (Forrás: Híradó / MTI)

**** Turkey
February 28, 2021   The government seeks to inoculate 60% of the country’s people against coronavirus over the next three months. Turkey rolled out the Chinese Sinovac vaccine on Jan. 14 and has so far given out 8.2 million doses. Ankara has also ordered 4.5 million doses of the Pfizer-BioNTech vaccine. Health Minister Koca said that Turkey aims to vaccinate 52.5 million people by the end of May. To date, around 10% of Turkey’s 83 million population has received at least the first dose. Health care workers, older people and people with serious medical  conditions were among the first to receive the jab. President Erdogan is expected to announce the easing of coronavirus restrictions tomorrow. Infections have spiked in recent days, with Turkey recording more than 9,000 daily cases, the highest level since mid-January. The country has seen more than 2.6 million cases since March last year and nearly 28,500 confirmed COVID-19-related deaths. Experts say all confirmed numbers worldwide are undercounts due to missed cases and limited testing. (Source: AP)

* United States
March 4, 2021  A new strain of the coronavirus, known as B.1.526, is proliferating vigorously across New York City, after having originated in February in a part of upper Manhattan known as Washington Heights. It was now spreading along the Eastern Seaboard and to many other regions, including Chicago, Wyoming and Oregon. The New York City variant is problematic because of a mutation known as E484K, which researchers have found allows it to evade antibodies and makes it more likely the virus will successfully infect people. According to Columbia University virologist Dr. Ho, who has been tracking the new variant, 26 percent of the coronavirus cases identified last week were of the B.1.526 variant. Throughout February, it represented 12 percent of cases. In the city more than 29,000 have died from COVID-19 up to now. Vaccines appear to be broadly effective against the new variant. The CDC has warned, that opening up while new strains of the coronavirus are gaining force may ultimately prolong the pandemic. (Source: Yahoo)

February 27, 2021  The FDA has determined that the Janssen COVID-19 Vaccine has met the statutory criteria for issuance of an EUA. The issuance of an EUA is different than an FDA approval (licensure) of a vaccine, in that a vaccine available under an EUA is not approved. The EUA allows the Janssen COVID-19 Vaccine to be distributed in the U.S for use in individuals 18 years of age and older. The Janssen COVID-19 Vaccine may be effective in preventing COVID-19. The data also show that the vaccine’s known and potential benefits outweigh its known and potential risks. The Janssen COVID-19 Vaccine is manufactured using a specific type of virus called adenovirus type 26 (Ad26). The vaccine uses Ad26 to deliver a piece of the DNA, or genetic material, that is used to make the distinctive “spike” protein of the SARS-CoV-2 virus. Ad26, which can cause cold symptoms and pink eye, has been modified for the vaccine so that it cannot replicate in the human body to cause illness. After a person receives this vaccine, the body can temporarily make the spike protein, which does not cause disease, but triggers the immune system to learn to react defensively, producing an immune response against SARS-CoV-2. The Janssen COVID-19 Vaccine is administered as a single dose. The available safety data to support the EUA include an analysis of 43,783 participants enrolled in an ongoing randomized, placebo-controlled study being conducted in South Africa, certain countries in South America, Mexico, and the U.S. The participants, 21,895 of whom received the vaccine and 21,888 of whom received saline placebo, were followed for a median of eight weeks after vaccination. The most commonly reported side effects were pain at the injection site, headache, fatigue, muscle aches and nausea. Most of these side effects were mild to moderate in severity and lasted 1-2  days. The effectiveness data to support the EUA include an analysis of 39,321 participants in the ongoing randomized, placebo-controlled study being conducted in South Africa, certain countries in South America, Mexico, and the U.S. who did not have evidence of SARS-CoV-2 infection prior to receiving the vaccine. Among these participants, 19,630 received the vaccine and19,691 received saline placebo. Overall, the vaccine was approximately 67% effective in preventing moderate to severe/critical COVID-19 occurring at least 14 days after vaccination and 66% effective in preventing moderate to severe/critical COVID-19 occurring at least 28 days after vaccination. Additionally, the vaccine was approximately 77% effective in preventing severe/critical COVID-19 occurring at least 14 days after vaccination and 85% effective in preventing severe/critical COVID-19 occurring at least 28 days after vaccination. There were 116 cases of COVID-19 in the vaccine group that occurred at least 14 days after vaccination, and 348 cases of COVID-19 in the placebo group during this time period. There were 66 cases of COVID-19 in the vaccine group that occurred at least 28 days after vaccination and 193 cases of COVID-19 in the placebo group during this time period. Starting 14 days after vaccination, there were 14 severe/critical cases in the vaccinated group versus 60 in the placebo group, and starting 28 days after vaccination, there were 5 severe/critical in the vaccine group versus 34 cases in the placebo group. At this time, data are not available to determine how long the vaccine will provide protection, nor is there evidence that the vaccine prevents transmission of SARS-CoV-2 from person to person. The EUA for the Janssen COVID-19 Vaccine was issued to Janssen Biotech Inc., a Janssen Pharmaceutical Company of Johnson & Johnson. (Source: FDA)

** South America
March 2, 2021  The Amazonian strain, P.1, emerged in the Brazilian city of Manaus late last year. The variant’s large number of mutations to the spike protein, which helps the virus penetrate cells, have caused particular concern. Brazil’s daily death toll from the disease rose to its highest level yet this week. Today, Brazil reported a record 1,641 Covid fatalities. P.1, is supposed to be 1.4 to 2.2 times more contagious than versions of the virus previously found in Brazil, and 25% to 61% more capable of reinfecting people who had been infected by an earlier strain. The health systems of many states in Brazil are already in collapse and others will be in the next few days, said Waldman, an epidemiologist at the University of São Paulo.Several doctors have reported a surge in younger patients in their Covid-19 wards, many in their 30s and 40s with no underlying health problems. “We therefore cannot determine whether the estimated increase in relative mortality risk is due to P.1 infection, stresses on the Manaus healthcare system, or both,” authors of the P.1 study led by Faria, a professor of virus evolution at Oxford University and Imperial College London wrote. The new strain is largely to blame, so too is a lack of preparation and prevention by the region’s governments. Hospitals are operating at ICU occupancy rates above 80% in almost two-thirds of Brazilian states. After scores of patients suffocated to death in Manaus earlier this year when hospitals ran out of oxygen, prosecutors are investigating reports from another Amazonian city that intubated patients were tied to their beds following a shortage of sedatives. With mass vaccination a long way off across the region and a more prolonged pandemic could devastate the economies of countries such as Brazil, expanding the country’s already large debt pile as the government extends payouts to the poor. Brazilian cities such as São Paulo and the capital, Brasília, have introduced tougher restrictions over recent days. Brazil has administered vaccines to only 3% of its population. If Latin America doesn’t find a way to speed up its vaccination campaigns, other countries such as Colombia and Bolivia that have seen recent slowdowns in new infections could also fall victim to the new variant. Peru and Colombia have vaccinated less than 1%. In Peru, where the government has detected the P.1 strain, hospitals were quickly pushed beyond capacity as infections surged in January after one of the world’s worst outbreaks last year. Peru has imposed a nighttime curfew in Lima and other states with high infections. Some doctors said patients are becoming seriously ill faster, just three or four days after the first symptoms emerged, compared with an average of nine to 14 days last year. Doctors are now choosing among dozens of patients when an ICU bed opens up, while Chile is donating lifesaving oxygen amid acute shortages. (Source: TheWallStreetJournal)

Globalization
04 March 2021  Covid-19 death
rates are 10 times higher in countries where more than half of the adult population is classified as overweight, a report from the World Obesity Foundation has found. Of the 2.5 million covid-19 deaths reported by the end of February 2021, 2.2 million were in countries where over half the population is classified as overweight — defined as a body mass index above 25. The UK has the third highest death rate globally (184 deaths per 100 000) and the fourth highest prevalence of overweight at 63.7%. The United States has the next highest death rate at 152.49 deaths per 100 000 and has 67.9% of the population overweight. A small number of countries seem to run against the trend including New Zealand, Australia, and several Gulf states, where prevalence of overweight among adults is high, but reported deaths from covid-19 are low. This was likely to be due to national responses to the pandemic, including border controls. Vietnam, Japan and South Korea have very low levels of covid-19 deaths as well as very low levels of adult obesity. The Foundation said that governments must invest in obesity prevention to prepare for future pandemics. It called for people with obesity to be among priority groups for Covid-19 vaccines and testing. (Source: TheBritishMedicalJournal)

March 4, 2021  COVID-19 has the potential to wipe out populations of gorillas, chimpanzees, orangutans and bonobos. Last month, four orangutans and five bonobos at the San Diego Zoo have received an experimental COVID-19 vaccine developed specifically for animals by the veterinary pharmaceutical company Zoetis. In January, eight gorillas at the zoo became the first great apes in the world to test positive for coronavirus. They are now recovering. Infections have also been confirmed in dogs, cats, mink, tigers, lions and several other animals around the world. Zoetis started development on a COVID-19 vaccine for dogs and cats after the first dog tested positive for the virus in Hong Kong over a year ago. It was deemed safe and effective in October - but testing had only been done in dogs and cats. Because vaccines are made for a specific pathogen and not a specific species, it's common to give a vaccine meant for one species to another, Lamberski, chief conservation and wildlife health officer at the San Diego Zoo Wildlife Alliance said. The company expects more vaccines to be available in June. Apes at the zoo get flu and measles vaccines developed for humans. The company is currently conducting trials of the vaccine in mink. (Source: CBSNews)

Feb 27 2021  Pfizer to test Covid vaccine on children aged five to 11. The pharmaceutical company's boss said it has already finished enrolling volunteers aged 12 to 15 and is now looking at younger subjects. He hopes they will have data on the trials by the end of the year.  "We are already doing trials with kids 12 years old, all the way to 16 and I hope that we will be able to have data in a couple of months" - he said. Children as young as six are already being given the Oxford/AstraZeneca vaccine in a new trial in the UK. Researchers are studying 300 kids aged between six and 17 to examine whether the jab produces a strong immune response in youngsters. (Source: TheU.S.Sun)

February 26, 2021  On Feb. 17, the World Health Organization reported a cluster of Ebola cases in Guinea. Out of seven reported cases, five people died; the other two are in isolation in dedicated health care facilities. As of Feb. 15, 192 contacts had been identified. The WHO “considers the risk of spread in the country as very high given the unknown size, duration and origin of the outbreak. All six nations bordering Guinea are finalizing their national preparedness and readiness operational plans. The 2014-16 outbreak in West Africa was the largest, resulting in more than 28,000 cases and more than 11,000 deaths - a case fatality rate of about 63 percent. A separate WHO alert, sent out on Feb. 11, detailed reports of Ebola outbreaks in Democratic Republic of Congo. Since 2017 there have been five outbreaks in Congo, including one that raged from 2018 to 2020, causing nearly 2,300 deaths. The current outbreak is occurring in the same region. White House orders enhanced airport screenings for Ebola for passengers arriving from Guinea and the Democratic Republic of Congo. The changes will to into effect next week. (Source: Yahoo)

Előzmény / Previously:

A 2021. február 17-24.-i előzmények itt érhetők el / About the period of 17 - 24 February 2021:

https://tinyurl.com/umfbjhy9

.

 

Szólj hozzá!

Címkék: magyarország chile vírus franciaország peru olaszország india izrael oroszország japan törökország mexikó china brazília who europe vietnam guinea singapore bolivia canada africa colombia switzerland egyesültkirályság australia serbia philippines newzealand europeanunion egyesültállamok persiangulf southkorea southafrica southamerica indianocean globalization southchinasea balcans democraticrepublicofcongo

22 February 2021. Globalization. Share of total population that received at least one dose of COVID-19 vaccine

2021.02.23. 11:50 Eleve

                                               (Source: OurWorldinData)

 

Szólj hozzá!

Címkék: brazil chile hungary virus bahrain france bangladesh germany denmark italy israel turkey poland slovakia spain norway serbia indonesia unitedkingdom unitedstates globalization

2021. II. 17-24. Vírusfertőzés és védőoltás adatok. Magyarország, Germany, Slovakia, European Commission, European Union, Russia, United Kingdom, South Africa, Africa, India, Israel, United States, WHO, globalization

2021.02.17. 23:28 Eleve

2021. II. 24.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
112 409 584

Országonként:

Egyesült Államok * 28 313 003
India ** 11 030 176
Brazília 10 257 875
Egyesült Királyság *** 4 156 703
Oroszország **** 4 153 735
Franciaország 3 721 053

...
Magyarország ***** 410 129

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 492 420

Országonként:

Egyesült Államok 504 295
Brazília 248 529
Mexikó 181 809
India 156 567
Egyesült Királyság 121 979
Olaszország 96 666

...
Magyarország 14 552

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
63 440 310

Országonként:

 Egyesült Államok (vonatkozó összesített adatot nem közöl)
India 10 726 702
Brazília 9 197 566
Oroszország 3 709 938
Törökország 2 540 293
Olaszország 2 362 465

...
Magyarország 313 450

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 2/24/2021 10:24 p. m."

------------------------------------------------

*****  Magyarország
2021. 02. 22.  Megszavazta az Országgyűlés a koronavírus-világjárvány elleni védekezésről szóló törvényjavaslatot. Ezzel felhatalmazta a kormányt a veszélyhelyzetben alkotott rendeletei hatályának meghosszabbítására. Varga igazságügyi miniszter előterjesztését 133 igen szavazattal, 55 nem ellenében, egy tartózkodás mellett fogadta el a Parlament. A most megerősített kormányrendeletek hatálya 90 napra hosszabbítható meg, de a Parlament ennél korábban is visszavonhatja felhatalmazását. Az előterjesztés indoklása hangsúlyozza: e megerősítés által az Országgyűlés politikailag elismeri a járvány megakadályozására tett eddigi kormányzati lépéseket. Szemelvények a vitából: Varju (DK) a tavalyi, a tervezettnél jóval magasabb, a GDP 8-9  százalékát elérő, 5 500 milliárd forintos költségvetési hiányt tette szóvá s hogy az államadósság eléri a GDP 82%-át, magasabb a szintje, mint amikor az Orbán-kormány hivatalba lépett egy gazdasági világválság után. Tállai, a Pénzügyminisztérium parlamenti államtitkára közölte: a képviselő korábbi pártja már próbált válságot kezelni. Akkor is magas volt a költségvetési hiány és az államadósság, de akkor jelentős volt a munkanélküliség is – mondta. Hozzátette: most nem nő a munkanélküliség, növekszik viszont az emberek jövedelme és a beruházások volumene. Az ellenzéki képviselő a választ nem fogadta el. Hohn (LMP) azt kérdezte: mikor rendezik végre érdemben a háziorvosok helyzetét? Szerinte egyszerre sújtja a háziorvosokat a 'praxis-közösségek' kialakításának a kényszere, amivel "megzsarolta" őket a kormányzat, valamint a koronavírus elleni oltás megszervezése, lebonyolítása. Azt mondta: nem támogatható, hogy a háziorvosok bérrendezését a kormányzat összeköti a 'praxis-közösségek' kialakításával. Rétvári, az Emberi Erőforrások Minisztériumának államtitkára visszautasította, hogy a  kormány zsarolná a háziorvosokat és azt is, hogy kötelező lenne a "közösségbe szerveződés'. Közölte: a 'praxis-közösségbe' be nem lépő háziorvos is kap majd emelést - 30%-os mértékben. Hohn nem fogadta el a választ. A Ház elfogadta az ezekre az interpellációkra adott kormányzati válaszokat is. Kocsis-Cake (Párbeszéd) arról beszélt, hogy a kormánynak volt egy jó javaslata az orvosi béremelésről és a hálapénz megszüntetéséről, de ezt is sikerült elrontani, mert az egészségügyi dolgozók új munkavállalói jogállása körül sok a bizonytalanság. Sok probléma van az új szerződésekkel, és sokan nem szeretnének az új szabályok szerint dolgozni, ami súlyos munkaerőhiányt okozhat az egészségügyben - vélekedett. Rétvári közölte: a jogviszony-váltást két hónappal 'kitolták', 'hogy mindenkinek több ideje legyen átgondolni a változásokat'. Mesterházy (MSZP) az oltóanyag-beszerzésről tett fel kérdéseket. A többi közt arra várt választ, hogy az egyes oltóanyagokból mennyit rendelt a magyar kormány? Szijjártó külgazdasági és külügyminiszter azt felelte: a kormány az Európai Unió központosított közbeszerzése keretében - ahhoz, hogy minden magyar beoltható legyen - a Pfizer oltóanyagából 6,6 milliót, a Moderna-éból 1,7 milliót, az AstraZeneca vakcinájából bő 6,5 milliót, a Janssen-éből 4,4 milliót, a CureVac készítményéből 500 ezret rendelt. Eddig a lekötött mennyiség 4,45%-a érkezett meg - tette hozzá - vagyis 879 ezer adag oltóanyag. Az ország más forrásokból is vásárolt, 'ha azt a jogosultsággal rendelkező magyar hatóságok biztonságosnak találták' - 'Oroszországból 2 millió adagot, Kínából pedig 5 milliót'. (Forrás: Híradó / MTI)

2021. 02. 21., vasárnap.  Holnap és holnapután mintegy ötezer háziorvoshoz szállítják a kínai oltóanyagot, szerdától már oltanak vele – jelentette be Müller országos tiszti főorvos.  A tervek szerint két hét alatt az összes elérhető oltóanyaggal több mint 465 ezer embert oltanak be itthon. (Forrás: Híradó / MT1)

2021. 02. 21. Müller, országos tisztifőorvos elmondta: a brit mutáns vírus megbetegítő képessége 70%-al magasabb a korábbinál. Magyarországon 322 esetet detektáltak. A  Sinopharm oltóanyag Kínából négy gyártási tételben érkezett. Az Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet (OGYÉI) veszélyhelyzeti engedélyezését követően a Nemzeti Népegészségügyi Központnak (NNK) gyártási tételenként kell a felszabadítást végeznie; a gyártó által küldött dokumentációt minden esetben össze kell vetni egy független  vizsgálat eredményével. Utóbbihoz volt szükség a kínai oltóanyag esetében hiánypótlásra és csak ezután engedélyezték a hatóságok az emberi felhasználást – mondta. (Forrás: Híradó / M1)

2021. 02. 21.  Eddig 445 535 embert oltottak be, közülük 190 705-en már a második oltást is megkapták. Európa több országához hasonlóan Magyarországon is nőtt az újabb fertőzöttek s a kórházi betegek száma az elmúlt napokban. /Forrás: Híradó / MTI/

2021. 02. 20.  Eddig 427 309 embert oltottak be, közülük 172 739-en már a második oltást is megkapták. Tart a védőoltásra regisztrált legidősebbek oltása a kórházi oltópontokon a Pfizer és a Szputnyik oltóanyaggal. A háziorvosok az AstraZeneca oltóanyaggal folytatják a 60 év alatti krónikus betegek oltását. /Forrás: Híradó / MTI/

2021. 02. 20. Úton van Magyarországra a második orosz oltóanyag-szállítmány. Szentpétervárról indult egy kamion százezer adaggal. Az orosz oltóanyaggal már oltanak egy ideje; azok a 60 és 75 év közöttiek kapják, akiknek nincs krónikus betegségük. (Forrás: Híradó / M1)

2021. 02. 19.  A mai napig 1 474 715 adag oltóanyag érkezett Magyarországra, 60%-uk nyugati oltóanyag. 550 ezer Sinophram oltóanyag érkezett részteles dokumentációval. 'A vizsgálatok kimutatták, hogy a gyártói specifikációnak megfelelt a hatósági vizsgálat is' - közölte Müller országos tiszti főorvos. 'Erről tájékoztatták az Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézetet. Ha ez az intézet is jóváhagyja a vakcinát, akkor elkezdődhet az oltás a kínai készítménnyel is'.  A kínai oltóanyag elölt, inaktivált teljes vírust tartalmaz, az összes fehérjéjével, tüskéjével és a burokkal. 79%-os hatékonyságot ígérnek. Minden 18 év feletti állampolgár megkaphatja, az állapotos nőket kivéve. Két adag oltóanyg beadására van szükség a teljes védettséghez; 21 nap múltán kell az oltást ismételni.  2-8 Celsius-fokon tárolható az oltóanyag, egyadagos fecskendőbe van töltve, tűvel ellátott kiszerelése miatt könnyen alkalmazható. (Forrás: Híradó / M1)

2021. 02. 18.  Ma érkezik egy AstraZeneca-szállítmány. Eredetileg 88 ezret  vártak, azonban 83 500 adag érkezik. Ezzel a jövő héten oltanak. (Forrás: Híradó / M1)

2021. 02.17., szerda.  Eddig 193 személynél mutatták ki a brit vírus-variánst Magyarországon. Közülük 9 járt külföldön, találkozott külföldi rokonnal vagy olyan személlyel, aki külföldön járt az elmúlt pár hétben - közölte Müller országos tiszti főorvos. Tegnap megérkezett az első Sinopharm oltóanyag-szállítmány és az oltás dokumentációja, amit a Nemzeti Népegészségügyi Központ (NNK) szakemberei tanulmányozznak. (Forrás: Híradó / M1)

Germany
February 22, 2021  Germany mulls vaccinating thousands of officials with AstraZeneca after many essential workers refused the British-Swedish shot. Clinical trials showed it to be less effective than an alternative shot from Pfizer vaccine, developed by Germany’s BioNTech, that accounts for most doses administered so far in the country. The latest round of skittishness over the vaccine was triggered when Germany’s medicines agency declined to approve AstraZeneca’s product for use on the over-65s, citing a lack of trial evidence that it was effective on that age cohort. To date, Germany has administered around six doses of vaccine per 100 residents. (Source: Reuters)

Slovakia
February 18, 2021  Slovakia has recorded the highest coronavirus death rate in the world, with the seven-day rolling average of daily deaths at 1.782 per 100,000 citizens as of February 16, followed by Portugal (1.352), Montenegro (1.319) and Czechia (1.245). The most significant factor that has prevented coronavirus cases from falling in Slovakia is a high occurrence of the variant that was found in Britain, said Slovak epidemiologist and vice rector of Trnava University Majdan. Two weeks ago, the British mutation of coronavirus was found in 74% of almost  2,000 samples examined recently in the country. As of February 17, the government approved a list of 19 districts to be labelled as the most severe degree concerning coronavirus. It's  forbidden to leave or enter these districts. People who have exclusively visited EU countries, and Iceland, Norway, Liechtenstein, Switzerland, the United Kingdom in the past 14 days are subject to isolation. The Slovak Pandemic Commission has recommended the government to start talks with the Russian side aimed at acquiring the Sputnik V vaccine. The ministers are set to discuss the issue today. All coalition parties but For The People support the recommendation of the Commission. (Source: bneIntelliNews)

European Commission
17 Feb 2021  The European Union has approved a second contract with the US pharmaceutical company Moderna for an additional purchase of 300 million doses of its Coronavirus vaccine. Under the deal, the bloc will get 150 million doses this year, with an option to purchase an extra 150m in 2022. “With a portfolio of up to 2.6 billion doses, we will be able to provide vaccines not just to our citizens, but to our neighbours and partners as well,” von der Leyen said. Yesterday the Belgian-based company Janssen Pharmaceutica, owned by US pharmaceutical giant Johnson & Johnson submitted its COVID-19 vaccine to EMA for conditional marketing authorisation. A decision could be made by mid-March. (Source: NewEurope)

European Union
February 19, 2021  The EU’s Health Security committee agreed yesterday on a list of rapid antigen tests, which will be mutually recognised by member states, as well as on a common standardised set of data to be included in COVID-19 test result certificates. The move followed a Council recommendation on January 21. This is essential, particularly in the context of travel (Source: NewEurope)

17 Feb 2021  EU allocates an additional €150m for research on coronavirus variants. In addition, the Commission announced the launch of an international clinical trial network for Covid-19 vaccines - Vaccelerate - which encompasses 16 EU countries and five non-EU countries including Israel and Switzerland. The scope of the networked trials will expand to include children as participants. (Source: ResearchProfessionalsNews)
Pro Domo: Legally permissible ?

****  Russia
February 20, 2021  Russia has registered the first case of a strain of bird flu virus named A(H5N8) being passed to humans from birds and has reported the matter to the World Health Organization (WHO) several days ago. Seven workers at a poultry plant in Russia’s south had been infected in an outbreak at the plant in December. The reported cases were workers exposed to bird. This situation did not develop further, the individuals involved felt fine now. Outbreaks of the H5N8 strain have been reported in Russia, Europe, China, the Middle East and North Africa in recent months but so far only in poultry. Other strains - H5N1, H7N9 and H9N2 - have been known here to spread to humans. There was no sign yet of transmission between humans. Siberia’s Vector Institute said today it would start developing human tests and a vaccine against H5N8. (Source: Reuters)

February 20, 2021  Russian President Putin announced in October that the country had registered its second vaccine, EpiVacCorona, which health officials had said would enter mass production this month. PM Mishustin said today that Russia had produced 10 million doses of Sputnik and 80,000 batches of the EpiVacCorona vaccine developed by the Siberian Vektor laboratory. Moscow announced today that it had registered its third vaccine - CoviVac - against the coronavirus and promised to introduce the jab to the Russian population already in mid-March. The first 120,000 doses will be distributed within the civilian circulation. CoviVac was produced by the state-run Chumakov Centre based in Moscow, which employed a different method of development from Sputnik and EpiVacCorona, using an inactive virus. The vaccine is due to complete a final stage clinical trial with 3,000 participants in March and has so far been recommended for people below the age of 60. (Source: TheTimesofIsrael)

***  United Kingdom
24.02.2021  AstraZeneca’s total supply to the EU by late June might reach 130 million doses instead of the promised 300 million it had originally committed to deliver by that timeline. AstraZeneca’s contract with the EU was leaked last week, revealing that the drugmaker had signed up to deliver 180 million doses to the 27-nation bloc in the second quarter.  The British–Swedish multinational pharmaceutical giant told the bloc during internal meetings that it would deliver less than 90 million doses in the second quarter. The drugmaker planned to deliver about 40 million doses in the first quarter – also less than half the amount of jabs it developed with the University of Oxford and was under contract to supply. British plants were supposed to be part of the EU supply chain. The UK supply deal relies on production at AstraZeneca's two facilities in Oxford and Wrexham, Wales. Besides the two UK plants, AstraZeneca is committed to producing vaccines at a facility in Belgium and one in the Netherlands. Problems at a vaccine factory in Belgium run by partner Novasep were reportedly cited. AstraZeneca also has vaccine plants in other sites around the world and it has told the EU it could provide more doses from its global supply chain, including from India and the United States. The company is not currently exporting vaccines made in the United Kingdom, in line with its separate contract with the British government, EU officials said. (Source: Reuters)

17 Feb 2021  UK to conduct first Covid-19 human challenge study, backed by £33.6 million from the government. It will involve up to 90 volunteers aged 18 to 30 being infected with Covid-19 in a safe and controlled environment, to increase understanding of how the virus affects people. The study will initially use the version of the virus that has been circulating in the UK since March 2020 and has been shown to be of low risk in young, healthy adults. A report in New Scientist says that the UK variant of coronavirus appears to have combined with the California variant to form a heavily mutated hybrid, according to data from the United States. "This kind of event could allow the virus to have coupled a more infectious virus with a more resistant virus,” Korber from the Los Alamos National Laboratory in New Mexico, who discovered the hybrid, told on 2 February. (Source: ResearchProfessionalsNews)

South Africa
February 18, 2021  South Africa plans to start rolling out the Pfizer/BioNTech vaccine in the coming months, after yesterday launching its vaccination programme with Johnson & Johnson’s shot in a research study targeting healthcare workers. South African scientists will meet today to discuss a laboratory study that suggests the dominant local coronavirus variant may reduce antibody protection from the Pfizer vaccine by two-thirds, the health ministry said. The study was published in the New England Journal of Medicine late yesterday. Health Minister Mkhize said yesterday that the country was expecting 500,000 doses of the Pfizer vaccine initially and about 7 million doses by June. (Source: Reuters)

Africa
23 February 2021   Will Africa ever get the Covid vaccine? With a reported death toll of more than one hundred thousand and more than three million reported cases, the African continent appears to be at the bottom of the pile of countries likely to receive vaccines for the deadly Coronavirus. As of February 19, confirmed cases of Covid-19 from 55 African countries reached 3,799,304. Reported deaths in Africa reached 100,325 and 3,347,374 people have recovered. South Africa has the most reported cases - 1,498,766 - and 48,708 people died. Other most-affected countries are Morocco ( 480,056 ), Tunisia ( 226,015 ), Egypt ( 176,333 ), Ethiopia ( 150,179 ), and Nigeria ( 150,246 ). Concerns come as U.S. President Biden has announced that the United States intends to provide an initial $2 billion, out of a total planned $4 billion, to Gavi, the Vaccine Alliance, to support the Gavi COVAX Advance Market Commitment (Gavi COVAX AMC) to provide COVID-19 vaccines for 92 low- and middle-income countries. 'This support is critical to controlling the pandemic and slowing the emergence of new variants as well as helping restart the global economy, all of which will ultimately benefit the American people'. (Source: AllAfrica)

**  India
February 24, 2021  Two highly mutated SARS-CoV-2 variants - N440K and E484K - were found circulating in three states, in Kerala, Maharashtra and Telangana, informed Paul, head of the National Task Force on Covid-19. He clarified that the variants cannot be attributed to the upsurge in the number of infections in some of the districts in Maharashtra and Kerala. Last week, the Indian Council of Medical Research (ICMR) found as many as 192 cases of Covid-19 affected by the new variants of mutated SARS-CoV-2 in the last two months, including four from the variant that emerged in South Africa and one from Brazil. The remaining 187 were found infected by the UK variant. (Source: GulfToday.ae)

Israel
February 21, 2021  Nearly half of people who contract mild or moderate cases of COVID-19 still experience symptoms six months later, according to Israeli researchers. The research, which is slated to be published this month in the Journal of Clinical Microbiology and Infection, evaluated 103 people over the age of 18 who had coronavirus between April and October 2020. They were not hospitalized with a more severe case of the disease. 44% of people experienced headache, 41% fever, 39% muscle aches and 38% dry cough as their first COVID-19 symptom, usually around the second day of disease onset. But many of those symptoms resolved themselves relatively quickly. At six months, 46% of the patients had at least one unresolved symptom, most commonly fatigue (22%), smell and taste changes (15%) or breathing difficulties (8%). Smell and taste changes were among the longest lasting. A total of 14 symptoms were included in the final analysis. These include taste change, smell change, fever, dry cough, productive cough, muscle aches, headache, runny nose, sore throat, diarrhea, breathing difficulty, vomiting, nausea, loss of appetite. Other symptoms that were mentioned by some of the patients included memory loss, hair loss and depression. (Source: TheJerusalemPost)

*  United States
February 23, 2021 The new variant, which they call B.1.427/B.1.429
is a coronavirus variant that probably emerged in May and surged to become the dominant strain in California. It spreads more readily than its predecessors and evades antibodies generated by COVID-19 vaccines or prior infection and is associated with severe illness and death, researchers said. In a study scientists at UC San Francisco said the cluster of mutations that characterizes the homegrown strain should mark it as a “variant of concern” on par with those from the United Kingdom, South Africa and Brazil. This rival strain is probably just as worrisome and will probably account for 90% of the state’s infections by the end of next month, said Dr. Chiu, an infectious diseases researcher and physician at UCSF. B.1.427/B.1.429's genome includes three mutations that affect the crucial spike protein, which the virus uses to sneak into human cells and convert them into factories for its own production. One of those three mutations, dubbed L452R, affects the so-called receptor binding domain, helping the virus attach more firmly to  target cells. This variant is 19% to 24% more transmissible. But in one nursing home outbreak, B.1.427/B.1.429 spread at a rate that was six times higher than that of its predecessors. Compared with people infected with other strains of SARS-CoV-2, those who were infected with the California strain had viral loads in the nasopharynx that were twice as high. A coronavirus engineered to have only that mutation was able to infect human lung tissue at least 40% more readily than were circulating variants that lacked the mutation. Compared with those so-called wild-type strains, the engineered virus was more than three times more infectious. When the neutralizing antibodies went up against the homegrown strain, their effectiveness was cut in half. By comparison, when these antibodies encountered the coronavirus strain that's now dominant in South Africa, their effectiveness was reduced to one-sixth of their usual levels. Based on the medical charts of 324 patients hospitalized at UCSF, a relatively small sample, the researchers found that the 21% of these patients who contracted B.1.427/B.1.429 were more likely than their counterparts to have been admitted to the ICU, and they were 11 times more likely to die. This greater transmissibility caused hospitals to become so overwhelmed and healt care resources to be stretched so thin that more deaths were the result - especially in Southern California. A “nightmare scenario” is that the first detected by United Kingdom and the Californian viruses will meet in a single person, swap their mutations and create an even more dangerous strain. (Source: Yahoo / LosAngelesTimes)

WHO
23 February 2021   Data as received by WHO from national authorities, as of 21 February 2021 show that the number of global new cases reported continues to fall for the sixth consecutive week, with 2.4 million new cases last week, an 11% decline compared to the previous week. The number of new deaths also continues to fall for the previous three weeks, with nearly 66 000 new deaths reported last week, a 20% decline as compared to the previous week. This brings the global cumulative numbers to 110.7 million cases and over 2.4 million deaths since the start of the pandemic.     In the past week, the African Region reported over 66 400 cases and 2 000 deaths, a 2% and 20% decrease respectively compared to the previous week.     Over 1 million new cases and over 34 300 new deaths were reported in the Region of the Americas this week, a 19% and 23% decrease respectively compared to the previous week.     The Eastern Mediterranean Region reported over 181 000 new cases, a 7% increase compared to last week. The region reported just over 2400 new deaths, a 3% decrease.     The European Region reported over 939 000 new cases and over 24 000 new deaths, a decrease of 7% and 19% respectively when compared to the previous week.     The South-East Asia Region reported over 157 000 new cases, an increase of 2% compared to last week. The region reported over 2 100 new deaths, a 6% decrease.     The Western Pacific Region reported just under 45000 new cases the past week, a 9% decrease compared to the previous week. The region reported 1200 new deaths, a 6% increase.      In the past week, the five countries reporting the highest number of new cases continue to be the United States of America (480 467 new cases, a 29% decrease), Brazil (316 221 new cases, a 1% decrease), France (131 179 new cases, a 3% increase), the Russian Federation (92 843 new cases, an 11% decrease), and India (86 711 new cases, a 10% increase).     WHO relies on the Strategic Advisory Group of Experts on Immunization (SAGE) to issue policy recommendations on COVID-19 vaccination to Members States. SAGE has issued three sets of interim recommendations to date, covering: the Pfizer-BioNTech BNT162b2 vaccine, the Moderna mRNA-1273 vaccine, and the AstraZeneca–Oxford University AZD1222 vaccine.      As of 23 February - regarding key variant of concern VOC 202012/01 first detected by United Kingdom - a total of 101 countries across all six WHO regions have reported cases of this variant. Community transmission has been reported in at least 45 countries across five WHO regions. The variant was detected in Spain - varied across the different regions from 0.4% to 53.3%. From 7 to 14 February 2021, Germany detected VOC 202012/01 in 22% of the specimens analysed (23 000 samples were tested). 36% was in France, and 47% in Denmark.  In the United States of America, genomic sequencing by one commercial laboratory suggested prevalence of VOC 202012/01 to be approximately 1% nationwide, and over 2% in some States as of 3 February 2021.     20H/501Y.V2 first detected by South Africa has been reported from 51 countries across all six WHO regions. Community transmission of this variant has been reported in 13 countries across four WHO region. It may compromise immunity indicating potential increased risk of reinfection. There is now growing evidence that the mutations present in this variant may help the virus evade immune system responses triggered by previous infections of SARS-CoV-2 or by vaccines.     Variant P.1 first detected by Brazil is reported in 28 countries across all six WHO regions. Community transmission of P.1 has been reported in at least three countries in one WHO region.     Currently two emerging variants of interest or concern are under review.    Variant B.1.525 (also referred to as VUI-202102/03, and previously UK1188), was first detected in the United Kingdom and Nigeria in December 2020. Since then, it has been detected in at least another 13 countries. This variant is partially similar to the 501Y.V2 variant and contains mutations which may be associated with some degree of biological significance.    A variant of B.1.1.7 withan E484K mutation (labelled VOC 202102/02 by the United Kingdom health authorities) has been detected in South West England. As of 17 February 2021, 26 cases of this variant have been detected in the United Kingdom. E484K has been labelled as an escape mutation, so called because it may help the SARS-CoV-2 virus to evade host immune defences. It has been identified as an adaptation of SARS-CoV-2 in at least one immunocompromised patient with long lasting infection.     Working definitions of SARS-CoV-2 variants of interest and variants of concern have been developed and are currently under review, with an aim to publish later this week. (Source: who.int)

Globalization
February 19, 2021  Lipid nanoparticles and vaccine production. E.U. threatens drug companies with legal action if it doesn’t get its vaccines.     Acuitas Therapeutics, a tiny biotechnology firm in Vancouver, B.C., has just 30 employees and leases its labs from the University of British Columbia. Until last year, it outsourced production of only small volumes of lipid nanoparticles, fat droplets used to deliver RNA into cells, for research and a single approved treatment for a rare disease. Now, one of Acuitas’s discoveries has become a precious commodity; a proprietary molecule called an ionizable cationic lipid is a crucial piece of the mRNA vaccine made by Pfizer and its German partner BioNTech, and it is in urgent demand for production of billions of vaccine doses worldwide. The federal government has committed about $16 billion to vaccine development and manufacturing since last year. Operation Warp Speed, the government’s vaccine effort launched under President Trump, vowed last spring that 300 million doses of vaccine would be ready by the beginning of 2021. That goal was downgraded by early December to a promise of 40 million doses by Jan. 1, enough for 20 million people to be immunized under the two-shot regimen. But by Dec. 30, only 12.4 million doses had been shipped. As of yesterday, according to data disclosed by the Centers for Disease Control and Prevention, Pfizer and Moderna had delivered 72.5 million doses combined. That represents only 36 percent of the 200 million doses that Moderna and Pfizer have pledged to deliver by March 31. Pfizer said that it has made unspecified changes to its facilities and manufacturing that will allow it to double vaccine output. It said it will produce 2 billion doses by the end of the year. It makes its vaccine in Kalamazoo, Mich., and Belgium. In late December, as part of a deal to obtain additional doses, the Trump administration agreed to use the Defense Production Act to help Pfizer gain access to more lipids. And the federal government continues to use its authority to direct domestic suppliers of lipids to prioritize Pfizer’s orders. Moderna invented its own ionizable lipid and also has been racing to build production capacity.     The vaccine makers are also experiencing a lack of machine capacity to fill vaccine vials. The Pfizer-BioNTech team has struck agreements with two other drug giants, Sanofi and Novartis, in Europe for “fill-finish” services, the process of putting vaccine doses into vials and preparing them for shipment.     The idea of using lipid nanoparticles to cocoon a genetic payload for release into human cells had been pursued by researchers at the University of British Columbia since the mid-1990s. Its first approved use was in 2018 for a drug called Onpattro, which is made by the biotech firm Alnylam. The drug is infused into people with transthyretin-mediated amyloidosis, a rare hereditary disease that affects 50,000 people worldwide. For the coronavirus vaccine, the lipid nanoparticle releases messenger RNA into a human cell, instructing the cell to make a replica of the coronavirus spike protein. The spike protein then trains the immune system to fight the real virus. Of the four lipids that make up the protective droplet, the ionizable cationic lipid is the one needed in the highest volume and is subject to restrictive patents held by Acuitas and a few other companies. Its electrical charge changes when it enters a cell, causing the mRNA payload to break free and deliver its instructions.     Pfizer and Moderna have now committed to producing 300 million vaccine doses each for the United States by the end of July, in addition to hundreds of millions more for Europe and elsewhere.     The biggest difficulty is to make the lipid nanoparticles. It is difficult to know the extent of any shortfalls because companies typically do not make such details public.     Acuitas is supplying its technology to CureVac, a German company that is developing an mRNA coronavirus vaccine.     These are the top coronavirus vaccines to watch:       The company producing the Acuitas lipids used in the Pfizer-BioNTech vaccine, is Avanti Polar Lipids, of Alabaster, Ala. Avanti was bought last summer by a British company, Croda, for $185 million.     CordenPharma, which has plants in Europe and Boulder, Colo., is supplying Moderna with lipids. Making ionizable cationic lipids requires 10 manufacturing steps and takes months.    Pfizer-BioNTech made agreements this month for more supply from two German companies, but that new capacity will not come online for months.   One of those German suppliers, Merck KGaA (which is not related to the American pharmaceutical manufacturer Merck & Co.), said in a Feb. 5 news release that it would significantly accelerate the supply of urgently needed lipids, with delivery “toward the end of 2021.”   A second German company, Evonik, said last week it was ramping up lipid supply that would be available in the second half of this year.     They have multiple dependencies on third parties for supply of the materials, said Zarur, chief executive of GreenLight Biosciences, a biotechnology company that is working on its own mRNA vaccine.     Executives in the industry also pointed to potential bottlenecks in the production of certain nucleotides and DNA plasmids (which provide the blueprint for the mRNA in vaccine), as well as synthetic capping agents that attach to the end of a string of mRNA. The synthetic capping molecules are produced under patent by a single company, TriLink, in San Diego. TriLink’s list price for capping agent is $197 for just 0.0012 grams, according to its website, although it says it offers bulk pricing. TriLink’s parent company, Maravai, went public in November as the frenzy for its products grew. It raised $1.6 billion. TriLink said in a news release in August that it would expand capacity at its San Diego facilities to make more mRNA raw ingredients. Increasing production of TriLink’s RNA capping agent is not difficult, requiring only more space and equipment, said McCaffrey, a co-inventor of the capping agent who recently left TriLink. (Source: msn)

Előzmény / Previously:

A 2021. január 31 - február 16.-i előzmények itt érhetők el / About the period of 31 January - 16 February 2021:

https://tinyurl.com/e27jjzx8

.

Szólj hozzá!

Címkék: brazil magyarország vírus russia olaszország india japan törökország mexikó sweden china virus egypt who france belgium germany montenegro europe denmark országgyűlés asia israel nigeria slovakia switzerland portugal spain norway ukraine indonesia unitedkingdom europeanunion unitedstates europeancommission southafrica czechia globalization pacificocean nemzetinépegészségügyiközpont

2021. I. 31 - II. 16. Globalizáció. Vírusfertőzés és védőoltás adatok. Magyarország - Hungary, Poland, European Union - Európai Unió, Russia, Serbia, Ukraine, United Kingdom, Guinea, South Africa, Tanzania, China, India, United States, South America

2021.02.01. 23:55 Eleve

 

2021. II. 16.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
109 386 022

Országonként:

Egyesült Államok * 27 744 089
India ** 10 925 710
Brazília 9 921 981
Egyesült Királyság *** 4 070 326
Oroszország 4 053 535
Franciaország 3 400 302

...
Magyarország**** 389 622

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 416 282

Országonként:

Egyesült Államok 487 656
Brazília 240 940
Mexikó 174 657
India 155 813
Egyesült Királyság 118 421
Olaszország 94 171

...
Magyarország 13 837

-----------------------------------------

'Gyógyultak' száma *****
('Global Recovered ')
61 528 693

Országonként:

India 10 633 025
Brazília 8 847 264
Oroszország 3 584 477
Törökország 2 489 624
Olaszország 2 251 734

...
Magyarország 298 773

***** Az Egyesült Államokra vonatkozó összesített adatot nem közöl.

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 2/16/2021 11:25 p. m."

**** Magyarország
2021. 02. 12.  Minden hazánkba érkező oltóanyagot bevizsgálnak a magyar szakemberek. "A politikusok nem járványügyi szakemberek. Az nem elég, hogy megadták a sürgősségi engedélyt, hogy behozzák a kínai vakcinát az országba. Ők is a szakemberektől kérdeznek, és a tanácsukat kell, hogy megfogadják, bennük kell bízni, és ha ők azt mondják, hogy az oltóanyagok hatékonyak, akkor azokkal be lehet oltani az embereket. Nagyon sok vizsgálatot kell elvégeznie a Népegészségügyi Központnak. Minden egyes külföldi gyártásból származó szállítmányt megvizsgálnak" – mondta Orbán Viktor miniszterelnök. "Megértettem, hogy hány vizsgálatot kell elvégezni a kínai vakcinán a Népegészségügyi Központnak ahhoz, hogy felszabadítsa a beérkezett kínai vakcinákat az orvosok számára, hogy beolthatóvá váljék. Nem elegendő, ami eddig történt, hogy adtunk egy vészhelyzeti engedélyt, hogy be lehet hozni és használni lehet általában a kínai vakcinát, hanem minden szállítmányt meg kell vizsgálni egy magyar biztonsági rendszernek megfelelően, bizonyos számú vizsgálaton át kell esni, hogy az a konkrét szállítmány, ami beérkezett, az bevethető-e, azt szabad-e beadni az embereknek." 310 448 legalább egyszer beoltott, és 383 ezer a betegségen hivatalosan igazoltan átesett ember van jelenleg Magyarországon. A fertőzések száma újra emelkedik, ezért továbbra is tartani kell a szabályokat – mondta a kormányfő, hozzátéve, hogy a számok Európa-szerte romlanak. A szakértők szerint a háttérben a vírus angol mutációjának magasabb elterjedtsége állhat, de ebben még van bizonytalanság – tette hozzá. Szerinte további szigorításokra nincs szükség, mert van annyi oltóanyag, hogy a jól megszervezett oltással tudunk annyit javítani a helyzeten, hogy ennek a pozitív hozadéka kiegyenlíti a dolgok természetes romlását. Az oltóanyag a dokumentáció szerint csak hat hónapig érvényes, hat hónap után újra be kell oltani az embereket. Ezért is van az, hogy több mint tízmillió ember beoltására elegendő vakcinát kötött le eddig a kormány – mondta. 'Ezen belül 19,5 millió nyugati vakcinát, 2,5 millió kínait és egymillió ember beoltására elegendő orosz vakcinát kötött le eddig Magyarország" - közli az interjúkészítő. (Forrás: Híradó / KossuthRádió)

2021. 02. 12. A kormány február 10-én döntött a koronavírus elleni védettségi igazolvány bevezetéséről. A legfontosabb részleteket egy ma megjelenő kormányrendelet rögzíti. A kormányrendelet alapján háromféle módon lehet igazolni a koronavírus elleni védettséget: ha valaki megkapta a védőoltást, vagy igazoltan átesett a koronavírus-fertőzésen, illetve ha valaki vélhetően átesett a fertőzésen, de nem tudott erről vagy nem készült erről teszt és utólag elvégzett ellenanyag-vizsgálat igazolja a fertőzésen való tuljutását.    Aki megkapta a védőoltást, nem kell igényelnie az igazolványt; az állam hivatalból postázza az ingyenes kártyát, annak kiállítását külön nem kell kérni. A védőoltást igazoló kártyának nincs érvényességi ideje. Az igazolvány a személyi adatok mellett tartalmazza majd a védőoltás idejét, valamint típusát.    Aki igazoltan átesett a koronavírus-fertőzésen, a fertőzésből való felgyógyulásának a napja jelenti a védettség kezdetét. A felgyógyulás napja az az Elektronikus Egészségügyi Szolgáltatási Térben (EESZT) nyilvántartott dátum, amikor negatív PCR-tesztje vagy antigén-gyorstesztje lett, miután korábban pozitív tesztje vagy tesztjei voltak.    Akinek csak a fertőzést igazoló pozitív tesztje van, de több teszt nem készült mert például tünetmentes vagy enyhetünetes volt és otthoni karanténban maradt –, a felgyógyulásának hivatalos napja a teszt utáni 10. nap. Közölték: a védettségi igazolvány érvényessége az igazolt felgyógyulást követő 6 hónap. A kártya ebben az esetben is ingyenes, az állam hivatalból postázza, annak kiállítását külön nem kell kérni.     Ha valaki vélhetően átesett a fertőzésen, de nem tudott erről vagy nem készült erről teszt, igazolhatja a fertőzésen való átesését ellenanyag-vizsgálattal is. Ebben az esetben a vizsgálat önköltséges, de hatósági áras lesz, melynek összege tizenegyezer forint. Emellett ki kell fizetni a védettségi igazolvány kiállításának 3000 forintos összegét is. Ha az ellenanyag-vizsgálat igazolja, hogy valaki korábban valóban fertőzött volt, akkor a védettségi igazolvány érvényessége négy hónap. Ebben az esetben a védettségi igazolványt elektronikus úton – a fővárosi és megyei kormányhivatal által rendszeresített elektronikus űrlapon – vagy személyesen is lehet igényelni bármely kormányablakban. A védettséget az igazolványon túl applikációval is lehet igazolni. Az applikáció az érintett azonosítását követően – az EESZT-ből szerzett adatok alapján – igazolja az érintett oltottságát; az oltott nevét, TAJ-számát, az oltás idejét, a védőoltás típusát, a fertőzéssel szembeni védettség tényét vagy annak hiányát jeleníti meg. A kártya személyazonosító igazolvány vagy útlevél felmutatásával együtt érvényes, és az egyes adatok megjelölését angol nyelven is tartalmazza. (Forrás: Híradó / MTI )

2021. 02. 12  Tegnap, elsőként Budapesten megkezdődött az oltás a Szputnyik-oltóanyaggal. A Nemzeti Népegészségügyi Központ (NNK) február 7-én engedélyezte felhasználásra ezt a -  Magyarországra decemberben érkezett, most oltásra kiosztott - oltóanyagot, amivel e héten 2800 idős embert oltanak be, négy budapesti kórházi oltóponton. A február 2-án érkezett 40 ezer adag Szputnyik V vizsgálata még zajlik, azokkal később kezdődhet meg az oltás. A magyar gyógyszerészeti hatóság január 20-án engedélyezte az orosz oltóanyagot, amely 18 év felett adható és két oltás szükséges belőle, 21 napos különbséggel; koronavírusos megbetegedést nem okozhat. Az oltóanyag a szövődményekkel járó, illetve súlyos lefolyású, halállal végződő betegség kialakulása ellen nyújt védelmet. Az oltóanyag által biztosított védelem ideje még nem ismert. Müller országos tiszti főorvos azt mondta: az orosz alkalmazási előiratban volt egy olyan rész, amely arról szólt, hogy bizonyos krónikus megbetegedések esetén kellő óvatossággal kell adni ezt az oltóanyagot. Ezért a magyar gyógyszerészeti hatóság úgy döntött, hogy – a biztonságot előtérbe helyezve – egyelőre azokban a betegség-csoportokban nem alkalmazzák. Ugyanakkor életkor szerinti határ nincsen, tehát azok az idősek, akik nem szenvednek ezekben a krónikus betegségekben, ugyanúgy megkaphatják az orosz oltóanyagot, mint a többi oltóanyagot – mondta az országos tiszti főorvos. Nem javasolt az oltás: akut lázas betegség, az oltás összetevőivel szembeni allergiás reakció, kórelőzményben szereplő bizonyos gyógyszerallergia, várandósság, szoptatás, 18 évnél fiatalabb életkor, krónikus vesebetegség vagy májbetegség, endokrin betegségek, jelentős eltérések a pajzsmirigyfunkciós értékekben, nem megfelelően kezelt cukorbetegség, súlyos vérképzőszervi betegségek, epilepszia és más központi idegrendszeri betegség, akut koronáriaszindróma, akut agyi keringési probléma, szívizomgyulladás, szívbelhártya-gyulladás, szívburokgyulladás, autoimmun betegség és rosszindulatú daganatos betegség esetén - ismertették a Koronavirus.gov.hu oldalon. (Forrás: Híradó / MTI)

2021. 02. 11. Ma újabb oltóanyag-szállítmány érkezett: a Modernából 21 600, az AstraZenecából 4060 (sic!) adag jött Magyarországra.' (Forrás: Híradó / M1, MTI)

2021. 02. 11.  Az első, 40 800 adagot tartalmazó AstraZeneca-oltóanyag szállítmány érkezett Magyarországra pénteken, február 5-én. Ma újabb, 45 600 adagot tartalmazó AstraZeneca-vakcinamennyiség érkezett. Március végéig több százezer vakcina várható. A gyártók közleménye szerint a koronavírus elleni oltóanyaggal első körben a szív- és érrendszeri, tüdő- és vesebeteg, a magas vérnyomásban szenvedő, a daganatos és a transzplantált 60 év alattiakat oltják be. Az Egyesült Királyságban folytatott klinikai vizsgálat részeredményei szerint oltóanyaguk hatékonysága 75 százalékos a brit típusú koronavírus-variáns ellen. (Forrás: Híradó / MTI)

2021. 02. 11.  Az amerikai Moderna oltóanyagból  21 600 adag érkezett ma délben.  Ma elkezdték az orosz oltóanyaggal is az oltást; azok a 75 év alattiak kapják, akiknek nincs krónikus betegségük. A brit AstraZeneca oltóanyagával  is elkezdődik az oltás. Ugyanakkor fennáll a betegszám növekedésének lehetősége, miután Magyarországon is megjelent a brit vírusmutáns. (Forrás: Híradó / M1)

Poland
February 13, 2021  A variant of coronavirus discovered in mink in Poland can be transmitted from mink to humans and humans to animals, Poland's agricultural ministry said today. The strain was found last month at a farm in Kartuzy county, about 30 kilometres west of Gdansk. Polish authorities said all mink there would be culled. The industry has more than 350 farms. (Source: NationalNewsUAE)

European Union    Európai Unió
February 16, 202EU records over 450,000 excess deaths between March and November 2020. The increase peaked in November at 40 percent above average, according to data released by the statistics agency Eurostat. Researchers calculate “excess deaths” as a percentage of additional deaths compared to the average for the corresponding month between 2016 and 2019. They calculate the estimated EU average using data from all member countries. Using data on direct COVID-19 deaths might be a less useful comparison because countries use different ways to classify COVID-19 deaths. (Source: Politico)

2021. 02. 13.  "December óta 26 millió adag koronavírus elleni oltóanyag jutott el a tagállamokba, és több mint 17 millió ember már meg is kapta a vakcinát”, vázolta a jelenlegi helyzetet az Európai Parlamentben Ursula von der Leyen. 'Túlságosan bizakodók voltunk a tömeggyártás kérdésében, és talán abban is a kelleténél biztosabbak voltunk, hogy a megrendelt mennyiség időben megérkezik' - tette hozzá. Az elkövetett hibák ellenére kitartott amellett, hogy a közös beszerzés, és a népességarányos elosztás jó döntés volt és hogy nyár végére a felnőtt európai lakosság 70 százaléka megkapja majd az oltást. Bizakodásának alátámasztására nem hozott fel újabb érveket. További források – 10 milliárd euro – felszabadítását javasolta az Európai Néppárt a mutáns és rendkívül fertőző vírustörzsek elleni harcra. A legnagyobb frakció kitartott a sokat bírált exportkorlátozás mellett, exporttilalomban gondolkodik az EU-ban gyártott oltóanyagok kapcsán. (Forrás: Híradó)

February 11, 2021  According to the EMA, Sputnik has absolutely not filed an application. The agency “has to date not received an application for a rolling review or a marketing authorization for the vaccine ... despite reports stating the opposite,” the EMA stated in February 10. Yes we did, retorted the Sputnik team on Twitter, publishing a screen grab of a submitted file. The image showed a submission to the Heads of Medicines Agencies, a conglomerate of national drugs agencies in the EU and European Economic Area that includes the EMA. It is not the correct destination for data to support a license application. (Source: Politico)

Serbia
11.02.2021 Serbia received a shipment containing half a million vaccine doses from Chinese pharmaceutical company Sinopharm late yesterday. The plane was welcomed by Prime Minister Ana Brnabic and Chinese Ambassador to Serbia Bo. A million doses of the vaccine arrived in Serbia earlier. "We receive a contingent of 500,000 vaccines. It means that we have 1,500,000 Sinopharm vaccines in Serbia which, with excellent vaccination organization, has enabled us to be the second country in Europe and seventh in the world in the number of vaccinated," Brnabic said. Serbian President Vucic announced that another 50,000 doses of the Sputnik V vaccine, 88,000 doses of the Pfizer vaccine and between 125,000 and 150,000 doses of the AstraZeneca  vaccine will arrive in Serbia by the end of February. (Source: AnadoluAgency)

 *** United Kingdom
13 Feb 2021  The University of Oxford has launched a study to assess the safety and immune response of the Covid-19 vaccine it has developed with AstraZeneca Plc in children for the first time. The new mid-stage trial will determine whether the vaccine is effective on people between the ages of 6 and 17. Around 300 volunteers* will be enrolled and first inoculations are expected this month. AstraZeneca has a target to produce 3 billion doses this year and aims to produce over 200 million doses per month by April. (Source: malaymail)
* Pro Domo: 'volunteers' (?)

Guinea
February 15, 2021 Guinea declared an Ebola epidemic yesterday after three people died and four fell ill with diarrhoea, vomiting and bleeding after attending a burial in Goueke sub-prefecture in the southeast. The person buried on Feb. 1 was a nurse at a local health centre and died after being transferred for treatment to Nzerekore, a city near the border with Liberia and Ivory Coast. Health workers will open a treatment centre in Goueke, which is less than an hour’s drive from Nzerekore. The 2013-2016 outbreak of Ebola in West Africa started in Nzerekore. It went on to kill at least 11,300 people, with the vast majority of cases in Guinea, Liberia and Sierra Leone. The Ebola virus has a much higher death rate than COVID-19, but unlike the coronavirus it is not transmitted by asymptomatic carriers. The authorities have asked the World Health Organization (WHO) for Ebola vaccines, which have greatly improved survival rates in recent years. Guinea, a country of about 12 million people, has so far recorded 14,895 coronavirus infections and 84 deaths. (Source: Reuters)

South Africa
10 Feb 2021  South Africa scraps AstraZeneca COVID vaccine. Health Minister Mkhize says South Africa will launch inoculation campaign with Johnson & Johnson shots instead. “The Johnson & Johnson vaccine has been proven effective against the 501Y.V2 variant. South Africa is considering trading its doses of AstraZeneca’s COVID-19 vaccine. The country has suspended its vaccine roll-out that was due to begin with Oxford-AstraZeneca vaccine this week after a study found the jab failed to prevent mild and moderate illness caused by a variant discovered in South Africa dubbed 501Y.V2. The vaccination delay has set back an ambitious plan to inoculate about 40 million people – 67 percent of the population – by the end of 2021. Officials are deciding on the fate of more than one million Oxford-AstraZeneca vaccines already secured from the Serum Institute of India (SII) and set to expire at the end of April, though that date could potentially be adjusted. Mkhize pointed at several options, including selling or swapping the doses with countries tackling the original coronavirus strain. “There are already countries who are asking to sell it to them,” Mkhize said. South Africa received its first jabs, one million AstraZeneca shots on February 1. An additional 500,000 doses have been bought from the SII and are due to be delivered this month. The government had secured vaccine doses from Pfizer for health workers. Negotiations with Moderna, China’s Sinopharm and over Russia’s Sputnik V vaccine are continuing. Officials previously said the country had secured nine million J&J single-dose shots, and Mkhize said a deal could be finalised soon. The J&J vaccine was 89 percent effective at preventing severe disease and 57 percent effective against moderate to severe disease in the South African leg of a global trial. Ninety-five percent of infections observed in the local study were due to the 501Y.V2 variant first identified late last year. South Africa’s neighbour eSwatini, earlier known as Swaziland, also said today that it would not be using the AstraZeneca vaccine. (Source: AlJazeera)

China
February 14, 2021  Investigators from the World Health Organization (WHO) looking into the origins of coronavirus in China have discovered signs the outbreak was much wider in Wuhan in December 2019 than previously thought. The lead investigator for the WHO mission, Embarek, told there were over a dozen strains of the virus in Wuhan already in December. The mission -  which comprised 17 WHO scientists and 17 Chinese - was able to gather for the first time 13 different genetic sequences of the SARS-COV-2 virus from December 2019. The sequences, if examined with wider patient data in China across 2019, could provide valuable clues about the geography and timing of the outbreak before December. The discovery of so many different possible variants of the virus could suggest it had been circulating for longer than just that month, the virus spread for some time undetected before the December outbreak in Wuhan. The team also had a chance to speak to the first patient Chinese officials said had been infected, an office worker in his 40s, with no travel history of note, reported infected on December 8. "He has no link to the markets," said Embarek. Embarek said the disease could have hit an estimated 1,000-plus people in Wuhan that December. He said the mission was given analysis by Chinese scientists of 92 suspected Covid-19 cases from October and November 2019 - patients who had Covid-like symptoms and were severely ill. The WHO team asked these 92 be tested in January this year for antibodies. Of these, 67 agreed to be tested and all proved negative, Embarek said. The 92, as presented to the WHO team, did not emerge in clusters as is common in disease outbreaks. Instead, they were spaced out in small numbers across both months, and across the whole province of Hubei, where Wuhan is located. The WHO team hopes to return to Wuhan in later months to continue its investigations, Embarek said, although he was unable to provide concrete dates for a confirmed trip. He said the team hopes to urgently examine biological samples the experts say were unavailable to them on this first trip, specifically thousands of samples from Wuhan's blood donor bank that date back two years. "There is about 200,000 samples available there that are now secured and could be used for a new set of studies," said Embarek. (Source: CNN)

** India
February 16, 2021  India has detected both the South African and Brazilian coronavirus variants, and people returning from those countries may be tested more aggressively, health officials said today. The South African variant was detected in four people last month and the Brazilian one in one person this month. The strains can more easily infect a person's lungs than the UK mutation, they added. The Indian government is now considering mandating RT-PCR tests for all people coming from Brazil and South Africa, as is being done for those flying in from the United Kingdom. India has so far reported 187 cases of infection with the UK variant. There are no direct flights from South Africa or Brazil. India's Covid-19 cases rose by 9,121 in the past 24 hours, taking the total to 10.93 million. Deaths rose by 81 to 155,813. (Source: StraitsTimes)

* United States
February 15, 2021  A study finds 7 new own unique 'worrying' "lineages" of the virus in the U.S. While the lineages evolved independently of one another, they seem to display the same genetic mutation. The change is seen in a gene that influences how the virus finds its way into a host's cell, suggesting it could make these variants more contagious -  though this hasn't been confirmed. It's hard to tell just how prevalent they are or where they began because the U.S. performs genome sequencing on just a tiny fraction of coronavirus test results. The country is administering 1.66 million vaccine doses a day. Governors across the country ease pandemic restrictions -  like mask mandates and limits on gatherings - while health experts are nervous. Rasmussen, a virologist at Georgetown University, told that letting guard down now would be "courting disaster." (Source: Yahoo)

13 Feb, 2021  New York Governor Cuomo administration is accused of 'cover-up' over nursing home deaths. Secretary to the governor DeRosa told Democratic lawmakers that the administration took months to release data revealing how many people living at nursing homes died of Covid-19 because officials "froze" over worries the information was "going to be used against us."  Cuomo is a third-term Democrat who says he'll run again in 2022 and penned a book touting his handling of the pandemic. In recent weeks, a court order and state attorney general report has forced the state to acknowledge the nursing home resident death toll is nearly 15,000, when it previously reported 8500 -  a number that excluded residents who died after being taken to hospitals. The new toll amounts to about one-seventh of the people living in nursing homes as of 2019 in New York. (Source: NZHerald)

WHO
Feb 9, 2021  The World Health Organization mission to China to uncover the origins of the coronavirus failed to identify the source of the COVID-19 pandemic. Experts believe the disease - which has killed more than 2.3 million people worldwide - originated in bats and could have been transmitted to humans via another mammal.  It also quashed the theory that a leak from a virology lab in Wuhan could have caused the pandemic. The WHO experts spent a month in China, including two weeks in quarantine. the group spent just an hour at the seafood market where many of the first reported clusters of infections emerged over a year ago. They also appeared to spend several days inside their hotel, receiving visits from various Chinese officials without venturing out into the city. Liang, head of the China side of the joint mission, said studies showed the virus could be 'carried long-distance on cold chain products,' appearing to nudge toward the possible importation of the virus - a theory that has abounded in China in recent months. Deeper research was carried out at the Wuhan Institute of Virology, where the WHO delegation spent nearly four hours. (Source: JapanTimes)

------------------------------------------------

2021. II. 8.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
106 420 830

Országonként:

Egyesült Államok * 27 074 482
India 10 838 194
Brazília ** 9 524 640
Egyesült Királyság *** 3 971 287
Oroszország **** 3 929 162
Franciaország 3 400 302

...
Magyarország ***** 377 655

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 323 540

Országonként:

Egyesült Államok 464 747
Brazília 231 534
Mexikó ** 166 200
India 155 080
Egyesült Királyság 113 014
Olaszország 91 580

...
Magyarország 13 155

-----------------------------------------

'Gyógyultak' száma ******
('Global Recovered ')
59 305 523

Országonként:

India 10 534 505
Brazília 8 468 459
Oroszország 3 434 163
Törökország 2 429 273
Olaszország 2 133 523
Németország 2 054 340

...
Magyarország 281 839

****** az Egyesült Államokra vonatkozó összesített adatot nem közöl

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 2/8/2021 11:24 p. m."

 

Európa     Europe

*****  Magyarország     Hungary
2021. 02. 08.  2,5 millió ember oltásához elég kínai Sinopharm oltóanyag fog érkezni a következő négy hónapban.     Az AstraZeneka oltóanyaggal a 18-60 éves krónikus betegeket fogják oltani; Magyarországon 4 hét telhet el a két oltás között. ​(Forrás: Híradó)

2021. 02. 07.  A Nemzeti Népegészségügyi Központban (NNK) jó eredménnyel lezárult a Szputnyik V orosz oltóanyag vizsgálata, az használható Magyarországon. A magyar szakemberek november óta tanulmányozzák ezt az oltóanyagot, mindenik gyártási tételt megvizsgálták. Európában elsőként hozzánk érkezett a szer itthoni vizsgálatra. Az Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet január 20-án adta meg az engedélyt használatára. Február 2-án az első jelentős mennyiségű szállítmány - 40 ezer ampullányi, azaz 20 ezer ember beoltására elegendő - Szputnyik V oltóanyag érkezett. Magyarországra 3 hónap alatt érkezik 2 millió ampullányi, 1 millió ember beoltására elegendő orosz oltóanyag, amely ugyanazzal a technológiával készül, mint az AstraZenecáé; a koronavírus tüskefehérjéjének génjét egy ártalmatlanított vírus segítségével juttatják be a szervezetbe. Orvosi szaklap, a  brit The Lancet is beszámolt  a vizsgálatok szerinti több, mint 90 százalékos hatékonyságról. Időseknél is biztonságosan alkalmazható, 18 év felett mindenkinek adható.     Az országos tiszti főorvos szerint kizárólag orvosi javallatra előfordulhat, hogy az orvos előnyben részesíti az egyik oltóanyagot a másikkal szemben a betege számára. Müller jelezte: eddig 286 379 embert oltottak be az első adag oltószerrel, több mint 105 ezren a másodikban is részesültek. Elkezdődött a legidősebbek oltási kampánya is, a háziorvosok segítségével. (Forrás: Híradó / M1, MTI)

2021. 02. 06.  Megérkezett Budapestre az oxfordi egyetem és az AstraZeneca gyógyszergyár által közösen fejlesztett oltóanyag első szállítmánya, amely a tervek szerint több mint 20 ezer ember beoltására lesz elegendő. Az Európai Gyógyszer-ügynökség által engedélyezett oltóanyagot a 65 év alatti, regisztrált, krónikus betegséggel küzdők kapják majd. Vektorvakcina ez; egy csimpánz-adenovírust használ fel arra, hogy az emberi szervezet azt koronavírusként ismerje fel. Ebből az oltóanyagból is két oltás kell, a második dózis beadása után több, mint nyolcvan százalékos lesz a védettség. "A kórházba kerüléstől, a súlyos tünetektől és a haláltól szinte száz százalékban véd.'  Hűtőszekrényben lehet tárolni, ami nagyban megkönnyíti használatát a háziorvosi rendelőkben. (Forrás: Híradó /MTI)

February 5, 2021  First Sinopharm vaccines will arrive in Hungary this month. Hungary completed a deal for the Chinese two-dose inactivated coronavirus vaccine in January. The Chinese company will provide doses to vaccinate 250,000 people each month through April.     Hungary also received the first doses of Russia's Sputnik V vaccine this week, and Orbán said that it plans to start using them as early as next week. The prime minister criticized the EU's vaccination strategy for "progressing slowly" and focusing on getting vaccines at low costs. (Source: Politico)

2021. 02. 04.  Mától február 7-ig, vasárnapig 1080 háziorvosi körzetben tíz-tíz regisztrált, idős személy kaphat védőoltást. És minden háziorvosi körzetből hat-hat, szintén regisztrált, idős embert kórházi oltópontokon oltanak be. Az oltópontokon Pfizer-vakcinával történik az immunizálás, a háziorvosok a területi népegészségügyi hatóságokon keresztül kijuttatott Moderna-oltóanyaggal oltanak. (Forrás: Híradó / MTI)

European Union
February 1, 2021   The AstraZeneca Covid-19 vaccine has fuelled debate over its effectiveness among the elderly. Although the European Medicines Agency recommended the vaccine for adults of all ages last week, several countries have advised against administering the jab to older people. The EMA said there was insufficient data to know for certain how effective the AstraZeneca vaccine is in older individuals. It concluded that the vaccine "can be used in older adults," as is already the case in Britain. Germany it will not advise over 65s to get it. Italy's medicines agency in January 30 approved the vaccine for all adults but recommended alternatives for people aged over 55. "It is clear that seniors will not be vaccinated with this vaccine," Dworczyk, the Polish government official in charge of vaccinations, told. France is set to be the next EU nation to announce its own recommendation on the AstraZeneca vaccine. The main problem centres around the lack of data among elderly trial participants. Developers AstraZeneca and Oxford University have been transparent in disclosing that fewer than 10 percent of those it tested the vaccine on were 65 or older. Just 450 participants were over 70. (Source: Yahoo)

**** Russia
February 6, 2021  Sputnik V has been approved in more than 15 countries. Authorities in mid-January said that 1.5 million people had been inoculated with Sputnik V around the world. Russia says it has received pre-orders of more than a billion doses of Sputnik V, but it is unable to meet that level of demand. Brazil, India, Kazakhstan and South Korea are currently producing the jab, Viktor Orbán's Hungary sidestepped the European Medicines Agency (EMA) and registered the vaccine on its own. More Russian coronavirus vaccines are expected to be rolled out in the coming weeks: Sputnik Light,; EpiVacCorona vaccine, developed by the Siberian Vektor laboratory and CoviVac. And the fourth, with the Anglo-Swedish pharmaceutical firm AstraZeneca - they are working to combine their respective vaccines. (Source: BuenosAiresTimes)

03/02/2021  The Lancet medical journal published results showing Sputnik V to be safe and 91.6 percent effective. Russia began inoculating its citizens with the jab in December. The Russian Direct Investment Fund (RDIF) applied for registration of Sputnik V in the European Union last month. German Chancellor Angela Merkel has expressed openness to its use once the jab receives the regulatory nod. (Source: France 24 / AFP)

Ukraine
Feb. 3, 2021  Ukrainian lawmakers last week approved a bill that officially banned vaccines made in Russia, (The Russian government had already started administering Sputnik V in Crimea, and this week, Russian-backed separatist areas in eastern Ukraine also began using the vaccine.) In Ukraine, with a population of more than 40 million, the pandemic has infected 1.25 million and caused more than 23,000 deaths. Through the global Covax program, Kyiv secured 8 million doses of the vaccine developed by U.S. pharmaceutical giant Pfizer and Germany's BioNTech. The first round, due later this month, is expected to bring only 200,000 doses. Ukraine also was signing a deal for 1.8 million doses of China's Sinovac vaccine in December. (Source: StamfordAdvocate)

*** United Kingdom
February 5, 2021  Britain had agreed on a deal with German biotech firm CureVac to develop vaccines against coronavirus variants, placing an initial order for 50 million doses in case they are needed. In February 3, CureVac announced a partnership with Britain’s GlaxoSmithKline (Source: Reuters)

Feb 4, 2020 The so called British variant, known as VUI-202012/01, has mutations including a change in the spike protein that viruses use to bind to the human ACE2 receptor. Britain today launched a trial to assess the immune responses generated if doses of the vaccines from Pfizer and AstraZeneca are combined in a two-shot schedule. Initial data on immune responses is expected to be generated around June. AstraZeneca's shot is separately being trialled in combination with another viral vector vaccine, Russia's Sputnik V. Mixing different shots had proven effective in Ebola vaccine schedules. Vaccines against Hepatitis A and B were interchangeable from two different manufacturers. Similar work has been undertaken for human papillomavirus (HPV). (Source: Reuters)

2 February 2021  UK finds more coronavirus cases with 'concerning' mutations. Tests show a mutation, called E484K, that is already seen in the South Africa variant. Early results from Moderna suggest its vaccine is still effective against variants with this mutation. Two new coronavirus vaccines that could be approved soon - one from Novavax and another from Janssen - also appear to offer good cover against variants, protecting against serious illness. (Source: BBC)

Africa

South Africa
7 Feb 2021  South Africa has suspended the use of the Oxford/AstraZeneca coronavirus vaccine in its immunisation programme after receiving 1 million doses produced by the Serum Institute of India today. The University of Witwatersrand in Johannesburg, which conducted the trial of the Oxford/AstraZeneca vaccine, said in a statement today that the vaccine “provides minimal protection against mild-moderate COVID-19 infection” from the501Y.V2 coronavirus variant, which is dominant in South Africa. (Source: AlJazeera)

Tanzania
8 Feb 2021  A strange disease emerged in an administrative ward of Ifumbo, Chunya district in the Mbeye region of Tanzania which causes people to throw up blood kills at least 15 victims. The unidentified illness left more than 50 people needing hospital treatment. Dr Kisandu, the district chief medical officer in the Chunya district, was later suspended over making the claim of a strange disease. She said most people who had been affected were men, who were diagnosed with liver and ulcer complications. People vomit blood and die when they get to the hospital late. She said samples of blood and local water were being tested by the country’s government for any traces of mercury contamination. Tanzania's Health Ministry Gwajika has ruled out an outbreak. The region is said to have been hit by a similar illness back in 2018, which caused patients to suffer with high fever, vomiting blood and nausea. Tanzania’s president, Magufuli, has claimed coronavirus had been stopped in the country due to the power of prayer. (Source: DailyStar)
Pro Domo: Liqueur drinkers? (CitizensGo)

North America

* United States
Feb. 7, 2021  The United Kingdom variant officially known as B.1.1.7 is becoming dominant in the U.S. by late March. The report posted on the preprint server MedRxiv concludes that the variant has been 35 to 45 percent more transmissible than other strains of the virus in the United States. It had multiple introductions to the United States by end of November (first appeared in genomic surveys in the United Kingdom on Sept. 20). When the CDC issued its warning last month about B.1.1.7, it was still present in less than one-half of 1 percent of cases. That jumped to about 3.6 percent at the end of January, the research found. There are other variants. The B. 1.351, first seen in South Africa contains a mutation (E484K, nicknamed "Eeek") that limits but does not entirely undermined the efficacy of vaccines. A preliminary evidence from a clinical trial in South Africa conducted by Novavax, is showing that people previously infected by the coronavirus and given a placebo were becoming reinfected with B. 1.351. There was no evidence these follow-on infections were severe or deadly. The United Kingdom variant does not generally include the worrisome "Eeek" mutation. A report published recently in the journal Science, found that the Pfizer-BioNTech vaccine remained effective against B.1.1.7. (Source: SFGate)

** South America

February 02, 2021  The region encompasses 34 countries and territories in South and Central America and the Caribbean plus Mexico, has recorded 601,256 deaths. Brazil with more than 226,300 fatalities, and Mexico with at least 159,100 deaths account for about half the region's coronavirus deaths, which hit the grim figure of over 500,000 by the end of December. Peru is hardest hit with 125 deaths per 100,000 people, followed by Mexico and Panama with 123 each per 100,000. Many Latin American countries have experienced a deadly second wave of infections since December. (Source: JamaicaObserver)

Globalization

February 3, 2021  Researchers at the University of Nottingham found that the broad spectrum antiviral thapsigargin is not only very effective against COVID-19, but also against a common cold coronavirus called respiratory syncytial virus and influenza A. The scientists found that the antiviral, in small doses, triggers a “highly effective” immune response against the three major types of human respiratory viruses, including COVID-19. Thapsigargin, which has been tested in prostate cancer, is effective against viral infection when used before or during active infection. Professor Chang led the study along with colleagues at the Animal and Plant Health Agency, China Agricultural University and the Pirbright Institute. (Source: NewYorkPost)

------------------------------------------------

2021. I. 31.

E vírus-fertőzés áldozatainak száma ('Coronavirus COVID-19 Global Cases')

/Forrás: - térképes megjelenítéssel is -:

The Center for Systems Science and Engineering (CSSE)

at Johns Hopkins University (JHU)/:

https://tinyurl.com/uwns6z5

 

Bizonyítottan fertőzöttek száma
('Global cases')
102 871 614

Országonként:

Egyesült Államok 26 174 956
India 10 746 183
Brazília 9 176 975
Egyesült Királyság 3 828 183
Oroszország 3 808 348
Franciaország 3 255 920

...
Magyarország 367 586

-----------------------------------------

Elhunytak száma
('Global Deaths')
2 225 773

Országonként:

Egyesült Államok 441 200
Brazília 223 945
Mexikó 158 074
India 154 274
Egyesült Királyság 106 377
Olaszország 88 516

...
Magyarország 12 524

-----------------------------------------

'Gyógyultak' száma
('Global Recovered ')
56 981 674

Országonként:

India 10 423 125
Brazília 8 175 360
Oroszország 3 264 611
Törökország 2 362 415
Olaszország 2 010 548
Németország 1 940 046

...
Magyarország 262 968

 

A fenti adatok a honlap ekkori frissítésekor voltak érvényesek:
'Last updated: 1/31/2021 11:22 p. m."

------------------------------------------------

Előzmény / Previously:

A 2021. január 24 - 29.-i előzmények itt érhetők el:/ About the period of 24 - 29 January 2021):

2021. január 24 - 29. I. :

https://tinyurl.com/yyjb8py3

2021. január 24 - 29. II. :

https://tinyurl.com/y6e9l558

.

Szólj hozzá!

Címkék: térkép magyarország vírus franciaország peru olaszország india németország oroszország európa törökország mexikó sweden china virus brazília panama who book guinea poland egyesültkirályság ukraine serbia kazakhstan unitedkingdom tanzania europeanunion egyesültállamok southkorea liberia europeancommission southafrica southamerica sierraleone globalization crimea ivorycoast nemzetinépegészségügyiközpont

26 January 2021. Europe. Total vaccine doses given by country

2021.01.27. 14:18 Eleve

 

26 January 2021. Total COVID-19 vaccine doses given by country (Europe) /Source: DailyMail/

 

Szólj hozzá!

Címkék: hungary sweden romania france belgium germany europe denmark italy turkey ireland austria poland switzerland portugal spain greece norway serbia unitedkingdom czechia thenetherlands

2021. I. 24 - 29. I. Globalizáció. Vírusfertőzés és védőoltás adatok: Magyarország - Hungary, Czechia, Franciaország, Germany, Italy, Sweden, Európai Bizottság - European Commission, European Council, European Union

2021.01.25. 23:19 Eleve

.

A 2021. január 16 - 23-i előzmények itt érhetők el:/ About the period of 16 - 23 January 2021):

https://tinyurl.com/yxf2xw9a

Magyarország     Hungary
2021. 01. 29.    Magyarország eddig 19,7 millió adag nyugati vakcinát kötött le, több tízmilliárd forint értékben különböző gyártóknál (Pfizer-BioNTech, Moderna, AstraZeneca, Janssen, Curevac). Ezekből jelenleg csak a Pfizer és a Moderna vakcinák rendelkeznek az Európai Gyógyszerügynökség (EMA) engedélyével. A két gyártótól eddig összesen 201 ezer ember oltására elég vakcina érkezett Magyarországra (hét Pfizer-szállítmány és egy Moderna-szállítmány). Eddig 175 283 fő kapott oltást, közülük 37 727 fő már a második oltását is megkapta. Több európai országban tovább nő a fertőzöttek száma, miközben kevés az oltóanyag. Ezért a kormány március 1-ig meghosszabbította a védelmi intézkedéseket. (Forrás: Híradó)

2021. 01. 29.  Magyarország két és fél millió ember beoltását lehetővé tevő, ötmillió adag koronavírus elleni oltóanyagot vásárol a kínai Sinopharm vállalattól – közölte a külgazdasági és külügyminiszter, aki telefonon egyeztetett Vang kínai külügyminiszterrel. A szerződést 'sikerült aláírni' a déli órákban. 'Kiemelte: az Országos Gyógyszerészeti és Élelmezés-egészségügyi Intézet (OGYÉI) engedélyének kiadása után megnyílt a lehetőség a kínai Sinopharm által gyártott oltóanyag megvásárlására'. A szállítás négy szakaszban, négy hónap alatt történik. Megjegyezte: Szerbiában már több mint 300 ezer embert oltottak be vele, köztük sok magyart is a 'Vajdaságban'. (Forrás: Híradó / MTI)

2021. 01. 29.  Országosan 1845 szociális intézménybe jut el a koronavírus elleni oltóanyag a következő három napban - idősotthonokba, fogyatékos otthonokba, pszichiátriai- és szenvedélybeteg-otthonokba. Az előzetes jelentkezések alapján hatvanezer embert fognak beoltani vele. (Forrás: Híradó / MTI)

2021. 01. 28. A kormány úgy gondolja, hogy a jelenlegi szabályokat fenn kell tartani – jelentette be Gulyás, Miniszterelnökséget vezető miniszter ma. Hozzátette: ehhez a rendkívüli jogrend meghosszabbítása is szükséges, amelyet saját hatáskörben a kormány 15 napra rendel majd el február 7-én éjféltől, ezt követően pedig az Országgyűlést fogja arra kérni, hogy 90 nappal hosszabbítsa meg a rendkívüli jogrendet. A rendkívüli jogrend meghosszabbítását azért látja feltétlenül szükségesnek, mert ez kell a jelenlegi szabályok – így a kijárási korlátozás – fenntartásához. Beszámolt arról: 'a kormány a koronavírus-oltóanyagok engedélyezési eljárását felgyorsítandó arról döntött, hogy minden olyan, a világban alkalmazott oltás, amellyel több mint egymillió embert oltottak be és veszélyhelyzeti felhasználási engedélyt kapott, Magyarországon is megkaphatja ezt az engedélyt'. Minden behozott oltóanyagot a felhasználás előtt a Nemzeti Népegészségügyi Központ külön is ellenőriz. Három olyan oltóanyagot említett – a brit AstraZenecát, az orosz Szputnyikot és a kínai Sinopharmot –, amelyből a kormány vásárolni próbál. Jelezte: az Astra-Zeneca oltóanyagának Magyarországon van engedélye, 'mert a brit engedély erre alapul szolgált'. 'Hozzátette: az AstraZenecáé kiváló oltóanyag, amellyel 65 év felett is lehet oltani és eredményes a védettség szempontjából'. Közölte: az Oroszországgal kötött szerződés alapján február végéig 300 ezer emberre elég oltóanyag érkezik Magyarországra, azt követően további 700 ezer emberre elegendő oltóanyag fog onnan érkezni. A kínai Sinopharm oltóanyagról azt mondta, a következő hónapban 500 ezer vakcinát kaphat Magyarország, ez 250 ezer ember beoltására elegendő. Erről szólva kiemelte: 'a hatékonysága kifejezetten jó, az eddigi tapasztalatok kiválóak, több mint 16 millió embert oltottak be vele a világon, például Szerbiában is'. 'Kifejezett felelőtlenség, ha nagyon hosszú vizsgálatok előzik meg az engedélyezést – hangoztatta'. Megjegyezte: nem hiszi, hogy nagy mértékben eltérne a kínai vakcina ára a Pfizerétől. (Forrás: Híradó / M1)

2021. 01. 26. Újabb, több mint 25 ezer ember beoltására elegendő Pfizer-szállítmány érkezett az országba. Eddig mintegy 150 ezer embert oltottak be itthon a koronavírus ellen. Országszerte oltják az egészségügyi dolgozókat. 12 ezren már a második oltáson is túl vannak. Lezárul az egészségügyi dolgozók kampányszerű oltása, az idősotthonokban pedig tovább folytatódik. Amint elegendő oltóanyag érkezik az országba, elkezdődik a további idősek beoltása is. (Forrás: M1 / Híradó

2021. 01. 26.  Doctor honoris causa kitüntető címet adományoz a Szegedi Tudományegyetem (SZTE) Karikónak, a Covid-19 világjárvány elleni küzdelemben kulcsszerepet játszó oltóanyag egyik kifejlesztőjének. Karikó kisújszállási diákként részt vett a szegedi József Attila Tudományegyetem (JATE) tehetséggondozó programjában. 1973-ban kezdte meg egyetemi tanulmányait a JATE Természettudományi Karának biológia szakán. Az akkori legrangosabb támogatás, a Népköztársasági Ösztöndíj három tanévben is segítette. Kiváló eredménnyel végezte be egyetemi tanulmányait 1978-ban. 1978 és 1982 között a Szegedi Biológiai Kutatóközpontban (SZBK) végezte kutatómunkáját. 1983-ban a JATE-n szerzett egyetemi doktori címet. Két évig kutatómunkáját az SZBK Biofizikai Intézetében folytatta. 1985-től az Egyesült Államokban – Philadelphiában és Washingtonban – dolgozott kutatóként. Kutatásainak fő tárgya a biológiai információ üzenethordozójának, a hírvivő – angolul 'messenger' – RNS-nek vagy mRNS-nek a vizsgálata. Eredményeivel meghatározó mértékben járult hozzá ahhoz, hogy az mRNS hatékonyan használható irányított fehérjetermeltetésre - megfelelő módosítással és tisztítással - az élő rendszerekben, amivel sokoldalú terápiás fejlesztések alapjait teremtette meg. A védőoltások előállításának forradalmian új megközelítését jelenti a kutatásainak és fejlesztéseinek eredményeire támaszkodó mRNS alapú oltóanyag. Hogy a technológiai áttörést jelentő oltóanyag előállítását is segítse, Karikó az alapkutatási eredményeit továbbfejlesztő biotechnológiai céghez csatlakozott 2013-ban. A cég 2020-ban - egy multinacionális gyógyszergyártó céggel együttműködve - előállította a napjainkban már világszerte alkalmazott Covid-19 oltóanyagot. Kitartó, fókuszált kutatómunkája, az arra épülő, az egész társadalom számára kiemelkedő jelentőségű fejlesztő tevékenysége, innovatív attitűdje példaértékű. (Forrás: Híradó / M1)

2021. 01. 26.  „Engedélyeztek Magyarországon egy, a koronavírus új típusú, angliai mutációja ellen is hatékony készítményt” – jelentette be az emberi erőforrások minisztere. Kásler azt mondta: Magyarország Európában elsőként alkalmazhatja a készítményt, amely egy koronavírus-fertőzésből felgyógyult beteg vérplazmájából készült monoklonális antitest. Március végéig három ütemben több mint 6200 ampulla érkezik belőle Magyarországra, az első szállítmány holnap. „Az antitestalapú készítmény hetven-hetvenöt százalékkal csökkenti a súlyosabb szövődmények kialakulását, így a betegek háromnegyedének állapota nem súlyosbodik, és kórházi felvétel sem szükséges. Ezáltal jelentősen csökken a kórházakra és az egészségügyi dolgozókra nehezedő nyomás” – tette  hozzá Kásler. A Pfizer és Moderna után az AstraZeneca is azt közölte, hogy egyelőre nem teljesíti korábbi ígéreteit, és a vállaltnál kevesebbet szállítanak az Európai Uniós tagállamoknak. A cég március végéig csak 31 milliót akar leszállítani – a vállalt 81 millió adag helyett – az Európai Uniónak. Egyes feltételezések szerint a cég az EU-n kívüli országoknak drágábban adott el oltóanyagot, és ezért szállít az EU-ba az első negyedévben 60 százalékkal kevesebbet, mint a szerződéses kötelezettsége. (Forrás: Híradó / M1)

2021. 01. 25.     Ma 11 155 ember beoltására elegendő Pfizer–BioNTech oltóanyag érkezik hazánkba. Vasárnap, február 1-én pedig az amerikai Modernától kilencezer ember beoltására elegendő védőoltás szállítmányra számíthatunk. A két nyugati gyártó folyamatosan változtatja a szállított vakcina mennyiségét és időpontját. Múlt héten Szijjártó külgazdasági és külügyminiszter egymillió ember beoltására elegendő vakcinára adott le rendelést Oroszországból - mondta Müller országos tiszti főorvos. "A Szputyik V vakcinaszállítmányokat minden esetben a Nemzeti Népegészségügyi Központ (NNK) fogja bevizsgálni" – hangsúlyozta. Azok, akik már a második adag védőoltásukat is megkapták, komolyabb melléhatásokat is észlelhetnek. Említette a bőrpírt, de egy-két napig lázas állapot is előfordulhat, illetve levertség, izomfájdalom. A szakértők azt tanácsolják, hogy lázas tünetek jelentkezése esetén paracetamollal csillapítsák azt.  Eddig 1,775 millió ember jelentkezett az oltásra. Említette azt is: már nemcsak Nagy-Britanniából indult mutáns vírus kering hazánkban, hanem a dél-afrikai eredetű vírustörzs is. (Forrás: Híradó / M1)

25 January 2021  After submitting a freedom of information request to the prime minister’s office, the human resources ministry, the interior ministry and the foreign ministry, none had taken responsibility for the national vaccination plan as the data controller, socialist MEP Ujhelyi – who started making requests on 18 November – told a press conference in 23 January. Hungary’s chief medical officer Müller told state media MTI yesterday that vaccinations are proceeding according to “a well-thought-out vaccination plan,” since a second dose needs to be available to those who have already had the first jab. According to Müller, 80% of health care workers who have asked for the vaccine have already received it, while 8,000 have already received the second dose. (Source: EURActiv)

2021. 01. 24. Vasárnap.  Elérkeztünk abba a szakaszba amikor már az elhunytak számának csökkenését is tapasztaljuk - mondta az országos tiszti főorvos. Dr. Müller hangsúlyozta: a fertőzöttek számának a csökkenését jellemzően körülbelül 4-5 hét múlva követi az elhunytak számának a csökkenése, most ennek vagyunk tanú. 100 000 körüli aktív fertőzött van még az országban, közel 4 000 beteg még kórházi kezelésre szorul – tette hozzá. „A kórházban ápoltak száma is csökken; a mai napon 3793 főt ápolnak kórházainkban és 254-en szorulnak lélegeztetésre". Az egészségügyi ellátó rendszer terhelése is csökkenőben van, ez egy nagyon kedvező adat Magyarország szempontjából. Jelentős lépés hogy az egészségügyi dolgozók, akik kérték a védőoltást közel 80 százalékban már meg is kapták azt, és közel 8 ezer fő van aki már a második oltást is megkapta. „Azt remélem, hogy az újabb vakcinabeszerzésekkel megcélozhatjuk már a hatvan feletti krónikus megbetegedésben szenvedő korosztályt, illetve azokat, akik nem szenvednek semmilyen betegségben, ugyanakkor életkoruknál fogva már egy magasabb kockázati csoportba tartoznak. Ezt úgy tervezzük, hogy a 89 év feletti korosztállyal fogjuk elkezdeni, őket majd nagy valószínűséggel elsősorban a háziorvosok, illetve oltócsoportok fogják beoltani” - közölte. Elmondta: szeptember 1-jét követően 16 000 fő jött be az országba Angliából. Rendszeresen kezdték el vizsgálni, utazási előzménnyel társítva, azok leleteit, akik közülük pozitív eredményt produkáltak. Ennek során fény derült arra, hogy sajnos Magyarországon is itt van a brit mutáns törzs. A Szputnyik V vakcina már itt van Magyarországon, kétszer 3000 adag mennyiséget tárol a Nemzeti Népegészségügyi Központ. (Forrás: Híradó / M1)

Czechia
25/01/2021  Anger on Czech border as Germany demands virus tests. Tens of thousands of Czechs regularly travel to Germany for work, many of them in healthcare. Long queues of cars formed at the Czech-German frontier today and cross-border workers voiced frustration as tighter restrictions for travel into Germany came into force. They are going to have to test every 48 hours. Tempers flared as people waited around two hours to cross what is now an internal EU border. Centre for carrying out antigen tests had been hastily set up in a customs building. The Czech Republic is now classed as high risk by Germany because of an elevated coronavirus infection rate. Bavaria plans to open more rapid test centres at various border crossing points, according to local media. In the neighbouring German state of Saxony, the rule has been relaxed to allow workers to undergo tests twice a week on the German side, before starting work. (Source: France24)

Franciaország
2021. 01. 27.  A Sanofi besegít a Pfizer-BioNTech konzorciumnak a koronavírus elleni oltóanyaga gyártásába, a francia gyógyszergyár több mint 100 millió adagot szállít le az Európai Uniónak 2021 végéig – jelentette be Hudson vezérigazgató. Elmondta: ma írt alá szerződést arról, hogy a Sanofi a frankfurti üzemében fogja júliustól kezdve a konkurensei által rendelkezésre bocsátott oltóanyagot gyártani. „Ez a gyártótelep közel van a BioNTechnek a Mayence-ban található székhelyéhez, ez megkönnyíti a dolgokat” – mondta a francia cég vezetője. „Az itt gyártott termékek az Európai Unióba mennek, így részben Franciaországba” – tette hozzá. A francia gyógyszergyártó maga is két oltóanyag kifejlesztésén dolgozik, de a legfőbb projektje, a GlaxoSmithKline (GSK) brit székhelyű multinacionális gyógyszeripari vállalattal együtt fejlesztett oltóanyag késedelmet szenvedett, s 2021 utolsó negyedévében kerülhet forgalomba. (Forrás: Híradó / MTI)

Germany
January 28, 2021  Germany’s immunization commission recommended that AstraZeneca Plc’s Covid-19 vaccine be authorized only for people between the ages of 18 and 64. The group, which evaluates vaccines for the German government, said there was insufficient information on the shot’s effectiveness for people over 65 years old. (Source: Bloomberg)

Italy
Jan. 27, 2021   A primary care physician from one of the hardest hit regions in Italy has been arrested for lethally injecting weak COVID patients to free up beds during the peak of the pandemic. The 47-year-old was arrested on double homicide charges this week. Two patients who died under his care, were exhumed last month as the prosecution built the case against the primary care physician using text messages among nurses who watched the once-loving physician transform from Dr. Jekyll into a sinister Mr. Hyde. When nurses started refusing his orders, he allegedly started injecting the patients personally.  Authorities are now combing through records of all of his dead patients to search for anomalies in their treatment and deaths. They do not rule out exhuming further bodies, although the majority of the people who died during the height of the first wave of the pandemic were cremated.   (Source: TheDailyBeast)

Sweden
January 26, 2021  Sweden’s Health Agency has paused COVID-19 vaccine payments to Pfizer and is seeking clarification over the amount of doses available in each vial. Sweden is seeking clarity on the number of doses it has been billed after Pfizer charged for six doses in each vial rather than the agreed upon five doses. Sweden now want the EU Commission and Pfizer to reach an agreement on how many doses there are contained in each vial. EU and Pfizer originally agreed that each vial contained five doses, but it was later discovered that six doses could be extracted if a special syringe was used. (Source: Reuters)

Európai Bizottság    European Commission  
2021. 01. 29.   Az Európai Bizottság feltételes engedélyt adott az AstraZeneca brit-svéd gyógyszeripari vállalat és az Oxfordi Egyetem új típusú koronavírus ellen közösen kifejlesztett oltóanyagának forgalomba hozatalára, megkezdődhet tömeges alkalmazása az Európai Unió 27 tagországában. A brit egyetem és a gyógyszeripari vállalat január 12-én nyújtotta be forgalmazási kérelmét az EMA-hoz.  Ursula von der Leyen, EB elnök reményét fejezte ki, hogy a vállalat teljesíti vállalását, és a megállapodásban foglaltak szerint szállítani fogja mind a 400 millió adag oltóanyagot. (Forrás: Híradó / MTI)

2021. 01. 29.  Ma az Európai Gyógyszerügynökség (EMA) forgalmazásra ajánlotta az Európai Unióban a SARS-CoV-2 koronavírus elleni harmadik hatékony oltóanyagot. Az AstraZeneca brit-svéd gyógyszeripari vállalat és az Oxfordi Egyetem által az új típusú koronavírus ellen közösen kifejlesztett védőoltás feltételes forgalomba hozatali engedélyének megadását javasolja az EU gyógyszerfelügyeleti hatóságának szerepét betöltő ügynökség. E védőoltás beadását 18 éves kor felett ajánlja. A megfelelő védelemhez két oltásra van szükség. Az AstraZeneca  tájékoztatása szerint az oltás első adagját követő második dózist legalább négy, legfeljebb 12 hetes különbséggel kell beadni. Az EME megjegyzi, hogy még nincs elegendő vizsgálati  eredmény arra vonatkozólag, hogy az oltás mennyire lesz hatásos az idősebb, 55 év feletti korcsoportcsoportban. Kevés adat áll rendelkezésre arra vonatkozóan is, hogy az oltóanyag milyen hatást vált ki várandós nők szervezetében - beoltásukat személyre vonatkozóan meg kell fontolni. Az oltóanyag normál hűtőszekrényben, kettő és nyolc Celsius-fok között tárolható, szállítható és alkalmazható a gyártástól számított legalább hat hónapon keresztül. Az EMA ez esetben is gyorsított eljárás keretében hozta meg döntését, az oltóanyag egyéves feltételes alkalmazását javasolva. Az Európai Uniós forgalmazást az EMA ajánlást követően az Európai Bizottságnak kell hivatalosan engedélyeznie. A testület várhatóan rövid időn belül bejelenti jóváhagyását. (Forrás: Híradó / MTI)

29 January 2021  Contract between European Commission and AstraZeneca now published. The contract the European Commission negotiated together with the EU Member States was approved on 14 August and entered into force on 27 August. It is financed by the Emergency Support Instrument. Through the contract, all Member States are able to purchase 300 million doses of the AstraZeneca vaccine, with an option for a further 100 million doses, to be distributed on a population-based pro-rata basis. The contract also allows the Member States to donate their vaccine doses to lower and middle income countries or to re-direct them to other European countries. (Source: ec.europa): https://tinyurl.com/y5m89vpw
Detail:
"1.9. “Best Reasonable Efforts” means     (a)   in the case of AstraZeneca, the activities and degree of effort that a company of similar size with a similarly-sized infrastructure and similar resources as AstraZeneca would undertake or use in the development and manufacture of a Vaccine at the relevant stage of development or commercialization having regard to the urgent need for a Vaccine to end a global pandemic which is resulting in serious public health issues, restrictions on personal freedoms and economic impact, across the world but taking into account efficacy and safety; and     (b)   in the case of the Commission and the Participating Member States, the activities and degree of effort that governments would undertake or use in supporting their contractor in the development of the Vaccine having regard to the urgent need for a Vaccine to end a global pandemic which is resulting in serious public health issues, restrictions on personal freedoms and economic impact, across the world".

January 29, 2021  The European Commission’s contract with AstraZeneca to supply COVID-19 vaccines includes Britain along with the EU as places where the Anglo-Swedish drugmaker should make its best efforts to manufacture vaccines for the EU. The contract is at the heart of a dispute over access to vaccines, after AstraZeneca announced last week it would fall short of delivering promised vaccines to the EU by March because of production problems in Belgium. The EU is standing its ground, pressing the Anglo-Swedish drugmaker to deliver the doses as promised in the contract. AstraZeneca has been making large quantities of its vaccine in Britain, but has said a contract it signed with the British government requires it to fulfil Britain’s order before it can send doses manufactured there abroad, including to the EU. The company agreed today to publication of its advance purchase agreement with the European Commission. The 41-page contract was published, although certain parts were redacted. The contract says that AstraZeneca must uses its “Best Reasonable Efforts” to manufacture the EU doses, but the parties disagree on what this means. A commission official said today it was an objective legal standard. The official pointed to a sentence in the contract by which AstraZeneca says it is not under any obligation to others that would impede complete fulfilment of the agreement’s requirements. AstraZeneca and the EU had signed a deal for up to 400 million doses of the vaccine. Last week, the firm unexpectedly announced cuts of up to 60% in supplies to the bloc, citing production problems at a Belgian factory, triggering a furious response from the bloc. The EU is now looking into a scheme to monitor and authorise export of vaccines, potentially blocking them if its own supply is not met. (Source: Reuters)

26 January / 8 January 2021  Questions and answers: COVID-19 vaccination in the EU (updated 26 January 2021) /Source: ec.europa/: https://tinyurl.com/ya2cp4lq
Detail: "The Commission has given the conditional marketing authorisation for the vaccines developed by BioNTech and Pfizer on 21 December, and Moderna on 6 January following EMA positive assessment of their safety, quality and efficacy. The EMA received an application for a marketing authorisation by AstraZeneca and Oxford University on 12 January. An opinion by EMA could be given by 29 January. No other vaccine producer has formally applied for a marketing authorisation to EMA. In order to accelerate the process, EMA has started a rolling review on the vaccine produced by Johnson and Johnson".

European Council
25 January 2021  The EU is leaving the door open for possible legal action against the pharmaceutical companies that have unexpectedly delayed the delivery of COVID-19 vaccines, European Council chief Charles Michel has said. “The EU intends to enforce the contracts signed by the pharmaceutical industry,” he told. Many leaders across the bloc have reacted strongly to the delays. (Source: EURActiv)

European Union
January 28, 2021  Vaccine utilization rates among EU governments continue to vary dramatically, even more than a month after EU approval of the first vaccine on Dec. 21. There is little evidence, however, that best practices have spread among member states.  As of Jan. 25, Denmark and Malta have managed to use more than 100 percent of the vaccines made available to them by the EU because they’ve been able to extract more than the officially designated number of vaccine doses from each vial. This stands in contrast, for instance, to the approximately 11 percent used in Bulgaria, 23 percent in the Netherlands, 49 percent in France, 62 percent in Germany, and 57 percent in the EU plus Norway as a whole.  The EU’s overall 57 percent usage rate of available vaccines suggests that some member states may be administering two-dose vaccines by reserving everyone’s second injection immediately on receiving the first - thus using only 50 percent of available vaccines. The COVID-19 vaccination rollout has also revealed how some European countries, such as the Netherlands, lack a centralized computerized vaccination register, which has evidently complicated the rapid mass rollout of a dual-dose vaccine by making it impossible for the government to keep track of progress. Other member states have been left relying on fax machines to collect vaccination data. These countries no doubt now regret their inadequate pre-pandemic investments in IT in the health care sector. Yes, Europe must insist that pharmaceutical companies  honor their existing contracts with the Commission and scramble to generate more vaccine supplies over the course of the coming months. If the AstraZeneca and also the Johnson & Johnson vaccines are approved for use in the EU in coming weeks, vaccine supplies should be drastically improved in the second quarter of 2021. (Source: ForeignPolicy)

January 28, 2021 Today the European Union said it would tighten oversight of exports after a row with AstraZeneca and Britain demanded that it receive all the shots it paid for. In the northern French region of Hauts-de-France, France’s second-most-densely-populated region, several vaccination centres were no longer taking appointments for a first jab. In several  other French regions, some online appointment platforms closed booking options. Spain’s Madrid region has ceased first vaccinations for at least this week and next and was using the few  doses it has to administer second shots to those who have had the first one. Germany’s most populous state, North Rhine-Westphalia, last week postponed opening its vaccination centres until Feb. 8, while the state of Brandenburg has also had to push back vaccination appointments originally scheduled for the end of January due to delivery delays. Germany’s top-selling Bild newspaper described the problems around procuring vaccines as a “scandal”. Tensions have risen as both New York-based Pfizer and AstraZeneca, headquartered in Cambridge, England, have had production problems. The EU scolded AstraZeneca yesterday and demanded the drugmaker spell out how it would supply the bloc with reserved doses of COVID-19 vaccine from plants in Europe and Britain. The EU publicly rebuked Anglo-Swedish drugmaker AstraZeneca for failing to deliver and even asked if it could divert supplies from Britain. “The reality is there is a shortage of vaccines,” the World Health Organization’s Europe director, Kluge, said. “Manufacturers and producers are working 24-7 to bridge the gaps and we’re confident the delays we are seeing now are going to be made up by extra production in the future.” (Source: Reuters)

27 January 2021  AstraZeneca company sparked the row by cutting EU vaccine supplies by 60 per cent. The CEO asked why supplies were being cut to the EU but not the UK, Soriot said that the EU placed its vaccine order late. 'The contract with the British government was signed three months before the one with the EU, therefore we had time to prepare and resolve similar issues. The UK and the EU have two different production chains and at the moment the British ones are more efficient because they started earlier.' Britain signed a contract for 300million doses of vaccine in mid-May, he revealed, but it took the EU until August to put pen to paper on the same deal. It appears that Germany, the Netherlands, France and Italy had originally been looking to do a deal with AstraZeneca in May - but were blocked by the EU, which insisted it take over negotiations. Explaining the delay in more detail, Soriot said the process involves pumping the virus into large vats of live cultures which then generate the vaccine. Because the process involves living things and many variables, the exact quantity of product is difficult to predict ahead of time - some vats will produce more, some less, and it takes time and a lot of tweaking to get all of them running at full capacity. According to Soriot, the company is meeting its obligations because it only signed a 'best effort' deal with the EU - promising to try and achieve 300million vaccines, but acknowledging that the complex process might be hit by delays. 'We are two months behind schedule,' Soriot admitted. 'But we are working to solve these problems.' As a final note, he said the vaccine has been developed on a non-for-profit basis, meaning any allegations that countries have paid to skip the queue are untrue. For now, it appears the EU has little choice but to sit and wait as the UK and US vaccine programmes ramp up while its own effort trails behind. Europe has been hit harder than any continent with coronavirus, suffering some 29.3million cases in total compared to second-place North America's 29million. Meanwhile the continent has amassed some 670,000 deaths compared to 610,000 in North America. The continent is now facing the grim reality that it will be March before its vaccine campaign can properly get underway. (Source: DailyMail)

January 27, 2021  "People receive the vaccine for free in the European Union, and this is something that significantly attracts refugees from Africa, Latin America, and Asia, therefore we expect an increase in illegal immigration," the Director-General of the International Centre for Migration Policy Development (ICMPD), Spindelegger said yesterday. The centre's experts indicated that they noticed new migration routes to Europe, for example through Lebanon to Cyprus or from Mauritania to the Canary Islands. (Source: MiddleEastMonitor)

.

Szólj hozzá!

Címkék: kína anglia magyarország vírus franciaország oroszország sweden virus who germany europe denmark italy országgyűlés asia malta africa mauritania bulgaria spain norway egyesültkirályság cyprus délafrika lebanon europeanunion egyesültállamok europeancommission szegeditudományegyetem southamerica thenetherlands europeancouncil northamerica nemzetinépegészségügyiközpont

2021. I. 24 - 29. II. Globalizáció. Vírusfertőzés és védőoltás adatok: United Kingdom, India, Japan, Mexico, Egyesült Államok - United States

2021.01.25. 00:27 Eleve

.

A 2021. január 16 - 23-i előzmények itt érhetők el:/ About the period of 16 - 23 January 2021):

https://tinyurl.com/yxf2xw9a

United Kingdom
29th January, 2021  The Novavax jab has completed Phase 3 trials, but still needs to get approval for use in the UK. Next, the jab has to be approved by the UK’s medicine regulator MHRA (Medicines and Healthcare products Regulatory Agency) before it can be administered. If approved, it would be the fourth coronavirus vaccine available in the UK and could be available in the second half of 2021. The vaccine is overall 89 per cent effective at providing protection against COVID-19. It appears to be 96 per cent effective against the original strains of coronavirus, and is also 86 per cent effective against the UK variant. It is unclear how effectual the jab is on coronavirus variants, such as the strains identified in Brazil. However,  one branch of tests was carried out in South Africa, where most cases were the South African variant. These tests showed that the jab was 60 per cent effective in preventing mild, moderate and severe coronavirus among those without HIV. Including the HIV positive participants, whose immune systems are compromised, overall the protection was just over 49 per cent. Clinical  data for early phases of the trial suggested the vaccine triggers an immune response greater than that in patients who have recovered from the disease. The Novavax jab is a protein adjuvant vaccine. It teaches your immune system to recognise the spike proteins on SARS-CoV-2 (the virus that causes COVID-19) - the Novavax vaccine injects them into your body directly. The spikes on their own can’t cause COVID-19: they are just the part of the virus that allows it to latch onto your cells. Your white blood cells attack the spikes, and then retain a ‘memory’ that will prepare your immune system in case of a real infection. (Source: BBC)

Jan 28, 2021  The UK has secured access to 367 million doses, enough for 5.5 per person More than 10 per cent of the UK’s population of 66 million has been inoculated against the virus, compared with about 2 per cent of the EU’s  447 million people. Prime Minister Boris Johnson said the UK was confident it would receive its full delivery of AstraZeneca vaccines after the EU demanded a share be delivered to the continent. French biotech company Valneva has begun large-scale manufacturing of its vaccine candidate in Scotland, even though the medication is yet to be approved by the UK’s medicines regulator. Health Secretary Hancock said the government had secured 60 million doses of the Valneva vaccine. The plant, set up with public funds, can produce 60 million doses by the end of the year.  "We will still have at least 10 tough weeks with a shortage of vaccine," German Health Minister Spahn said. Earlier this week, he pressed the EU to restrict exports of vaccines made on the continent, but the bloc instead opted to introduce a new "transparency mechanism" that forces manufacturers to notify authorities of vaccine shipments outside of Europe. Asked repeatedly if the British government would prevent AstraZeneca diverting essential vaccine supplies from Britain to the EU, UK Cabinet Office Minister Gove said the crucial thing was that Britain received its orders as planned and on time. (Source: TheNationalNews.uae)

Jan 28, 2021  United Kingdom quietly restricted Covid medicine exports to EU. The government last year placed export restrictions on medicines that could be used to treat Covid-19, despite criticising the EU for considering its own controls on vaccines produced on the continent. Around 100 medications that have been suggested as possible treatments were banned from export because they “are needed for UK patients”. The government imposed controls on the export of over 170 medicines to other countries since March last year. Two of the most recent additions to the list, added in November last year, were dabigatran etexilate, a blood thinner used on some coronavirus patients, and semaglutide, which doctors believe could help ease the impact of Covid-19 on patients’ hearts. The list also includes flu vaccines and a host of medicines associated with intensive care and long periods of intubation. 'We have restricted the exporting and hoarding [of] medicines that have been placed on the market in the UK for UK patients to ensure the uninterrupted supply for NHS patients,' the Department of Health and Social Care said. 'If medicines in the UK may be needed by our patients, they should not be diverted to other countries for financial gain.' Boris Johnson this week attacked the EU amid reports that the bloc was considering imposing export controls on the Pfizer Covid vaccine produced in Belgium. The prime minister said he strongly opposed “restrictions on the supply of drugs across borders” and “restrictions on vaccines or their ingredients across borders”.  (Source: TheWeek)

26 January 2021  EU health chiefs have demanded drug firms give them early notification when exporting Covid jabs to countries outside the 27 member states, EU health commissioner Kyriakides warned last night. 'The European Union wants to know exactly which doses have been produced by AstraZeneca and where exactly so far and if or to whom they have been delivered.' Ms Kyriakides said. The European Commission has accused the pharmaceutical company, which worked with Oxford University on the development of the Covid-19 vaccine, of failing to give a valid explanation for not delivering doses to the bloc. Liese, an EU lawmaker from the same party as Angela Merkel, said:  'AstraZeneca has been contractually obligated to produce since as early as October and they are apparently delivering to other parts of the world, including the UK without delay.' A senior EU official said the bloc had a contractual right to check the company's books to assess production and deliveries. The Anglo-Swedish drugmaker had received an up-front payment of 336 million euros from the EU when they struck a deal in August. The agreement for at least 300million shots was the first signed by the EU to secure Covid vaccines. AstraZeneca angered Brussels earlier yesterday by warning it would cut the number of vaccines it will deliver to Europe by the end of March from 80million to 31million due to 'supply issues'. Europe's vaccine roll-out has been hit by further problems as France's Pasteur Institute mothballed its jab yesterday. The UK could miss out on millions of doses of the coronavirus vaccine if the European Union suspends deliveries to countries outside the bloc. The UK is expecting to receive nearly 3.5million Pfizer doses within the next three weeks. Britain has ordered 40million doses of Pfizer jab. It means Pfizer - which has a jab-making plant in Puurs, Belgium - will be forced to tell EU officials about jab exports.  Earlier in January, Pfizer, which is currently the largest supplier of COVID-19 vaccines to the EU, announced delays of nearly a month to its shipments, but hours later revised this to say the delays would last only a week. 'The move would not, however, cut supplies of the AstraZeneca vaccine because the 'vast, vast majority' of their jabs are made in the UK'. UK has already ordered 100million doses and is expected to be first in line to get it once approved. The UK has already vaccinated more than six million of the most vulnerable against the virus, as it steams towards its mid-February target. Oxford / AstraZeneca expected to cost £2.23 per dose. The UK's full 100m dose supply could amount to just £223million. Vaccine battle took another twist last night when German papers reported EU officials could reject UK jab The papers said German officials now fear the European Medicines Agency (EMA), the EU's medicine regulator, may not approve giving the Oxford vaccine for usage in over-65s due to '8 per cent efficacy rates' . Oxford and AstraZeneca said there are no serious safety concerns about the vaccine. Phase three trial saw three out of  23,745 participants have 'serious adverse events' that were 'possibly' linked to the vaccine. All three have recovered or are recovering, and remain in the trial. The jab has already been approved in the UK, as well as Argentina, Dominican Republic, El Salvador, Mexico and Morocco, while Canadian officials have asked for more data before approving the vaccine. The EMA's approval of the vaccine is expected to take place in 29 January with first deliveries expected from February 15. (Source: DailyMail)

Jan 24 2021  The vaccination of domesticated animals might be required to halt further virus evolution and spillback events. Coronavirus can infect a wide range of domesticated animals - giving pets the jab is a "precaution," experts from the University of East Anglia, Earlham Institute, and the University of Minnesota wrote in the journal Virulence. Van Oosterhout, professor of evolutionary genetics at UEA, said dogs and cats can contract coronavirus - but that there are no known cases of them carrying it on to humans. He said: "Interestingly, the Russians have already started to develop a vaccine for pets, which there's very little information about." Tyler, editor-in-chief of Virulence, said: "Cats are asymptomatic but they are infected by it and they can infect humans with it". Prof van Oosterhout and Prof Tyler wrote the findings along with director of the Earlham Institute, Hall, and Ly of the University of Minnesota. (Source: TheU.S.Sun)

Asia

India
24 January 2021  India’s vaccine diplomacy. Nursing the South Asia neighbourhood, India is leveraging its position as a major provider of vaccines to reinforce ties across the South Asian neighbourhood, as January it tries to keep China out. Serum Institute of India (SII) and Bharat Biotech have reportedly stockpiled more than 70 million doses of vaccines and will scale up production to meet demands. India produces over 60 percent of the global vaccine requirement. Free shipments of AstraZeneca's vaccine manufactured by the SII have begun arriving in the Maldives, Bhutan, Bangladesh, Sri Lanka and Nepal. Doses have also been sent to Seychelles and Myanmar. The shipments are part of the government’s “Neighbourhood First” initiative, and will make India the first country to  deliver Covid-19 vaccines across South Asia to remind India’s neighbours that India will remain the first responder in a disaster situation - ahead of China, which has promised but not so far delivered. Delhi is considering giving away anywhere from 12 to 20 million shots to its neighbours in the first round of assistance over the next month. Bangladesh’s Health and Family Welfare Ministry announced it had ordered two million doses of Covishield. Under an agreement signed last November, Beximco, one of the largest Bangladeshi pharmaceutical companies, will also procure about 30 million vaccines from the SII on a commercial basis. Bangladesh has also held phase-3 trials for the Sinovac vaccine from China. The project has for now stalled for funding reasons. China has also tried to get a foothold with Nepal, which has also has outstanding issues with India. Beijing offered its Sinopharm shot to Kathmandu, but it is still awaiting approval for the roll-out. The Central Drugs Standard Control Organisation (CDSCO), India's drugs regulatory authority, has approved two coronavirus vaccines - Covishield, developed by AstraZeneca and Oxford University, and the locally developed vaccine COVAXIN, produced by Bharat Biotech. Several other countries, including Brazil, Morocco, Saudi Arabia, Dominican Republic and South Africa, have already made official requests to receive vaccines from India. (Source: rfi)

Japan
January 27, 2021  AstraZeneca Plc will license Japanese biotechnology company JCR Pharmaceutical, to produce some 90 million doses of its COVID-19 vaccine to help Japan avoid shortages and delays. The government in December agreed to buy 120 million doses of the vaccine developed by AstraZeneca and Oxford University with deliveries to begin in May. JCR Pharmaceuticals produces human growth hormones and a treatment for renal anaemia, among other drugs. By having the vaccine produced at home, Japan may be looking to avoid potential delays in deliveries. Japan is likely to begin inoculating its population from the end of February when it is expected to approve Pfizer Inc’s vaccine. It has ordered 75 million doses of that vaccine. (Source: Reuters)

North America

Mexico
28 January 2021  On Dec. 24, 2020, a national vaccination campaign was launched to immunize nearly 130 million Mexicans. Over 650,000 doses of the Pfizer-BioNTech vaccine have already been administered mainly to medical personnel. The Health Ministry signed deals with the U.S. pharmaceutical Pfizer for the purchase of 34.4 million COVID-19 vaccines. Likewise, 77.4 million doses will be acquired from the British AstraZeneca, 35 million from CanSino, 34.4 million from the United Nations' COVAX platform, and 24 million doses from the Russian-developed Sputnik V. Mexico's Foreign Affairs Minister Ebrard yesterday announced the arrival of COVID-19 vaccines produced by the German company CureVac to conduct phase three of clinical trials with 8,000 volunteers. CureVac's clinical trials will observe 36,500 volunteers worldwide, including patients from Argentina, Colombia, Dominican Republic, Panama, and Peru. Highlighting that the Mexican government's strategy was to allow phase three of clinical trials of different vaccine projects, Ebrard noted that the Chinese CanSino and the Belgian Janssen were already conducting research. Last December, the U.S. company Novavax also announced its intention to start phase 3 of clinical trials in Mexico and the U.S. with 30,000 volunteers. (Source:  TeleSurEnglish)

Egyesült Államok    United States
2021. 01. 29. A Johnson & Johnson amerikai multinacionális egészségügyi vállalat oltóanyaga mai tájékoztatásuk szerint összességében 66 százalékos védelmet nyújtott a Covid-19 betegség mérsékelt és súlyos formái, és 85 százalékos védelmet a legsúlyosabb tünetek kialakulása ellen, az Egyesült Államokban és hét másik országban végzett teszteken. Gorsky, a cég igazgatótanácsának elnök-vezérigazgatója ma kiemelte, hogy a védelem a Covid-19-betegség mérsékelt és súlyos formái ellen 72 százalékos volt az Egyesült Államokban, 66  százalékos Latin-Amerikában, s mindössze 57 százalékos Dél-Afrikában a beadást követő 28. napon. A hatékonyságot a klinikai kísérletek harmadik fázisa - amelyben csaknem 44 ezer önkéntes vett részt - eredményei alapján állapították meg. Az oltóanyagot csak egyszer kell beadni, nincs szükség második oltásra. A cég február elejéig meg kívánja szerezni a sürgősségi felhasználási engedélyt; az Egyesült Államokban várhatóan már a jövő héten benyújtjak a forgalmazási engedély iránti kérelmet. Célul tűzték ki, hogy rövid időn belül szállításra készen álljon az oltóanyag. (Forrás: Híradó / MTI)

28 January 2021  The US' COVID response was ranked 94th out of 98 countries followed only by Iran, Colombia, Mexico and Brazil in last place according to the Lowry Institute. To date, the US has recorded 25.6million cases and 429,125 deaths. Measured per million, the US has the eighth highest death toll in the world. New Zealand was ranked as the world's most effective handler. Vietnam came in second place, followed by Taiwan, Thailand, Cyprus, and Rwanda. Currently, the US is vaccinating 1.27 million people a day on average. Vaccinations began five weeks ago, but just 6.2 per cent of the US population have gotten their first doses of either Pfizer's or Moderna's two-dose vaccines. That comes to about 20.7 million having received at least one dose of the vaccine. About 3.8 million people have been fully vaccinated, according to the Centers for Disease Control and Prevention (CDC). Dozens of precious doses of the two vaccines have been wasted because no one could be found to take them before they spoiled, or due to careless errors like freezers getting unplugged. Collectively, Moderna and Pfizer have promised to supply 200 million doses by the end of March. More than 25.5 million infections have been reported in the US since the start of the pandemic. In January 26 Johnson and Johnson announced that it will likely publish results from phase three trials of its one-shot coronavirus vaccine next week. Its vaccine is cheaper and easier to store and transport which, along with the fact that it requires just one dose. It has a contract with the US for at least one million doses, and has pledged to distribute a billion doses globally this year. Fauci said that Johnson & Johnson's vaccine is being tested on the highly infectious 'super-covid' variants from South Africa and Brazil. But even if its results are positive, the FDA is not expected to clear the vaccine for emergency use until March, raising questions over why there must be an agonizing month-long delay. (Source: DailyMail)

January 27, 2021  Since the pandemic began a year ago, millions of conspiracies have spread over the Internet, fuelling misinformation about the coronavirus, its origins and the motives of those working to fight it. They include claims that Fauci and Gates created the pandemic to try and control people, that they want to profit from the virus’ spread, and that they want to use vaccines to insert trackable microchips into people. Gates, a billionaire who stepped down as chairman of Microsoft Corp in 2014, has through his Bill and Melinda Gates Foundation committed at least  $1.75 billion to the global response to the COVID-19 pandemic. That includes support for some makers of vaccines, diagnostics and potential treatments. Gates says he has been taken aback by the volume of “crazy” and “evil” conspiracy theories about him spreading on social media during the COVID-19 pandemic. (Source: Reuters)

.

Szólj hozzá!

Címkék: anglia brazil peru russia india taiwan japan sweden globalizáció china virus iran salvador panama mexico france belgium bangladesh germany vietnam srilanka canada scotland nepal argentina colombia seychelles thailand cyprus morocco newzealand unitedkingdom rwanda europeanunion dominica unitednations unitedstates europeancommission southafrica saudiarabia

süti beállítások módosítása